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Telomerase reverse transcriptase (TERT) is expressed by quiescent adult stem cells
(qASC) in numerous adult murine and human tissues but has never been explored in the adult
brain. Here, these data demonstrate that TERT+ cells in the adult mouse brain represent a novel
population of multipotent qASCs. TERT+ cells were localized to numerous classical
neuro/gliogenic niches including the ventricular-subventricular zone, hypothalamus and olfactory
bulb, as well as newly discovered regions of adult tissue plasticity such as the meninges and
choroid plexus. TERT+ cells expressed neural stem cell markers such as Nestin and Sox2, but
not markers of activated stem/progenitor cells, nor markers of mature neuronal or glial cells.
TERT+ qASCs also rarely expressed the proliferation marker Ki67, further confirming a quiescent
phenotype. When cultured, TERT+ cells behaved like brain stem cells by forming proliferative
neurospheres. Lineage tracing of TERT+ cells in adult transgenic mice revealed large-scale
expansion of TERT+ progeny and differentiation in multiple brain regions to diverse cell types.
Lineage-traced cells expressed markers of mature neurons, oligodendrocytes, astrocytes,
ependymal cells, microglia, and choroid epithelial cells, thus demonstrating the striking
multipotency of this stem cell population in basal tissue turnover. Finally, the neurogenic treatment
of caloric restriction (CR) in lineage tracing animals revealed a decrease in TERT-traced cell

signal within the median eminence (ME) of the hypothalamus, with no change in the arcuate
nucleus (ARC), when compared to unrestricted diet (UR)-treated animals. Single-cell RNA
sequencing of TERT-traced cells in mice administered CR treatment also revealed an increase in
the neuroprotective gene brain lipid binding protein (BLBP) in TERT-traced cells after 1 month of
CR. As neuroprotection is a classical response to inflammation, we then studied the role of TERT+
cells in the inflammatory process of aging. TERT+ cell numbers varied with aging across
neurogenic niches but remained a similar percentage of the full brain. However, TERT-traced cell
signal increased significantly with aging, although label retention decreased. Together, these data
demonstrate that TERT+ cells represent a new population of multipotent stem cells that contribute
to basal brain plasticity and regeneration.
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CHAPTER 1

REVIEW OF THE LITERATURE

This dissertation will describe the role of adult stem cells (ASCs) in the adult mammalian
brain and their role in the maintenance of neurons, glia, and other brain cell types. Section 1.1
will cover niches of the adult brain that contain ASCs, the process by which ASCs produce adultborn cell types, and the current methods of studying ASCs and their progeny. Section 1.2 will
compare the processes of adult neurogenesis and gliogenesis in humans and rodents and will
explain the current discrepancies in the field regarding the translation of mouse studies to
humans. Section 1.3 will detail the importance of quiescence signaling pathways in the brain and
their roles in the processes of ASC activation and differentiation. Section 1.4 will describe the
identification of telomerase reverse transcriptase (TERT) as a stem cell marker in multiple adult
mammalian tissues and the possibility of TERT as an ASC marker in the adult brain. Finally,
Section 1.5 will isolate the hypothalamus as a brain region of interest to the field of adult
metabolism and energy balance and provide reasoning for why the identification of a specific and
unique marker of ASCs in this brain region may provide insight into metabolic dysfunction during
dietary interventions such as caloric restriction (CR).
In Chapter 2 we will identify TERT+ cells in the adult mouse brain as quiescent ASCs
(qASCs) and detail their quiescence and multipotency throughout the adult brain. In Chapter 3 we
will study the role of TERT+ cells in the process of hypothalamic plasticity with both CR and aging
to learn more about these cells in the context of energy balance and metabolism. Further
information regarding the studies performed in this dissertation and signaling pathways of
relevance to both adult plasticity and metabolism are covered in the Appendices.

1

1.1. Adult Brain Plasticity – Significance and Function
The creation of adult-born cells in the adult brain allows for the maintenance of neural
pathways involved in learning, motor function, and metabolism, the upkeep of glial cell types
which are instrumental in proper brain function, and the replenishing of non-neuronal tissues
required for the proper transport of nutrients and growth factors. While the adult human brain was
not believed to generate adult-born neurons until the late 1990’s, numerous studies have since
provided evidence for neurogenic plasticity throughout our lifetimes (Section 1.2). Similarly, the
production of adult-born oligodendrocytes and astrocytes in the adult human brain has been
identified in recent years as well [1-3]. Together, adult brain plasticity encompasses the
generation of adult-born neurons and glia, as well as the integration of these newborn cells into
existing circuitry. In addition, the production of adult-born epithelial, ependymal, and endothelial
cells has also been observed in the mammalian brain (Section 1.1.5). These processes allow for
us to respond to various forms of learning, stress, exercise, olfactory cues, dietary changes, as
well as traumatic injury. Indeed, changes in the production of adult-born cells in the brain are
observed in various neurodegenerative and neurological diseases (Section 1.2.4) This section
will review previous research on adult neurogenesis, adult gliogenesis, and the turnover of tissues
in the adult brain made up of other cell types.
In the brain, adult neurogenesis, the process by which adult neurons are created,
encompasses one aspect of adult neural plasticity. The field of adult neurogenesis is still
conflicted regarding whether adult humans rely on quiescent adult stem cells (qASCs) to create
newborn neurons in the brain or if newborn adult neurons are birthed from a population of
proliferative neuronal precursors known as neuroblasts. In fact, debates are still ongoing
regarding whether adult humans can create fully integrating newborn neurons at all. Our
incomplete understanding of adult mammalian neurogenesis is linked to the limited time in which
of the field of adult neurogenesis has been studied. It was not until 1965 that the production of
newborn neurons in higher order vertebrates was discovered. Here, a pioneering study in rats
2

showed incorporation of the molecule 3H-thymidine into cells within the adult rat brain, specifically
within the dentate gyrus (DG) of the hippocampus [4]. 3H-thymidine is a radioactive nucleoside
that is incorporated into newly created strands of DNA. As DNA is naturally replicated during cell
division, the incorporation of 3H-thymidine into newly formed DNA indicates a cell that has divided
or resulted from a division. After 3H-thymidine treatment in adult humans, cells containing 3Hthymidine were found within a population of hippocampal neurons in the DG and it was believed
that these cells were proliferative after 3H-thymidine administration. This formed the argument for
the existence of adult neurogenesis in the mammalian brain. A second study was performed in
1977, replicating these results [5].
However, a study in 1985 slowed the field of adult neurogenesis. In this study, adult rhesus
monkeys were injected with 3H-thymidine and no newborn cells were found in the brain. It was
concluded that few to none of the adult rhesus monkey brain cells were formed following early
postnatal development [6]. The re-emergence of the study of adult neurogenesis occurred
following influential studies regarding the newborn production of neurons in adult songbird brains
[7]. Furthermore, additional evidence for adult neurogenesis as a process that not only produced
adult-born neurons but allowed for the integration of adult-born neurons into existing mossy fiber
tracts within the hippocampus of rat brains was established [8]. Functional studies also discovered
the rate of adult neurogenesis responded to levels of adrenal steroids in rats [9] and N-methyl-Daspartate (NMDA) signaling in tree shrews [10]. However, at that point in time we as a scientific
community had never observed adult neurogenesis in the human brain.
Finally, in 1998, a study examining brains from deceased humans treated with
bromodeoxyuridine (BrdU) prior to death identified cells in the human ventricular-subventricular
zone (V-SVZ) of the lateral ventricles and subgranular zone (SGZ) of the DG that contained BrdUlabeled cells [11]. This ingenious study provided evidence for the existence of adult neurogenesis
in the human brain by identifying cells in the brain that contained this thymine analog that could
only be taken up by cells that were replicating their DNA, which was correlated with the process
3

of mitosis. Indeed, activated stem cells and various intermediate neural and glial progenitor cell
types in the brain retain their proliferative capacity (as shown in Figure 1.1). BrdU has since been
a valuable utilized across the discipline to identify proliferating cells and their progeny. In the years
that have followed, much has been discovered regarding the processes of adult neurogenesis
and adult plasticity. We now understand much more about the stem cells that give rise to newborn
neurons and glia, the pathways that activate these processes, and the role of these adult-born
cells in responding to external stimuli that, as it turns out, are shaping our brains as a result.

Figure 1.1. Markers of adult neurogenesis in the mouse brain. Brain-region specific markers
are identified as SGZ or SVZ, indicating the regions where these markers are expressed.
Rounded arrows identify self-replicating cell types. Straight arrows indicate progression of
differentiation to mature neuron. Abbreviations: ASC (adult stem cell), TAC (transit amplifying
cell), SVZ (subventricular zone), SGZ (subgranular zone).

However, while 3H-thymidine and BrdU allow for the marking of proliferative cells and their
progeny in brain regions where stem cells are poorly understood, these studies were hindered by
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the downsides of the tools. 3H-thymidine induces cell-cycle arrest, apoptosis, and dosedependent DNA synthesis inhibition [12], while BrdU marks cells at varying levels depending on
the route of administration [13] and is taken up by cells during repair or apoptosis, as well as
during cell division [14]. More efficient labeling methods have been utilized recently, such as
labeling with 5-ethynyl-2’-deoxyuridine (EdU), but this molecule has many of the same issues as
BrdU [15]. This dissertation will propose a novel stem cell marker that can be utilized to mark
ASCs in the adult brain, which will not rely on proliferation or mark various other cell types.

1.1.1. Classical Neurogenic Niches of the Adult Mammalian Brain
Adult neurogenesis in the mammalian brain has been studied most thoroughly in the VSVZ and the DG of the hippocampus. These two areas of the brain were identified as areas of
proliferation and label retention in early studies of rats [4], mice [16], and tree shrews [10], before
they were identified in humans [11]. Additional mammalian species have since shown similar
patterns of neurogenesis, including sheep [17]. While expression of proliferation markers such as
Ki67 as well as BrdU label retention occurs in various other brain regions, the vastly heightened
amount of proliferation in these two regions and the neuronal identity of newborn cells, quickly led
to them being regarded as the only two neurogenic niches of the adult brain. Other niches have
more recently been identified, and for that reason the V-SVZ and DG will be denoted as ‘classical’
neurogenic niches. These two classical neurogenic niches contain quiescent adult neural stem
cells (qANSC), which undergo a combination of proliferation and differentiation to create neuronal
progenitors that will differentiate into adult-born mature neurons [18, 19]. Both the V-SVZ and DG
retain their neurogenic potential due to the presence of qANSCs.

1.1.1.1. The V-SVZ/OB Neurogenic Axis
In the V-SVZ, qANSCs are termed B cells (Figure 1.1) [19]. B cells express the astrocyte
markers glial fibrillary protein (GFAP) and glutamate aspartate transporter 1 (GLAST), proliferate
5

slowly, and give rise to all intermediate neurogenic cell types in the V-SVZ after mitotic inhibition
[19]. In a landmark study by Doetsch et al., the administration of the mitotic inhibitor cytosine
arabinoside (Ara-C) caused ablation of the proliferative C cells (proliferative transit amplifying
cells (also known as TACs)) and A cells (proliferative and migratory cells (also known as
neuroblasts)), leaving behind only B cells. After a few days however, the C cells began to return,
and A cells after that. Altogether, it was concluded that slowly cycling B cells must be creating C
cells, which in turn differentiate into A cells (Figure 1.1) [19].
While B cells are hypothesized to be qANSCs, the activation pathways wherein activated
ANSCs (aANSCs) are created, as well as the identity of these aANSCs remains unknown. B cells
differentiate via asymmetric mitosis into epidermal growth factor receptor (EGFR)-expressing
TACs, also known as C cells [20]. C cells then differentiate into the migratory intermediate cell
type of the V-SVZ known as neuroblasts or A cells which travel through the rostral migratory
stream (RMS) to the olfactory bulb (OB; Figure 1.2). The RMS is made up of migratory neuroblasts
and astrocytes, creating a niche wherein neuroblasts can travel and proliferate through large
swathes of neural tissue to the destination of the OB [21]. Within the granule cell layer (GCL) of
the OB, neuroblasts begin to lose expression of neuroblast markers and features and begin to
resemble immature neurons [19]. While many adult-born immature neurons will die before
maturation, most adult-born immature neurons will differentiate into mature neurons in the GCL
and integrate into existing neural circuitry [22, 23]. A small number of immature neurons will
become mature periglomerular neurons in the glomerular layer of the OB [24].
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Figure 1.2. The process of adult neurogenesis from the V-SVZ into the OB. GFAPexpressing qANSCs in the V-SVZ give rise to transit amplifying cells, which divide and
differentiate to form neuroblasts. Neuroblasts travel through the RMS until they reach the OB,
where they differentiate into immature neurons, and finally mature neurons.

While the ANSCs that generate mature adult-born neurons in the V-SVZ/OB axis are in
the V-SVZ, mature neurons resulting from adult neurogenesis are incorporated into the OB. The
OB functions to collect and relay messages from the olfactory epithelium (OE) regarding smell
[24]. One may then infer that the generation of newborn neurons in the OB allows for these
neuronal pathways to undergo upkeep throughout life. Indeed, adult neurogenesis in the VSVZ/OB axis allows for functional integration of adult-born OB neurons [24]. Accordingly, after a
4-week “pulse” of BrdU in adult mice, where BrdU was administered via the drinking water to label
proliferating or repairing cells, followed by a 3-week “chase” where BrdU+ cells and their progeny
could proliferate, migrate, and differentiate, exposure to odorants induced c-Fos expression in
BrdU+ periglomerular neurons [25]. In fact, approximately 17% of c-Fos+ cells were also BrdU+,
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indicating large-scale generation of functional neurons in the adult mouse OB [25]. Adult-born
neurons in the OB exhibited spontaneous synaptic activity and spiking activity only after
maturation, although throughout V-SVZ/OB neuronal maturation, each cell type exhibits
electrophysiologically distinguishable differences [26]. Mature adult-born neurons in the OB
exhibited electrophysiological properties of previously defined periglomerular cells and granule
cells, which were functionally affected by both GABA and glutamate [23]. Retrograde viral tracing
from the piriform cortex, where OB projection neuron axons reside, supports that these adult-born
neurons are integrated into the neuronal circuitry [25].
The functionality of adult neurogenesis in the olfactory system can be analyzed by the
abilities of 1) adult-born neurons to respond to olfactory cues and 2) the response of the adult
brain to produce differential levels of adult-born olfactory neurons based on the input from the
external environment. Odor deprivation studies where rats underwent naris occlusion showed that
reduced odor sensitivity decreased the complexity of newborn OB cells, while at the same time
increasing their excitability, indicating an activity-dependent system [27]. Similar findings from
mice housed in odor-enriched environments revealed that enrichment increased the number of
BrdU+ cells in the OB [28]. These newborn cells were found to express the mature neuron marker
Neuronal Nuclear protein (NeuN) at the same rate as mice without enrichment (~80%). The
increase in adult-born olfactory neurons was correlated with significantly longer olfactory memory
and odor recognition. This intervention did not affect neurogenesis in the SGZ or hippocampal
memory tasks. Similarly, other interventions that affect hippocampal neurogenesis such as
exercise did not affect neurogenesis in the OB [29].

1.1.1.2. The Dentate Gyrus of the Hippocampus
The DG of the hippocampus is the other major classical niche of adult neurogenesis in the
mammalian brain. The presence of proliferating cells in the adult DG was first discovered in adult
rats in 1965 with 3H-Thymidine [4]. These results were replicated in 1977, with electron
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microscopy analysis demonstrating that the newborn cells in this area were neurons [5]. By 1988
the neuronal integration of these newborn granule neurons (a mature neuronal population in the
hippocampus) could be traced with retrograde tracers to determine that adult neurogenesis in the
DG produced adult-born neurons that integrated within the existing mossy fiber tracts in the
hippocampus [8]. We now understand that within this niche, qANSCs within the SGZ produce
mature neurons through various steps of neuronal differentiation. Similar to the V-SVZ, radial glialike qANSCs begin the process of neurogenesis [18]. Also known as Type 1 cells, these qANSCs
sit within the SGZ of the DG and will remain quiescent until activated [18]. Upon activation, Type
1 cells will begin to differentiate into neuronal progenitor cells known as Type 2 cells. At this point,
the qANSC marker GFAP is no longer expressed [30]. Type 2 cells can then differentiate into
neuroblasts (Type 3 cells), which will further differentiate into immature neurons, and finally
mature neurons [31].
The hippocampus plays an integral role in learning and memory, mood, stress response,
and anxiety [32]. Unsurprisingly, the creation of new adult-born neurons within this brain region
therefore allows for the brain to respond to new instances of learning and memory and moodrelated stressors. The first example of the ability of the brain to respond to external stimuli such
as stress through changes in neurogenesis was in 1997, when Gould et al. measured label
retention in the tree shrew hippocampus after psychosocial stress [10]. This group determined
that stress decreased BrdU-labeled cells in the DG, indicating reduced adult hippocampal
neurogenesis [10]. In the time since, studies have shown that adult hippocampal neurogenesis
can also be increased via environmental enrichment, exercise, and learning [10, 33-39].
Integration of adult-born neurons in the hippocampus for functional response to external
stimuli requires newborn neurons to connect to the current synaptic framework. Two separate
groups determined that new adult-born granule cells in the DG integrated axons within existing
mossy fiber tracts in 1999 by utilizing retrograde tracers [40]. As adult-born neurons matured, they
were found to extend long axons throughout the hippocampus from the DG to field A3 [40].
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Injection of a retrograde tracer into the field A3 region resulted in labeling of BrdU+ adult-born
mature granule neurons, indicating that newborn neurons integrated into the hippocampal
synaptic pathways [40]. Furthermore, neurons in the cerebral cortex infected with pseudorabies
virus, another retrograde tracer, showed synaptic connection between neurons in the cortex, DG,
and CA3 [25]. Electrophysiological studies of retrograde marker-traced newborn hippocampal
neurons identified that mature adult-born neurons in this region respond to glutamatergic and
GABAergic inputs [41, 42], elicit similar electrophysiological signatures to mature granule neurons
in this region [43, 44], and produce c-Fos in response to external stimuli [45].
While adult-born neuronal electrophysiology and synaptic connectivity are well
understood, the relationship between adult neurogenesis and hippocampal functions such as
memory and cognition are only starting to be uncovered. For example, we understand that stimuli
such as exercise increases adult-born neuron generation, but what do these newborn neurons do
to support an environment where exercise was necessary? Is the process of neurogenesis
important to hippocampal function in times of increased exercise? This was first examined in
2001, when mitotic inhibition decreased hippocampal-dependent conditioning, examined via the
eyeblink memory test, wherein puffs of air are associated with additional stimuli and can blinking
can become trained through associated memory [46]. Mitotic inhibition did not have an effect on
the ability to navigate a Morris water maze [47], although there is a correlation between the spatial
memory performance in this test and the levels of hippocampal neurogenesis [48]. While there is
clear evidence that adult neurogenesis is impacted by neurogenic stimuli, we still do not fully
understand the role of adult hippocampal neurogenesis in cognition.

1.1.2. Non-Classical Niches of Adult Neurogenesis in the Mammalian Brain
Newly identified neurogenic niches have recently been discovered in addition to the two
classical neurogenic niches of the adult brain. These neurogenic niches are much less completely
understood than the V-SVZ and SGZ, due in part to the lack of a well characterized stem cell
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population in these niches. While lineage tracing studies and label retention studies have
identified the presence of proliferative and newly formed cell types, the stem cells that give rise
to these newborn cells are not well understood. These novel niches include the hypothalamus,
striatum, cortex, and OE. While the OE is not a part of the brain, the newborn neurons within this
neural tissue reach directly into the OB and integrate into the neural circuitry in this neurogenic
brain region. For that reason, the OE will be discussed in this section.

1.1.2.1. The Hypothalamus
The hypothalamus is a more recently identified neuro/gliogenic niche of the adult brain.
This niche contains two populations of stem cell-like cells, parenchymal oligodendrocyte
progenitor cells (OPCs) and tanycytes, radial glial-like cells that line the ventral third ventricle.
NG2+ and Olig2+ OPCs make up most of the proliferative cells within the hypothalamus, as
identified via EdU immunofluorescence [49]. These OPCs are located within the hypothalamic
parenchyma, including the arcuate nucleus (ARC) and median eminence (ME) [49]. ME OPCs
form self-renewing and multipotent clusters of stem-like cells known as neurospheres, with a
higher tendency to form oligodendrocytes than other mature cell types in vitro [50].
Transplantation of ME-derived OPC neurospheres into myelin basic protein (MBP)-null Shi mice
revealed expansion of these cells and the regenerative capacity of ME-derived OPCs in periods
of demyelination [50].

cells require additional study in the adult hypothalamus, as these

neuro/gliogenic cells may reveal themselves as the true quiescent stem cell population of the
basal hypothalamus and could shed light on the changes occurring during neurogenic and
gliogenic interventions.
Tanycytes, radial glial-like cells that act as stem cells and can receive signals from the
cerebrospinal fluid (CSF) and traffic them into the hypothalamic parenchyma [51]. Tanycytes line
the floor and ventro-lateral portion of the ventral third ventricle (V3V) and utilize extensions that
extend laterally to transport signaling molecules to neurons within the hypothalamus. These cells
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can be divided into four major subtypes - alpha 1 tanycytes (a1), alpha 2 tanycytes (a2), beta 1
tanycytes (B1), and beta 2 tanycytes (B2). Each of these occupies a specific area of the
hypothalamus and plays a unique role in the process of hypothalamic plasticity [52]. Alpha
tanycytes reside below ependymal cells at the dorsal portion of the V3V (Figure 1.1), with a1
tanycytes more dorsal than their a2 counterparts. Beta tanycytes reside on the floor of the V3V
(B2), and along the ventral portion of the V3V (B1). Importantly, the localization of tanycytes
changes from a rostro-caudal perspective, with fewer tanycytes in the rostral portion of the
hypothalamic V3V, and greater numbers near the caudal end [51]. The organization of
hypothalamic tanycytes allows for these subsets of tanycytes to play distinct roles in the process
of hypothalamic plasticity. For example, while both alpha and beta tanycytes are exposed to the
milieu of factors and nutrients within the CSF, only beta tanycytes are positioned to receive input
from the fenestrated capillaries within the median eminence [53]. As with B cells in the V-SVZ,
these cells are exposed to factors within the CSF and blood.
Tanycytes are currently hypothesized as a qANSC population in the hypothalamus, as the
proliferation and differentiation of tanycytes into adult-born neurons and glia appears in many
ways similar to the processes undergone by qANSCs in the SGZ and V-SVZ. In fact, hypothalamic
progenitors in culture act identically to hippocampal progenitor populations [54]. Tanycytes
express common markers of adult stem cells, such as Nestin [52], Sox2, and Vimentin [55] and
beta tanycytes will proliferate in vivo [55]. BrdU studies identified label-retaining tanycytes within
the V3V which expanded upon treatment with EGF and bFGF [56]. Additional studies on the
neurosphere formation properties of tanycytes reveal the ability to form multipotent and selfrenewing neurospheres in adult mice and rats [56]. Lineage tracing of Nestin-expressing cells in
the young adult (P35) mouse reveal BrdU+ traced cells nearby to these beta tanycytes [55].
However, due to the expression of Nestin by various adult brain cell types, the localization of
these newborn cells in proximity to the tanycyte layer has been required to identify them as
tanycyte-derived cell types [55, 57]. Metabolic dysfunction resulting from decreased production of
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newborn cells in the tanycyte-enriched ME has also identified beta tanycytes as a stem cell niche
important for metabolic function (Section 1.6.2).
It is important to note that while tanycytes have long been hypothesized as the major stemcell population of the adult hypothalamus, more recent data support the hypothesis that these
cells are largely quiescent and respond to injury but do not contribute to basal turnover. All
tanycytes utilize the unique identifying promoter, retina and anterior neural fold homeobox
transcription factor (Rax), which is only expressed within the brain in tanycytes [49] and can thus
be followed during lineage tracing experiments. Recently, Rax-traced cells in the adult
hypothalamus were found to be largely quiescent and not produce the proliferation effects within
the hypothalamus. While Rax+ tanycytes respond to neural injury in the form of a needle jab in
the ME, they were not found to give rise to any significant number of cells in the basal brain [49].
Intriguingly, another study by Chaker et al. identified insulin-like growth factor 1 (IGF-1) signaling
as a major pathway responsible for the continued neurogenic effects in the hypothalamus, as
decreased IGF-1 signaling increased the age at which hypothalamic neurogenesis declined [57].
Alpha tanycytes were especially reliant on IGF-1 signaling, as adult mice not treated with IGF-1
revealed decreased proliferation in the alpha tanycytes of the V3V and reduced numbers of alpha
tanycytes as well [57]. Together, these studies shed light on IGF-1 signaling as a possible
neurogenic modulation pathway required for basal turnover and utilized to prevent heightened
levels of proliferation from reducing the stem cell pool early in life.
Indeed, it was discovered that nearly all the mitotic cells in this niche were NG2+ OPCs
and Olig2+ OPCs, identified within the hypothalamic parenchyma and not in the ventricular lining
[49]. Single-cell RNA sequencing revealed that Igf1r signaling is necessary for tanycyte-led tissue
repair [49]. For these reasons, there remains controversy regarding whether tanycytes or a
currently undescribed subset of ASCs in the hypothalamus produce adult-born mature neurons
and glia in this niche. While newborn neurons continue to be produced in the adult hypothalamus
into adulthood and old age [57], tanycyte-derived ‘adult’ neurogenesis has mostly been studied
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in young adult mice (postnatal neurogenesis), where neurogenesis is higher in all brain regions
when compared to adulthood (~12 weeks).
Adult hypothalamic neurogenesis is hypothesized to respond to an adapting metabolic
and nutritional environment, allowing for newborn neurons to modulate feeding behavior. Appetite
is modulated by actions of orexigenic (hunger-inducing) and anorexigenic (appetite suppressing)
neurons that reside within the hypothalamus. Two major appetite modulating neuronal
populations in the hypothalamus are orexigenic Agouti-related peptide (AgRP) and Neuropeptide
Y (NPY) expressing neurons, and anorexigenic pro-opiomelanocortin (POMC)-expressing
neurons. These neurons are found in the ARC of the hypothalamus, where they are exposed to
metabolic signals including leptin and ghrelin through the blood stream or CSF. Activation of
AgRP neurons and subsequent NPY release to POMC neurons will stimulate hunger while
inhibiting appetite suppressing signaling.
Importantly, a combination of high fat diet (HFD) and central administration of ciliary
neurotrophic factor (CNTF), which can induce weight loss in obese rodents and humans,
stimulated cell proliferation within the feeding centers of the hypothalamus of adult mice as
identified via BrdU incorporation in adult animals [58]. Resulting newborn cells expressed
neuronal markers and following leptin injections also expressed phosphorylated Signal
Transducer and Activator of Transcription 3 (pSTAT3), signifying that these newborn neuronal
cells can respond to appetite-suppressing leptin. Furthermore, these newborn cells were also
characterized by expression of NPY or POMC, supporting their role as appetite-regulating
neurons. Co-administration of the mitotic inhibitor Ara-C blocked the effects of CNTF on
hypothalamic neurogenesis and long-term weight loss, highlighting the importance of adult
neurogenesis and cellular turnover in body weight regulation [58].
Overall, hypothalamic neurogenesis is thought to be constitutive in action which may
contribute to the neural flexibility of the hypothalamus to respond to HFD and other metabolic
interventions [59]. This is supported by research which revealed that progressive degeneration of
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AgRP neurons in adult mice due to the deletion of the mitochondrial transcription factor A (Tfam)
gene, does not affect food intake, due to a compensatory increase in newly generated cells [59].
These adult-born cells were able to differentiate into leptin-responsive AgRP+ neurons.
Importantly, while the progressive degeneration of AgRP neurons could be reversed through
neurogenesis in the hypothalamus, acute ablation of these cells through the anti-proliferation drug
Ara-C induced significant weight loss and anorexia, which could not be saved through basal
neurogenesis of AgRP neurons [58].
Hypothalamic neurogenesis is also be affected by various neurotrophic factors, a family
of signaling molecules that protect neuronal populations during survival and differentiation [60].
Brain-derived neurotrophic factor (BDNF) is one such neurotrophic factor which increases
neuronal survival in the adult canary [61] and rodent brain [62]. BDNF works to improve dendritic
branching and synaptic plasticity [63] throughout the adult brain. In the hypothalamus, BDNF
regulates both central energy balance via effects on hypothalamic pathways and adult
neurogenesis in the hypothalamus [64]. The ability of BDNF signaling in the hypothalamus to
regulate appetite [65], as well as energy expenditure via sympathetic innervation of adipose tissue
[66] may be dependent on changes in hypothalamic neurogenesis.
Taken together, hypothalamic neurogenesis plays a critical role in the upkeep of proper
energy balance and metabolism through adulthood. While the suite of factors that mediate
hypothalamic neurogenesis, the physiological stimuli for promoting hypothalamic plasticity, and
the exact markers of the ANSCs in this brain region have not been identified, the role of niche
stem cells and neurogenesis within this niche cannot be overstated.

1.1.2.2. The Striatum
The striatum is a principal component of the basal ganglia and plays an important
role in voluntary movement. The striatum also plays a critical role in the reward system and is
activated by social behavior and addictive drugs. The wide range of inputs that are available to
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the striatum support the possibility of a plastic niche, due to the brain’s ability to learn and unlearn
reward pathways. Indeed, there is evidence that human neuroblasts from the V-SVZ may migrate
to the nearby striatum instead of the olfactory bulb. Cells expressing typical neuroblast markers
such as doublecortin (DCX) and polysialylated-neural cell adhesion molecule (PSA-NCAM) have
been identified in the striatum [67]. Analysis of lipofuscin accumulation, an indicator of cell aging,
revealed that some immature cell types expressed low levels of lipofuscin which indicated
newborn cell types within the striatum [67]. Adult-born striatal neurons are transient, as
demonstrated by one study in the adult guinea pig which found that BrdU label retention in
newborn neurons born from a population of qANSCs residing in the striatum decreased in number
from 13 to 23 days, and could no longer be seen after 65 days in vivo [68]. Much remains to be
learned regarding plasticity within this niche, but the striatum retains plastic abilities into
adulthood.

1.1.2.3. The Cortex
The neurogenic potential of the SVZ and SGZ are highlighted by the distinct expression
patterns of proliferation markers in the adult mammalian brain. In these niches, expression of Ki67
and uptake of BrdU and EdU are markedly higher than any other brain region in the basal state
[69]. However, adult neural plasticity allows for response to various stimuli as well and
understanding the role of plasticity throughout brain regions where injury or disease are common
is important if we are to understand the full story of adult neural plasticity. The cerebral cortex is
composed of layers of neurons that are associated with higher level processes such as
consciousness, emotion, and memory [70]. In the songbird, cortical neuronal death results in
neuron replacement from slowly cycling endogenous neural precursors [71]. In the adult mouse,
selective degeneration of layer II/III pyramidal neurons followed by transplantation of multipotent
neural precursor C17.2 cells resulted in integration and differentiation into pyramidal neurons,
indicative of a regenerative potential in this brain region [72]. While this study indicated the
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potential for transplantation for neural regeneration, the role of endogenous stem cells in the adult
mouse brain in cortical neurogenesis remained unknown.
To analyze the potential of endogenous stem cells in cortical neurogenesis, apoptotic
degeneration of adult murine cortical neurons nearby to the neurogenic V-SVZ was performed in
adult mice. This experiment resulted in adult-born mature and immature neurons in the cortex
[73]. These cells expressed the migratory marker DCX, early neuronal marker Hu, and mature
neuronal markers such as NeuN after a 28 week study [73]. These cells appeared to migrate to
the cortex from the V-SVZ through the corpus callosum, as trails of BrdU+DCX+ cells were found
between the V-SVZ and cortex after only 2 weeks [73]. These newly created cortical neurons in
the adult mouse brain were able to integrate with thalamic cell types, as retrovirus injected into
the thalamus was identified in the adult-born cell types [73]. While there appears to be a
regenerative response made possible by the neurogenic V-SVZ, there is also evidence of
endogenous stem cells throughout the brain that may play a role in regeneration. While most
proliferative and label retaining cells in the mouse brain are found in specific areas, it appears as
though various brain regions, including the cortex, are not outside the influence of adult neural
plasticity and neurogenesis. The characterization of cortical stem cells will be further discussed
in section 1.1.4.

1.1.2.4. The Olfactory Epithelium
The OE is a neural organ within the nasal cavity that is directly connected to the OB via
the axons of olfactory sensory neurons (OSNs). OSN axons synapse with periglomerular neurons
and allow for the transfer of information regarding odorants to the central nervous system (CNS)
[74]. Adult neurogenesis is well-characterized in the OE, as OSNs are produced at high numbers
throughout adult life, and can regenerate following injury [75]. The relatively robust regenerative
ability of the OE lends credence to the neurogenic potential of this tissue, as the destruction of all
OSNs as well as other cell types within the OE often results in a complete regeneration of the
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tissue [76]. Two stem cell populations reside within the OE, globose basal cells (GBCs), and
horizontal basal cells (HBCs). GBCs are multipotent and can give rise to both OSNs and glial cell
types within the OE under basal conditions as well as following injury [77-79]. The production of
OSNs occurs via the differentiation of GBCs into transit amplifying cells (Ascl1+) to immediate
neuronal progenitors (Neurog1+) to late neuronal progenitors (NeuroD1+). These cells are highly
proliferative and give rise to a constant supply of adult born OSNs throughout adult mammalian
life, and are therefore easier to study than their counterparts, HBCs. This population of ASCs, the
HBCs, are a potentially quiescent population, as they proliferate rarely and regenerate only small
numbers of OE cells following injury [80]. Additionally, while these cells were found to proliferate
2 weeks post-injury, tracing of these cells via X-gal showed no additional proliferation of these
HBC-derived cell types after 5 months [80]. In fact, mice treated with methyl bromide to induce
OE lesions showed 5-fold higher numbers of GBCs labeled with BrdU when compared to BrdU+
HBCs [79]. However, although HBCs give rise to few cells following injury, they are able to
differentiate into all OE cell types, indicating multipotency supportive of an ASC cell type [80].
Uncertainty remains regarding the ability of GBCs to differentiate into HBCs, as conflicting
results have been observed. Schwabb et al. reported the differentiation of GBCs into both HBCs
and OSNs following injury although the process was not determined and due to the lack of any
protein markers separating these cell types, morphological analysis was required [81].
Contradicting these findings, a study wherein GBCs were grafted into injured OEs in vivo
concluded that GBCs did not give rise to HBCs [82]. These studies indicate GBCs and HBCs may
be two separate ASC types within the OE with similar but separate functions. The creation of
newborn OSNs throughout adult life, while not directly within the brain, affects the olfactory bulb
directly, and is of great importance to brain function and neural control of full-body processes [83].
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1.1.3. Gliogenesis in the Adult Mammalian Brain
Gliogenesis, the production of newborn glial cells such as astrocytes and
oligodendrocytes, is a prevalent process that occurs throughout the adult mammalian brain. This
contrasts with neurogenesis, which is restricted to a few specific niches after birth. Gliogenesis
encompasses both astrogliogenesis and oligodendrogenesis, the formation of newborn
astrocytes and oligodendrocytes, respectively. Adult astrogliogenesis occurs in the cortex, where
mature astrocytes divide to produce newborn astrocytes [84]. NSCs also produce newborn adult
astrocytes in the SGZ and V-SVZ [85, 86]. Unlike astrocytes, mature oligodendrocytes are unable
to divide. Oligodendrogenesis relies on OPCs to proliferate and differentiate into mature cell
types. Chondroitin Sulfate Proteoglycan NG2 (NG2)-positive cells in the adult CNS are a
population of oligodendrocyte precursor cells. NG2+ glial precursor cells (GPCs) can be found
throughout the adult mouse brain and provide evidence for the wide-spread process of
gliogenesis when compared to the niche-specific process of neurogenesis [87]. While the word
glia comes from the Greek word for “glue”, indicating that glial cells were merely the scaffold by
which neurons could operate, we now understand that glia are vital to all processes within the
brain.

1.1.3.1. Astrogliogenesis
Astrocytes are specialized glial cells characterized by several branched processes, which
contact blood vessels, synapses, nodes of Ranvier, and other astrocytes [88]. These cells are
found throughout the brain and outnumber neurons five to one, highlighting their importance in
adult brain function [89]. Astrocytes have various functions, including the transport of glucosederived lactate to neurons, which allow neurons access to increased energy supplies [90].
Although separate from neuronal excitability, astrocytes can also perform gliotransmission,
wherein they can be excited and release gliotransmitters such as glutamate [91]. Astrocytes also
serve as a vessel for the uptake of neurotransmitters glutamate, gamma aminobutyric acid
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(GABA), and more [92]. While neurons and oligodendrocytes cannot undergo mitosis, astrocytes
can be produced in the brain via mitosis of mature astrocytes or through the activation and
differentiation of qNSCs and GPCs [93, 94]. Further confounding the study of gliogenesis is the
fact that qNSCs in the adult mammalian brain are astrocytic in nature. These qNSCs, which have
been characterized most completely in the V-SVZ and SGZ, express most markers of astrocytes,
including GFAP, brain lipid binding protein (BLBP), and achaete-scute homolog 1 (ASCL1), also
known as MASH1 (mammalian Ascl1 homolog). This has complicated efforts to characterize
qNSCs and hinders our understanding of astrogliogenesis and neurogenesis. Much remains to
be discovered regarding astrocyte function in the adult brain and thus the role that astrocytes play
in the process of adult neurogenesis, as well as the importance of astrocyte production through
astrogliogenesis, cannot be understated (Figure 1.3).

Figure 1.3. Adult gliogenesis in the mammalian brain. All glial cell types are able to
regenerate within the adult brain, through stem/progenitor activation or mitosis.
Astrogliogenesis in the adult brain occurs via the division of mature astrocytes in the
cerebral cortex [84]. This process is restricted to times of stress, such as following brain injury
[95, 96]. In one study, lineage tracing of GLAST-CreERT2 x R26R-Bgal astrocytes in adult mice
following stab wound lesion in the adult mouse neocortex identified astrocyte-driven reactive
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gliosis and proliferation of astrocytes [95]. While these cells were proliferative and multipotent in
vitro, they only formed newborn astrocytes in vivo, indicating a restricted astroglial lineage of
these GLAST+ astrocytes within the cortex. For information on astrogliogenesis in the V-SVZ,
DG, and hypothalamus, see section 1.1.3.4.

1.1.3.2. Oligodendrogenesis
Oligodendrocytes are specialized glia cells which wrap myelin sheaths around the axons
of neurons to improve the conduction of action potentials [97, 98]. During development,
myelination of neuronal axons is accomplished by oligodendrocytes, but throughout life, it is
necessary to remyelinate axons through the regeneration of oligodendrocytes [99]. These
oligodendrocytes can be lost via natural degradation, injury, or numerous diseases. The brain will
therefore create adult-born oligodendrocytes through the differentiation of OPCs. OPCs are able
to proliferate, migrate, and differentiate, and unlike qNSCs which reside within specific niches,
OPCs can be found throughout the optic nerve [100] motor cortex, corpus callosum [101], and
cerebellum [102]. These cells can be identified via their expression of NG2 and PDGFRa [103].
A small population of B-cell derived OPCs also exist within the V-SVZ [104]. These cells retain
the ability to divide during basal states, although they proliferate at higher rates following injury
[100].
Interestingly, for proper oligodendrogenesis from OPCs, the functionality of adult
oligodendrogenesis was demonstrated in a study performed by Mckenzie et al, when the inhibition
of oligodendrogenesis via the deletion of myelin regulatory factor (Myrf) in OPCs in healthy adult
mice resulted in an inability to learn new motor skills [105]. Other groups have identified that the
loss of NG2 glia in adult mouse brains results in improper function of both neurons and glia and
can cause depressive behavior [106]. While these cells are clearly critical for proper functioning
of oligodendrocyte turnover and neuronal function, it was previously determined that NG2+ glia
account for 5-8% of the cells in the CNS [107]. These numbers suggest a huge role for OPCs,
but other studies have determined that yearly oligodendrocyte turnover to be 0.3% [108]. This
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raises questions regarding the identity and role of NG2+ cells in the adult mammalian CNS and
highlights current needs in the field.

1.1.3.3. Microgliogenesis
Glial cell types can be separated roughly into macroglia, which include astrocytes and
oligodendrocytes, and microglia (Figure 1.3). Microglia are derived from myeloid tissue in the yolk
sac, although the specifics are unknown, and are a population of specialized immune cells [109,
110]. Microglia move into the brain during development, where they remain throughout adult life
as the major cell type of the CNS-specific immune system [111]. Indeed, the brain has been
described as immune-privileged for this reason. While we now understand that the brain requires
extensive immunological pathways to regulate both immune health and neural plasticity, the
importance of microglia, which make up about 10% of the cells in the brain and 80% of immune
cells within the CNS, cannot be overstated [112, 113]. Microglia maintain surveillance throughout
the CNS and can become actuated to an inflammatory state by signals of infection and viral DNA
and RNA (reviewed in [114]). Additionally, these cells are required for spatial memory [115],
neuroprotection [116], proper synaptic activity [117], and neural plasticity and learning [118].
Microglia regenerate entirely via self-renewal and are not created through the actions of
any adult stem cells within the brain or myeloid progenitors from the periphery [119]. At a basal
state, microglia enter the cell cycle each day at about 1% in adult mice [120], 2.35% in adult
macaque [121], and 0.2% in adult humans [122]. After chemical ablation of 90% of microglia in
the brain via the CSF receptor 1 inhibitor PLX5622 or diphtheria toxin, the microglial population
was restored after 7 days of removal of the treatment. Most of these newborn Iba1+ microglia
were EdU+ and found in pairs, indicating that they had undergone mitosis to repopulate [123].
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1.1.3.4. Gliogenesis in the V-SVZ, SGZ, and Hypothalamus of the Adult Mammalian Brain
Adult gliogenesis occurs throughout the brain in a less restricted manner than adult
neurogenesis (see sections 1.1.3.1 and 1.1.3.2). However, the classical neurogenic niches of the
SGZ and V-SVZ have also been identified as major gliogenic areas. Within the V-SVZ, the anterior
SVZ (aSVZ) contains qANSCs that give rise to mature neurons in the OB [19], while the posterior
SVZ (pSVZ) serves to produce adult-born glia [124]. Retroviral tracing of cells within the postnatal
rat SVZ identified progeny within the cortex and striatum with distinct astroglial and
oligodendrocytic morphology. In this study, the cells within the SVZ with the potential to
differentiate into mature glia, termed glioblasts, migrated into parenchyma where they then
differentiated into astrocytes or oligodendrocytes [124]. Interestingly, in vitro analysis of the
postnatal dorsolateral SVZ revealed the ability of these cells to differentiate into both neurons and
glia [125].
Recent research has identified the cell types within the V-SVZ that have the ability to
produce adult-born glia, namely, platelet-derived growth factor beta (PDGFRB)-expressing,
GFAP+ qNSCs [93]. When traced over 30 and 120 days, these cells were observed differentiating
into neuroblasts, mature neurons, and oligodendrocytes. Additionally, deletion of PDGFRB from
GFAP+ cells in the V-SVZ increased activation of these cell types, as well as more mature
neurons in the OB and oligodendrocytes in the corpus callosum. Platelet-derived growth factor D,
which binds PDGFRB and is present within the CSF in basal conditions, prevented mitosis and
differentiation of PDGFRB+ progenitors, indicating that under normal conditions these cells are
largely held in quiescence. These studies also identified astrocytic progenitors in the septal side
of the SVZ, distinguishing niche-specific differences in the V-SVZ regarding gliogenesis [93]. For
additional information regarding gliogenic reprogramming due to signaling pathways, see
Appendix A.
The hippocampal DG also contains GFAP+ qNSCs which allow for the production of adultborn neurons and glia throughout life. Initially believed to be a rare process within the DG [126],
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adult gliogenesis is understood to occur at a similar rate to neurogenesis in the SGZ [127]. Here,
the number of asymmetric and symmetric divisions from qNSC to mature cell type differs between
neurons and astrocytes, which confounds lineage tracing and label retention studies [127].
Astrogliogenesis can be stimulated in the DG by running, which also increases neurogenesis in
this niche, indicating that both processes are dynamic [126]. In rhesus monkeys, labeling of
proliferation via 3H-thymidine identified astrogliogenesis in young, juvenile, and adult ages, with
an increase in the ratio of astrogliogenesis in adults when compared to neurogenesis [128]. It is
important to note that the marked decrease in adult neurogenesis in rhesus monkeys into
adulthood may overstate the amount of adult gliogenesis. Additionally, 3H-thymidine may have
marked dividing mature astrocytes in the brains of these animals. However, it is clear that adult
gliogenesis in the SGZ is an important process that cannot be overlooked.
The hypothalamus contains adult stem and progenitor cells that give rise to both newborn
neurons and glia. Adult gliogenesis has been understudied in the adult hypothalamus, yet new
evidence for the role of adult gliogenesis in this niche offer clues into the role of this process in
this niche. For example, lineage tracing studies with tanycytes identified traced astrocytes within
the hypothalamus [129]. After treatment with FGF2, newborn BrdU+GFAP+ cells were identified
as well [129]. Of note, the mouse line used for the basal state experiments in this study traced
GLAST+ cells in the adult mouse brain, and while tanycytes express GLAST, it is also a marker
of astrocytes. It is possible, therefore, that the traced GFAP+ cells were astrocytes from the start.
Further, BrdU+GFAP+ cells were identified within the tanycytic layer of the 3V, raising questions
regarding the astrocytic vs. tanycytic nature of these newborn GFAP+ cells [129]. Newborn
oligodendrocytes and microglia have been observed in the adult hypothalamus as well. NG2+ glia
in the adult mouse hypothalamus give rise to oligodendrocytes and neurons [130], and are
required for hypothalamic leptin sensing and body weight control (Section 1.5) [131]. Metabolic
interventions can induce proliferation of microglia as well, as HFD-fed adult mice show increased
microglia in the ARC [132]. Mitotic inhibition during HFD treatment prevented this microglial
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expansion and in addition, weight gain [132]. These studies indicate a role for gliogenesis in
energy balance in the adult mammalian brain.
Additional evidence of adult gliogenesis within the hypothalamus can be gleaned from the
amount of EdU+ cells that did not express NeuN, Hu, or other neuronal markers in studies where
gliogenesis was not specifically studied. In one study where 16-week mice were treated with BrdU
via intracerebroventricular (i.c.v.) injections for 7 days, the percentage of Hu+BrdU+ cells to total
BrdU+ cells in the hypothalamus were about 60% after 4 weeks [133]. Clearly, 40% of the
newborn cells in the hypothalamus were non-neuronal, indicating a stem, glial, endothelial, or
infiltrating cell type. Due to the astrogliogenesis, oligodendrogenesis, and microgliogenesis
observed in previously discussed research, it is highly probable that a number of these label
retaining cells were glia [49].

1.1.4. Identification and Analysis of Stem Cells in the Adult Brain
Stem cells differ from all other cell types in that they: 1) have the ability to produce multiple
mature cell types, and 2) retain the ability to divide and renew tissues for long periods of time.
There are two major denominations of stem cells, embryonic stem cells (ESCs), which are present
during development, and ASCs. Adult stem cells are often found within developed tissues and
give rise to mature cell types required for the long-term regeneration of that tissue. For example,
ANSCs are located in the brain and give rise to mature neurons and glia. ANSCs produce adultborn mature cells through the processes of activation, proliferation, differentiation, and migration.
ANSCs, naturally in a quiescent state, can become activated by cues from the CSF, blood stream,
or nearby cells. They will then divide either asymmetrically into one ANSC and one more
differentiated cell type or symmetrically into two ANSCs or two differentiated cells. These more
differentiated cells are no longer stem cells, as they are no longer multipotent, and will continue
differentiating to a specific mature cell type unless they de-differentiate.
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There are multiple populations of qANSCs in the adult brain. These cells serve to replenish
neurons, astrocytes, and oligodendrocytes. These cells are astrocytic in nature, and express the
astrocyte markers GFAP, BLBP, and GLAST (Figure 1.4). The identification of qANSCs in the VSVZ utilized the mitotic inhibitor Ara-C to identify quiescent cells that could produce newborn
TACs, neuroblasts, and neurons after destruction of these mitotic cell types. GFAP+ qANSCs in
the V-SVZ are radial glial-like cells, with extensions that contact both the CSF and vasculature
[134]. These cells are therefore able to respond to quiescent and activating signaling effectors
within these environments. Indeed, qANSCs will proliferate more often when treated with CSF
taken from young mice compared to aged mice [135]. GFAP-expressing qANSCs reside within
the DG as well. These cells give rise to intermediate and neuronal cell types distinct from those
within the V-SVZ, although they share many similarities between these qANSCs and the cells
within the V-SVZ. These cells were identified through 3H-Thymidine label retention studies. Here,
short experiments with 3H-Thymidine identified that this thymidine analog was incorporated into
GFAP+ qANSCs only, while longer studies led to label retention in intermediate Type D cells as
well [18]. Further studies of GFAP+ qANSCs within the DG have supported these findings and
identified cell types and cell markers that have expanded our understanding of qANSCs in the
adult mammalian brain [30, 136].
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Figure 1.4. Evidence for GFAP+ cells in the adult brain as a population of qANSCs.
Experimental outline of studies from landmark papers reporting the presence of GFAP+ astrocytelike cells in the adult mouse brain which are quiescent and give rise to intermediate progenitor
and mature neuronal cell types in the V-SVZ/OB axis and SGZ.
Other markers such as Nestin and Sox2 are also expressed by ANSCs. These markers
are not specific to ANSCs and are expressed by various other cell types throughout the brain.
EGFR, which is expressed by aANSCs in the V-SVZ, is also expressed by more differentiated
cell types, such as transit amplifying cells. These ANSCs, as well as the intermediate cell types
and mature cell types generated during neuro/gliogenesis depends on their localization within the
brain. In the DG, the process of neurogenesis occurs when ANSCs give rise to type II cells, type
III neuroblasts, immature neurons, and then mature neurons within the hippocampus.
Comparatively in the V-SVZ, ANSCs give rise to type C TACs, which differentiate into migratory
type A neuroblasts, which then migrate through the RMS to the OB, wherein they mature into
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mature neurons. V-SVZ ANSCs also differ from DG ANSCs in that they are exposed to the CSF
in addition to the bloodstream. The CSF contains a milieu of growth factors that serve to activate
or hold ANSCs in quiescence. Signaling factors in the process of adult neuro/gliogenesis will be
covered in section 1.2.
The study of qANSCs in vitro has illuminated the abilities of these cells to proliferate and
differentiate. When cultured with the growth factors EGF and FGF, qANSCs will proliferate and
form floating neurospheres [137]. Primary neurospheres can be formed from single cells or from
the plating of multiple cells per well [138, 139]. These studies elucidate the stem-like nature of the
cells used for neurosphere formation, as the ability to self-renew and to differentiate into multiple
mature cell types and are thus indicative of a stem cell like population. Self-renewal is measured
via neurosphere growth, which can be divided into neurosphere size and clonal secondary
neurosphere growth from isolated cells derived from primary neurospheres [140]. The size of
individual neurospheres indicates the proliferative ability of the cells within neurospheres, as each
neurosphere will grow only when the cells within that 3D cell structure are proliferating [140].
Individual neurospheres are composed of NSCs and differentiated cell types, as well as an
extracellular matrix (ECM) [140]. For that reason, growth within individual neurospheres can be
attributed solely to the cells within each sphere. Secondary neurospheres are formed after
dissociation of primary neurospheres and indicate that the cells derived from primary
neurospheres still retain the ability to replicate. Interestingly, both primary and secondary
neurosphere formation relies upon unknown factors supplied by the cells in culture, as single
NSCs and neurosphere-derived NSCs plated at a low density will often not form neurospheres
[141-144]. Additionally, the low proliferative capacity of qANSCs is a major drawback when
attempting to analyze the growth or label retention of these cells (see section 1.1).
The differentiation of neurospheres into mature astrocytes, oligodendrocytes, and neurons
is key to understanding the multipotent potential of neurosphere-forming cells. Importantly, even
before these cells are treated with differentiation factors, neurospheres are differentiating into
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various proliferative non-mature cell types [145]. While there is high variability between
neurospheres formed depending on cell types, growth factors, surface adhesion, and more, most
often differentiated cells reside within the core of the neurosphere and undifferentiated GFAP+,
SOX2+, and/or Nestin+ cells reside in the outer layers of the sphere [146, 147]. It is clear that
these cells are differentiating constantly, even before differentiation is induced via factor
administration. Therefore, we as a community must take care to understand the role of factors
coming from neurospheres and their role in differentiation versus the factors administered to
induce differentiation. Ultimately however, the ability of a small number of cells to generate large
numbers of proliferative and differentiation-capable cells points to the stem-cell like nature of
neurosphere forming cell types.
The identification of a cell type as a stem cell in the adult brain is often supported by the
ability of that cell/ cell type to form neurospheres in culture. However, it is important to recognize
the caveats intrinsic to neurosphere studies. It can be difficult to isolate a stem cell population of
interest due to the lack of a specific and unique marker for qASNCs in the adult brain. The first
step of any neurosphere study begins with the identification and isolation of a population of cells
wherein identification of neurosphere potential is required. Often, cells will be labeled via antibody
and isolated through FACS sorting. However, even through a combination of markers designed
to isolate only qANSCs (GFAP+/EGFR-/CD133-), it remains highly likely that additional
populations of cells, especially GFAP+ astrocytes may be within these populations. Indeed,
astrocytes or oligodendrocyte progenitors cultured with EGF and FGF can form neurospheres in
vitro, requiring extreme care when isolating and culturing cells believed to be qANSCs [148, 149].
Questions also surround the state of qANSCs exposed to the factors within neurosphere media.
This is because the gene expression changes in cells that make up neurospheres are more ESClike in nature than gene expression patterns of cells from the in vivo V-SVZ [150]. While
improvements are being made to neurosphere culture, including the production of in vivo
structures such as pinwheel structures in culture [151], it is important that we work to uncover the
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implications of neurosphere studies in the adult brain to verify that these experiments are
applicable to the adult brain.

1.1.5. Plasticity of Non-Neuronal and Non-Glial Cell Types in the Adult Brain
In addition to neurons and glia, the adult brain retains plastic abilities of cell types such as
epithelial cells, endothelial vasculature and associated pericytes, non-microglial immune cells,
and meningeal cells. The choroid plexus (CP) is a circumventricular organ composed of choroid
epithelial cells (CPECs) connected by tight junctions. CPECs surround large blood vessels and
meningeal cell types and separate the blood from the CSF within the ventricles. Together, these
tissues form the blood-CSF-barrier (BCSFB), which feeds the brain’s ventricles with water, growth
factors, and necessary nutrients, allowing for the production of CSF. Breakdown of the CP across
all layers occurs with disease or aging and leads to unwanted factors entering the CSF. To prevent
breakdown of the BCSFB, the adult CP regenerates under a basal state through the use of
proliferation [69, 152]. This may occur through the use of stem cells that reside within the CP, as
isolation and culture of CP cells leads to neurosphere formation and differentiation to neurons,
astrocytes, and oligodendrocytes [153]. In vivo experiments with EGF and FGF2 infusion result
in increased numbers of label-retaining BrdU+ cells in the CP. Additionally, implantation into
injured spinal cords of adult rats, CP-derived cells differentiate into GFAP+/GLT-1+ astrocytes
[153].
The meninges, which is contained within and around the brain, is not composed of
neurons or glia. Instead, the meninges contain blood vessels, lymphatic vessels, fibroblasts, and
additional unknown cell types. Stem-like cells are found in this organ as well, as identified through
the expression of Ki67, Nestin, DCX, and Sox2 [154]. Cells isolated from the leptomeninges,
made up of the arachnoid mater and pia mater also form neurospheres and can be subsequently
differentiated into neurons in vitro [155].
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The CP and meninges both facilitate the infiltration of immune cells from the bloodstream
into the adult brain. In addition, CNS-associated macrophages reside at parenchymal borders
within the adult brain [156]. While many immune cells in the blood are mature hematopoietic cell
types, there also exist hematopoietic stem cells (HSCs), multipotent stem cells that can be found
throughout bone marrow and peripheral blood [157]. Indeed, in adult mice which cannot develop
myeloid cells (PU.1-/- mutant mice), transplantation of HSCs revealed the differentiation of these
cells into NeuN+ neurons in the brain [158]. Additionally, HSCs can differentiate into epithelial and
endothelial cell types across numerous adult organs, including the liver, lung, and skin [159]. Due
to the ability of these cells to infiltrate within the brain, it remains possible that stem cells from
both the brain and the periphery can lead to adult-born reconstitution of the adult brain. Taken
together, it is clear that ASCs reside within the brain to give rise to mature cell types other than
neurons and glia.

1.2. Adult Neural Plasticity in Humans and Rodents – Similarities and Differences
The field of adult neurogenesis has exploded since the discovery of adult-born neurons in
the adult rodent. We now know that adult neurogenesis occurs in cows [160], dogs [161], lemurs
[162], and many more species [163]. The study of neurogenesis in rodent models has revealed
much about the inner workings of the mammalian brain. However, stark contrasts exist between
rodent and human brain development and adult neurogenesis. Adult mice and rats produce
newborn intermediate progenitor cells in the thousands each day in both of the V-SVZ and SGZ,
while human SGZ neurogenesis is still hotly debated, and the human RMS has not yet been
identified to produce OB neurons [164]. While there is much to be learned about human
neurogenesis from model organisms in the lab, measures must be taken to validate that research
allows for accurate and representative translational results from rodent models.
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1.2.1. Prenatal and Postnatal Plasticity
The first stage of brain development in both humans and mice is the formation of the
neural tube [165]. In humans the neural tube forms within the first tenth of the prenatal
development period (3-4 weeks into gestation), while in rodents neural tube formation occurs near
the mid-gestation point (9-10 days into gestation) [165, 166]. Neural development sees the
differentiation of the spinal cord and brain from this organ, a highly conserved process across
humans and rodents [167, 168]. While the process of neural development is highly conserved,
the ages at which these processes occur differs drastically at times between humans and mice.
Mice and rats have short gestation periods and have brains that continue to develop postnatally
in ways that occur in human brains while in the womb [169]. For example, the rodent brain peaks
in gliogenesis at postnatal day 7, while in humans this process occurs at 36wks gestation [169].
It is for these reasons that the age at which neurogenesis is studied must be taken into account
when comparing this process between humans and rodents. Studies that examine postnatal
animal brains must be sure to use animals at an age where they can be comparable to humans
at the same stage of human development. Indeed, various murine studies which utilize animals
under postnatal day 60 yet claim to have implications for adult human neurogenesis should be
analyzed with care and should be replicated with animals at an age of mature adult brain behavior
[55].

1.2.2. Differences in Ventricular-Subventricular Zone Plasticity
Under normal conditions in the mouse V-SVZ, the role of stem and intermediate cells is to
produce newborn neurons in the olfactory bulb. Due to the large size of the OBs and the role of
smell in the lifestyle of rodents, the importance of neurogenesis within this niche is clear [170]. In
fact, in the mouse brain, newborn neurons enter the OB daily [171]. The human olfactory bulbs in
contrast, are quite small. We humans rely on smell to determine if the oven is burning or whether
the milk in our refrigerator has gone bad, which pales in comparison to the reliance on smell that
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mice have, which include: finding food, locating mates, and avoiding predators [172]. It stands to
reason that the role of olfactory neurogenesis would be enhanced in mice when compared to
humans. In fact, it is still unclear whether olfactory bulb neurogenesis occurs in humans.
The human V-SVZ was identified to contain neuron-producing cells in vitro in the mid1990s [173]. After this, BrdU administered to humans revealed BrdU+ cells within the V-SVZ in
the adult brain [11]. Indeed, neurosphere culture of human V-SVZ cells mimicked the ability of VSVZ qANSCs to produce self-renewing, multipotent cells in adult humans [174]. The human VSVZ is unique in that the structural layout of this niche is less dense than in the mouse, with layers
that differentiate it from the mouse V-SVZ. Here, the astrocytic layer, where astrocytes and
qANSCs reside is lateral to the ependymal cells (layer I) that contact the CSF and the hypocellular
gap (layer II) where extensions from the astrocyte layer (layer III) and ependymal layer are spread
[175]. In mice (as in dogs and other primates), B-cells reside directly behind ependymal cells and
have shorter extensions that contact the CSF [175]. Interestingly, this hypocellular gap is also
present in cows [175]. These cells produce C cells lateral to the ventricle. In humans, the final
layer of the V-SVZ is identified as the transitional layer (layer IV), which separates the V-SVZ from
the brain parenchyma.
While similarities in the neurogenic potential of the V-SVZ exist between humans and
mice, questions remain regarding the human RMS, which feeds the OB with chains of
neuroblasts. Initial studies revealed proliferating cells between the V-SVZ and OB that expressed
neuroblast markers. While this study could not confirm the maturation of adult neurons in the OB,
they observed the human RMS, pointing to a human V-SVZ/OB axis [176]. However, subsequent
studies were unable to identify any human RMS after 18 months of age [177] or neurogenesis in
the OB of significant proportion to the DG [178, 179]. In fact, it is hypothesized that human OB
neurogenesis may occur in the OB, without the presence of the RMS [24].
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1.2.3. Differences in Hippocampal Plasticity
In the adult mouse hippocampus GFAP+ radial glial-like Type I cells, qANSCs, in the SGZ
give rise to mature neurons in the CA1 region [18]. These qANSCs differentiate and proliferate to
form Type II precursor cells, which in turn differentiate into Type III neuroblast cells [18]. Adult
hippocampal neurogenesis (AHN) concludes with the differentiation of neuroblasts into immature
neurons and finally mature neurons. This process decreases with age in both rodents and humans
[179], but can be increased with exercise, environmental enrichment, and learning [35, 38, 39].
These newborn neurons impact mood regulation and learning and memory [180].
AHN in the aged human brain (67-72 years) was discovered via the incorporation of the
thymine analog BrdU into cells within the hippocampus [11]. Because these cells were identified
as mature neurons via immunohistochemistry with the marker NeuN, it was concluded that adultborn mature neurons were located in the dentate gyrus [11]. Additional evidence for AHN in
humans is supported by studies showing the presence of Ki67+ cells [181, 182] as well as DCX+
neuroblasts [183-185]. Additional support for the presence and functional importance of AHN
were found when comparing disease-state and control brains. Brains from epileptic patients,
patients with Alzheimer’s disease, and brains following hypoxic-ischemic encephalopathy showed
heightened AHN [181, 184].

1.2.4. Hippocampal Neurogenesis – Controversy in Mouse/Human Data
The current methods of analyzing AHN have been called to the forefront recently, due to
marked differences in the amount of AHN identified by different groups and techniques. For
example, in direct contrast to the studies described above, decreased AHN was associated with
depression, schizophrenia, and alcoholism [186-188]. While these conclusions have significant
implications for human health, subsequent studies have shown the opposite effects of Alzheimer’s
disease [189, 190], epilepsy [191, 192], and depression [193] in AHN. In fact, a variety of
prominent researchers in the field have argued that AHN in humans does not occur in any
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meaningful amount in adulthood [194-196]. An initial study of adult human neurogenesis showed
BrdU incorporation in the adult human brain in the neurogenic V-SVZ and DG after a number of
months [11]. Further experimentation with neuronal uptake of 14C, identified that in humans born
before nuclear testing had begun, neurons showed uptake of this carbon isotype, indicating these
cells had arisen from cellular division after development [179].
More recent experimentation, which has relied heavily on immunostaining of proteins in
fixed human brain tissue, has yielded conflicting results. Evidence for the presence of adult human
neurogenesis was identified in 17-53-year-old control brains with the use of antibodies for the
stem cell markers Nestin and GFAP, proliferation marker Ki67, and neuronal marker NeuN.
Furthermore, the number of stem-like cells was decreased with aging, showing similarities to adult
neurogenesis in rodents [182]. Additional studies on postmortem human brains showed similar
features of adult human neurogenesis [189, 197]. However, other groups report that during
childhood, cells that express markers of adult neurogenesis are absent, when compared to young
postnatal brains [194, 195, 198, 199]. Additionally, the morphology and location of DCX+
neuroblasts was changed with aging, as the cells had less complex extensions and were found
outside of the traditional SGZ. These studies are in direct contrast to other groups who show
expression of markers of adult hippocampal neurogenesis into adulthood [190, 200]. Due to these
conflicting studies, the field of neurogenesis is currently at an impasse, with prominent
researchers on each side of the spectrum.

There remain major limitations to the study of AHN in humans. Notably, the tissues utilized
to study this process come with a myriad of issues. In mice and rats, perfusion with a fixative
allows for the tissues to be fixed at death, keeping the tissues well-preserved and in their natural
state. Not only this, but the tissues are able to be fixed for well-defined periods of time.
Additionally, due to the large number of antibodies for rodent tissue neurogenic studies, the
process of tissue preparation for antibody usage has been well-documented. In human research,
35

brains must be fixed and collected post-mortem, potentially hours after death. Tissues are then
processed and disseminated via biobanks, which may take long periods of time and may result in
tissues being fixed differently across studies. Fixation technique affects the markers that can be
identified via immunohistochemical or immunofluorescent studies, further complicating the matter
[190, 201]. Finally, it must be mentioned that human lifestyles are largely heterogeneous. Unlike
that of a lab mouse that is provided with the same food, water, enrichment, and social life
throughout its lifetime, humans have a plethora of other stimuli and external factors that may
influence differences in AHN. These differences may produce changes that can be difficult or
impossible to attribute to the study of AHN.
Finally, due to the intrinsically fleeting nature of type II and III cells, as their presence is
due only to type I cell differentiation, it has been common for studies to correlate the number of
DCX+, PSA-NCAM+, or NeuroD1+ cells in the adult hippocampus to the amount of adult
neurogenesis occurring within this niche. Label retention studies in the hippocampus will often
quantify BrdU-positive or EdU-positive neuroblasts, immature neurons, and mature neurons to
identify patterns of adult neurogenesis within this niche. There are additional questions that
cannot be answered through these methods. One question that pertains to both mice and humans
is: is the increase in neuroblast/ newborn neuron number due to proliferation of intermediate cell
types, qANSCs, or both? To study adult neurogenesis, we require knowledge of the intermediate
cells as well as the qANSCs that supply them. Additionally, while the expression of DCX has
classically been used as a marker of neuroblasts in the V-SVZ and SGZ in both humans and
rodents [190], there is recent evidence for the possibility that DCX is a promiscuous marker that
is expressed by various human neuron populations, but not immature neurons [202].
Taken together it is clear that work must be done to bring the field of AHN to a point where
human brain studies can be consistently compared, be that through tissue processing, staining
techniques, and marker utilization.
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1.3. Signaling Pathways Involved in Adult Plasticity
The adult brain has access to important circulating factors from the CSF and blood such
as growth factors and neurotrophic factors, which govern a variety of processes, including adult
neuro/gliogenesis. Growth factors such as EGF, FGF, and nerve growth factor (NGF) can activate
qANSCs and intermediate cell types or hold them in quiescence and are directly associated with
proliferation, growth, and regeneration of tissues [137, 203, 204]. Neurotrophic factors, such as
BDNF are essential for the survival and differentiation of neuronal cell types [205]. In brain regions
exposed to the ventricular system, such as the V-SVZ and hypothalamus, CSF from young
animals can induce neural plasticity, even in cells from aged mice [135]. Therefore, it stands to
reason that the changes observed in adult plasticity with aging, with various metabolic
interventions, or during certain disease states, may not be due to changes in the stem/
intermediate progenitor cells themselves, but rather the signals acting upon them. This section
will provide evidence for the importance of signaling pathways involved in adult plasticity.

1.3.1. Niches Involved in Secreting Neurotrophic Signals: The Blood Cerebrospinal Fluid Barrier
and the Blood Brain Barrier
The BCSFB is created by the choroid plexus, a circumventricular organ present in all four
of the brain’s ventricles. This organ is composed of an outer layer of epithelial cells, which are
joined by tight junctions, so that any movement between the CP and the CSF requires transport
mechanisms in the cell membrane of these CPECs. Within the CP are fenestrated blood vessels,
which supply blood to CPECs to supply their intense supplies of mitochondria, as well as the
nutrients, water, and factors required for production of the CSF by the CPECs [206]. While still
poorly understood, there also exists an inner layer of meningeal tissue that forms within the
choroid plexus and may serve to protect the brain during infection [207].
An elegant study conducted by Silva-Vargas et al. outlined the natural interplay between
factors within the CSF on qANSCs in the V-SVZ and highlighted the significance of circulating
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factors on neurogenesis [135]. In this study, qNSCs, aNSCs, and TACs were grown separately
and exposed to the growth factor EGF or the lateral ventricle choroid plexus secretome
(LVCPsec). It was observed that exposure to the LVCPsec induced proliferation and sphere
formation in qNSCs and aNSCs at significantly higher levels than control or EGF-containing
media. This was not the case for TACs, which had similar levels of growth when exposed to EGF
or the LVCPsec, indicating that TACS, more differentiated than qNSCs or aNSCs, had lost the
ability to respond to a variety of stimuli. Furthermore, exposure of aNSCs, but not qNSCs or TACS
isolated from aged mice to the LVCPsec of young mice increased cell proliferation when
compared to the LVCPsec of aged mice. A huge number of factors are found in the LVCPsec,
which still need to be fully understood. However, it is clear that of these factors there lies a fine
balance of activation and proliferation of stem and intermediate progenitor cells [135]. This study
identified bone morphogenetic proteins (BMPs) within the CSF that modulated the growth of
NSCs in vitro. BMPs play a role in adult neural plasticity throughout the adult brain and are
important for quiescence and activation signaling in both ventricular niches and niches without
direct access to the CSF. The role of BMPs in neural plasticity is discussed in Appendix A.
The blood brain barrier (BBB) consists of continuous nonfenestrated blood vessels
connected with tight junctions, and the associated neural cells that form the neurovascular unit
(NVU) [208]. The NVU is composed of smooth muscle cells, pericytes and astrocytes. Together,
the NVU works to keep transcytosis levels low and prevent molecules from the blood from
infiltrating into the brain [209-212]. Similarly to the contact between qANSCs and the CSF in the
V-SVZ, qANSCs in the V-SVZ and SGZ utilize extensions to contact and interact with the blood
supply through the BBB [213]. These connections allow for factors such as pigment epitheliumderived factor to upregulate Notch signaling in qANSCs [214]. As with the effects of aging on the
LVCPsec, BBB breakdown with aging in the SGZ [215] and V-SVZ [216], consisting of decreased
flow rate and leaky blood vessels, occurs in tandem with decreased neurogenesis [217, 218].
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1.3.2. Activation and Quiescence
The first stage of adult neuro/gliogenesis begins with the activation of a quiescent stem
cell. Quiescence is characterized by cell cycle arrest, commonly at the G0 cycle checkpoint [219].
The quiescence of classical qANSCs is supported by the survival of GFAP+ qANSCs during
treatment with the anti-mitotic drug Ara-C [19]. While quiescent cells are held in cell cycle arrest,
it is not for a lack of cellular activity. qANSCs utilize glycolysis at high levels when compared to
more differentiated neuronal cell types, which require oxidative phosphorylation to fuel action
potentials and synaptic vesicle recycling [220]. Quiescent cells also overexpress transcriptional
repressor genes such as REST to suppress ribosome biogenesis [221]. qANSCs additionally
repress the expression of Sox2, Pax6, and Ascl1, activation and fate-determining factors
associated with more differentiated cell types [219, 222]. In fact, ingenious methods of inactivation
of these activating molecules include competitive binding of DNA, as is the case with FOXO3,
which outcompetes ASCL1 and induces quiescence [223]. Activation also occurs in conjunction
with the downregulation of inhibitory proteins like REST or ID4, allowing for transcription of Sox2
and Pax6. then leads to the generation of more differentiated progenitor cells through asymmetric
or symmetric proliferation and differentiation. This results in intermediate progenitor populations,
which will differentiate along a predetermined circuit, resulting in a newborn mature cell type.
Moreover, quiescent stem cells may also be acted on by quiescent factors, which work to keep
them quiescent. These signals are often found together, highlighting that the interplay between
factors that induce activation or quiescence is critical for proper adult brain upkeep and tissue
turnover.
Importantly, and in support of the idea that the qANSCs in the adult V-SVZ and SGZ are
highly similar, many signaling morphogens and growth factors induce neurogenesis (or prevent
it) in both niches. In cells derived from the adult mammalian brain, the neurotrophic factor BDNF
increases neurogenesis within the DG and V-SVZ [224, 225]. The morphogen sonic hedgehog
(Shh) also acts on the SGZ and V-SVZ in similar ways, with decreased neurogenesis occurring
39

when Shh signaling was interrupted in the DG [226]. Shh was found to act on both qANSCs and
neuroblasts in these niches [227, 228]. Notch signaling works to prevent aberrant neurogenesis,
causing the exit from the cell cycle by NSCs in the adult SGZ [229, 230]. Finally, the Wnt signaling
pathway is critical for neurogenesis in the DG [231] and V-SVZ [232]. Taken together, a variety
of signaling molecular and pathways are required for the proper functioning of adult neurogenesis
in the adult brain.

1.4. Telomerase Reverse Transcriptase (TERT)
The ribonucleoprotein telomerase synthesizes repeats of telomeric DNA to prevent
chromosomal damage in replicating cells [233]. Telomeres are structures at the ends of linear
chromosomes made up of telomeric DNA and proteins [234]. Telomeric DNA is made up of
multiple tandem repeats (5’-(TTAGGG)n-3’, followed by a G-rich tail of 150-200 nucleotides [235].
Telomerase reverse transcriptase (TERT) is the enzymatic component of telomerase [236]. The
TERT gene is made up of 15 introns, 16 exons, and a promoter core at chromosome 5p15.33 in
humans [237]. This gene is 42kb long and can encode any of 22 mRNA isoforms [238]. The RNA
component of telomerase is called Telomerase RNA Component (TERC; chromosome 3q26) and
is essential for the production of these telomeric repeats [239]. TERC and TERT, as well as a
variety of auxiliary proteins are required for proper formation and function of the telomerase
complex [240]. These accessory proteins include dyskerin, NOP10, NHP2, GAR21, p23, and
HSP90 [241]. Together, TERT and these proteins work together to bind TERT to TERC and to
telomeres (Figure 1.5).
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Figure 1.5. Organization of the telomerase complex and telomere associated proteins.
TERT and TERC are bound through the actions of ATPases and during S phase of the cell cycle,
this complex binds the shelterin protein complex on the telomere. The telomerase complex then
acts to extend telomeres through the actions of TERT and TERC.

While TERT expression is undetectable in most somatic cells in postnatal stages, this
protein has been identified in a subset of highly proliferative adult somatic cells in both mice and
humans. TERT has further been identified as a marker of stem cells in a quiescent state across
various adult mouse tissues. The reason that both highly proliferative cells and quiescent stem
cells in the adult body express TERT is currently unknown. It is hypothesized that within highly
proliferative cell types, such as cells within the epidermis of the skin, TERT is expressed at levels
that will allow for repeated telomere extension and continued proliferation but at low enough levels
to prevent cancer, and that in quiescent cell types such as qANSCs, TERT is expressed to fulfill
another role. For that reason, it is important to understand both canonical and non-canonical roles
of TERT. Overall, it is clear that understanding these cells would lend significant value to
discovering the regeneration of adult tissues.
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1.4.1. Canonical Roles of TERT
Telomerase functions to elongate telomeres after they are shortened following cell division
[234, 242]. Most adult somatic cells do not express telomerase [243]. In most somatic cells,
proliferation will cause shortening of telomeres, ultimately concluding with cellular senescence
[244]. It is for this reason that shortened telomeres occur with aging [245, 246]. In addition to the
“end-replication problem”, telomeric DNA can be damaged and shortened by factors such as age,
diet, stress, and more [247-249]. Upon senescence, the cell will utilize the checkpoint factors such
as p16INK4a to prevent cell apoptosis or a cancerous phenotype [250, 251]. However, while the
cell may avoid death or oncogenic activation, senescence will prevent the cell from proliferating
again [252, 253]. In tissues where increased senescence occurs during aging, regeneration and
repair are hindered and tissue function diminishes [254]. Therefore, the function of telomerase is
vital for cells that require high levels of proliferation, as senescence or oncogenic phenotype can
result when telomeres reach a dangerously short length [254].
High levels of telomerase activity and expression of both TERT and TERC are hallmarks
of development. Here, telomerase functions to prevent senescence in ESCs [255]. While in
cancerous cells telomerase functions to force immortality and unlimited proliferation, ESCs are
able to proliferate and differentiate without becoming cancerous [256]. Importantly, TERT is
expressed in around 90% of cancers, and is utilized for the unlimited proliferation of cancerous
cells. The role of TERT in cancer has been covered in depth elsewhere but will not be a topic of
interest here [257]. In humans, telomerase activity is reduced to undetectable levels from the
neonatal period onward except for in certain cell types [255]. Section 1.5.2. will cover these tissues
in more detail. As mammalian aging is directly correlated to telomere shortening, the loss of TERT
and telomerase is of importance to our understanding of tissue regeneration and turnover.
Telomerase activity in humans is highly regulated by the expression of TERT, the ratelimiting subunit of telomerase, as TERC is expressed ubiquitously in all tissues [258, 259].
Regulation of the TERT gene at the transcriptional level as evidenced by multiple promoter
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binding sites in the hTERT gene [260]. TERT mRNA is also regulated by pre-mRNA alternative
splicing, which can affect telomerase activity [261]. Additionally, while TERC expression remains
constant throughout differentiation of mouse erythroleukemia cells, mTERT expression
undergoes changes throughout differentiation [259]. The discovery that telomerase activity was
identified in immortalized cell lines where it prevented telomere shortening and chromosome
instability [262] was integral to the development of TERT overexpressing immortalized cell lines
[263]. TERT-immortalized cell lines include esophageal cells [264], fibroblasts [265],
keratinocytes [266], and more. As TERC is expressed ubiquitously throughout the body, TERT
overexpression is all that is required for immortalization. Importantly, TERT overexpression-based
immortality does not cause major changes in cell physiology and cell cycle control. However,
whether TERT overexpression affects non-canonical roles of TERT in these cell types is still not
understood.

1.4.2. TERT Marks Adult Stem Cells in Human and Mouse Tissues
The role of TERT as a telomere-restoring protein supports the findings that tissues and
organs where TERT is expressed often contain rapidly renewing cell types. This has been
observed in both humans and mice [259, 267]. However, more murine tissues express TERT than
in humans [259, 267]. In the adult mouse, mTERT mRNA expression has been identified in the
brain, heart, lungs, liver, kidney, intestine, muscle, skin, testes, spleen, and thymus [259, 268].
Some adult tissues, such as the brain, exhibit TERT mRNA expression, but have low telomerase
activity [268, 269]. Analysis of hTERT transcripts showed expression only in the spleen, testis,
thymus, and bone marrow, with lower expression in the brain and uterus [267]. Support of hTERT
expression in various human tissues can be found by analyzing Dyskeratosis congenita, a
disease that results in the dysfunction of telomerase [270]. Patients exhibit issues with
regeneration of the skin, gut, and bone marrow, and have reduced telomere length when
compared with non-affected individuals [271]. Mouse TERT (mTERT) transcripts in the same
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study were identified in more tissues than humans TERT (hTERT), including the mouse liver,
spleen, testis, muscle, kidney, heart, thymus, lung, brain, bone marrow, and uterus [267]. It is
important to note that lab mouse telomeres are significantly longer than human telomeres, which
could be a confounding factor when interpreting TERT expression or telomerase activity between
these organisms [272].
The skin is one such organ where the high turnover of epidermal cells requires proliferation
to support the constant cell death. Here, human keratinocytes utilize telomerase activity to prevent
senescence of the mitotic cells within this highly regenerative tissue [273]. While this discovery
was made by analyzing telomerase activity, other studies have demonstrated the expression of
hTERT in human skin samples from young, aged, and photo-aged skin [274]. Of note, hTERT
levels are increased with photo-aging, indicating that the skin responds to sun damage by
increasing TERT expression. Similarly, patients with psoriasis show increasing levels of TERT
with psoriatic severity, indicating a role for TERT in injury response as well as basal turnover
[275].
Immune cells are another cell type that exhibits TERT expression into adulthood in
humans. B and T cells, also known as lymphocytes, migrate throughout the body through the
bloodstream and perform immunological functions. Lymphocytes rely on proliferation to perform
their immunological functions and are a highly proliferative cell population. For this reason, it is
not surprising that these cells exhibit TERT expression and telomerase activity [276, 277]. While
telomerase activity is increased transiently in T cell cultures, hTERT expression is decreased with
differentiation of T cells [278]. This paired with the characteristic decrease of telomerase activity
of T cells with aging, supports the function of telomerase to allow for proliferative ability of mitotic
cell types with an age-associated decrease [279]. In fact, induction of TERT expression in T cells
improves the proliferative potential of these cells [280].
Other adult somatic tissues where telomerase activity is present include the endometrial
tissue and hair follicles, which rely on proliferation for basal upkeep [281, 282]. While telomerase
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activity is an indicator of the presence of TERT, the identification of TERT+ cells was unknown
until recently. TERT+ cells have now been identified within the endometrium [283] and intestinal
crypts of adult mice utilizing mTert-GFP and mTert lineage tracing transgenic mice [284, 285].
However, unlike the skin or immune system where TERT was expressed by rapidly proliferating
cell types, TERT+ cells in the endometrium and intestines were identified to be qASCs [284, 285].
These cells make up a small population of the proliferating cells within these regions and are often
non-proliferating. TERT+ cells were identified in proximity to more differentiated intermediate
progenitors but did not express markers for these cell types [284, 285]. In the intestine TERT+
cells give rise to various mature cell types after a lineage trace and respond to injury by
proliferating [285]. Similarly, in the liver lineage traced TERT+ cells replenish the liver’s
hepatocyte population, are self-renewing, and respond to injury by regenerating the lost cell types
[286]. More recently, TERT+ cells were identified as ASCs in adult mouse long bones [287] and
adipose tissue [288]. Telomerase activity and TERT expression have also been identified in the
adult brain, which will be covered in section 1.5.3.
It is important to note that while many TERT studies in vivo rely on transgenic mice, there
are differences between mice and human telomerase activity, TERT expression, telomere length,
and even transcriptional control that may result in imperfect translation of TERT research to
humans. To start, murine telomerase activity is more widespread throughout tissues than in
humans [267]. While hTERT mRNA expression is absent in the skeletal muscle, kidney, and lung,
each of these tissues in the 8-week-old mouse exhibits mTERT expression [267]. This species
difference is hypothesized to result from a nonconserved GC-box, which is present in mice but
not humans [267]. Transcription factors that induce TERT expression include c-Myc [289], Sp1
[290], human papillomavirus 16 E6 [291], estrogen [290], and progesterone [292]. Negative
regulators of TERT include Mad1 [293], p53 [294], and more (reviewed in [258]). TERT expression
and activity are regulated not just at the transcriptional level, but also via mRNA splicing, posttranslational modifications, subcellular localization, and assembly. In fact, phosphorylation of
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TERT causes translocation of hTERT to the nucleus from the cytoplasm, which may control
telomerase function [295]. Hypomethylation and hypermethylation of the hTERT promoter have
been observed in cancer cells with varying effects on hTERT expression [296]. Indeed,
hypermethylation upstream of the hTERT core promoter, which increases TERT expression, is
often observed in various forms of cancer [297]. Due to the various regulatory processes of TERT
expression, there may exist additional differences between humans and mice TERT expression
that are currently unknown.

1.4.3. TERT and Telomerase in the Adult Mouse Brain
Telomerase activity has been mapped throughout the adult mouse brain to specific brain
regions and cell types. These studies have determined that while most telomerase activity
observed in development [298, 299] is lost after birth, some areas of the adult mouse brain retain
activity into adulthood [269]. The brain regions where telomerase activity is retained include the
V-SVZ and OB, two regions of the brain where adult neurogenesis is present [269]. Interestingly,
telomerase activity in the V-SVZ is found within NSCs and intermediate progenitor cells, indicating
that telomerase may be functioning to allow for repeated proliferation [269, 300]. Evidence for the
role of TERT in ASCs is supported by the loss of this protein after differentiation. TERT expression
is lost following differentiation of NSCs into astrocytes following TGF-B treatment [301] or NSCs
into neurons following treatment with NGF [302, 303].
The role of TERT in the adult brain has not yet been well characterized, yet it is understood
that TERT KO severely impacts basal brain processes. In the V-SVZ, KO of TERT decreases
neurogenesis through a reduction in Sox2+ stem cells, DCX+ neuroblasts, and Ki67+ proliferative
cells when compared to WT animals [304]. These effects were reversed following TERT reexpression in KO animals, utilizing a TERT-ER mouse line [304]. TERT-/- mice also exhibit
inhibited spatial learning and memory formation, which is improved with lentiviral TERT
overexpression in the hippocampus [305]. The learning and memory formation differences were
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correlated with decreased branching point, dendrite length, and circuit incorporation of
hippocampal neurons within the dentate gyrus of adult mice, implicating a role for this protein in
adult neural plasticity [305]. Taken together, TERT clearly plays a role in adult brain plasticity, but
the exact role of TERT in these regions remains unknown.
The differences observed between levels of TERT and telomerase activity provide
evidence TERT does not function purely to extend telomeres. In the hippocampus, telomerase
activity drops to nearly undetectable levels following P10 into adulthood, while mTERT mRNA
remains at consistently low levels throughout adulthood [299, 306]. Many studies have also
identified a role for TERT as a neuroprotective protein. Fu et al. demonstrate that TERT
expression is required for embryonic neuron survival [307], and can protect neurons exposed to
DNA damage [308]. This was also demonstrated in cerebellar Purkinje neurons, where X-ray
radiation induced TERT expression in the nucleus, likely to repair damaged DNA, while glutamate
exposure resulted in TERT expression in the mitochondria [309]. The role of TERT as a
mitochondrial effector in the brain has been identified by a number of studies. One such study
discovered that reducing TERT levels in neurons led to increased oxidative stress and
mitochondrial dysfunction when responding to beta amyloid peptides [310]. Furthermore, an
increase in TERT expression following dietary restriction or rapamycin treatment lowered radical
oxygen species in the brains of aged mice [311].

In support of the role of TERT as a

neuroprotective protein, ectopic expression of TERT prevented neuronal death following ischemia
[312].

1.4.4. Non-Canonical Roles of TERT
Non-canonical roles of TERT reveal the ability of this protein to respond to damage or
stressors [313]. When utilized for the purpose of telomere extension, TERT is localized to the
nucleus and does not migrate throughout the cell during cell cycle progression [268]. While the
canonical role of TERT is telomere extension, this protein also regulates non-telomeric DNA
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damage, chromatin modulation, and transcription [313]. Although we are aware of various noncanonical roles of TERT both in vitro and in vivo, the reasons that certain cell types utilize TERT
for these processes are poorly understood. For example, outside of the nucleus TERT plays a
role in protecting mitochondrial DNA (mtDNA) following oxidative stress [313]. Why then, do
embryonic neurons express TERT in the cytoplasm if their primary role is believed to be telomere
extension for high levels of proliferation during development [307]? We must understand the
canonical and non-canonical functions of TERT to fully glean the roles that TERT plays in adult
stem cells throughout the body and the adult brain.
The hTERT gene has various transcripts that result from alternative splicing [314]. The
full-length transcript is the only one associated with telomerase activity [314, 315]. The other
known transcripts have been detected only in human fetal tissue [314]. Here, hTERT gene
expression did not correlate with telomerase activity, and it was determined that the hTERT splice
variants lacked critical enzymatic domains [314]. The function of these variants is currently
unknown.
Non-canonical TERT functions can be measured through the inhibition of TERT compared
to the inhibition of TERT to bind telomeres, wherein the non-canonical roles of TERT are still
intact. When the binding of TERT to telomeres is inhibited in CD34+ hematopoietic precursors
from bone marrow there is no change in differentiation capacity. However, when TERT is inhibited
in totality, these cells showed decreased capacity to differentiate into myeloid and granulocyte
lineages [316].
Cell survival and protection appear to be major non-canonical roles of the protein TERT.
The apoptosis prevention factor protein nuclear factor kappa B (NF-KB) can induce TERT
expression, potentially so that TERT can act to increase cell survival [317]. TERT expression can
also be induced via the cell survival and immortalization factor c-Myc [318]. In fact, downregulation
of TERT in embryonic neurons in vitro induces apoptosis [307, 310] whereas upregulation
prevents cell death [307]. These results were replicated in human breast cancer cells [319].
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However, rescue of TERT expression with a mutant hTERT that lacked the ability to extend
telomeres was still able to prevent apoptosis [319]. Further evidence for the non-canonical role of
TERT as an anti-apoptotic agent independent of its telomeric function has been accumulated in
other cancerous cells ex vivo and in vivo [302, 320-323]. In many studies, the method of
preventing apoptosis by TERT has been linked to improved mitochondrial function [311, 324,
325]. Indeed, TERT protects mtDNA [326, 327] and prevents mitochondrial dysfunction resulting
from mtDNA damage (reviewed in [328]).

1.5. Adult Hypothalamic Neurogenesis in the Context of Metabolic Health
1.5.1 Interventions that Affect Hypothalamic Plasticity – Caloric Restriction and High Fat Diet
While the role of stem and progenitor cell in the hypothalamus remains unclear,
hypothalamic plasticity in the form of gross proliferation and newborn neuron creation has been
more comprehensively studied. Although these studies do not locate the stem cells that led to the
production of newborn neurons and glia, they provide context to the role of various treatments
and interventions that affect adult hypothalamic plasticity. In addition, these studies give insight
into the role of hypothalamic neurogenesis and full body energy balance and metabolism. CNTF
is a neurocytokine that causes leptin-independent weight loss through reduced food intake [329]
for weeks or months after treatment has ended [330]. A landmark study on the effect of CNTF on
hypothalamic neurogenesis revealed that a HFD followed by CNTF treatment increased BrdU+
cell numbers and revealed newborn neurons in the adult hypothalamus when compared to
vehicle-treated animals [58]. Furthermore, the adult-born neurons expressed the orexigenic and
anorexigenic markers NPY and POMC [58]. A subset of these neurons was responsive to leptin
as well. Furthermore, the weight loss that accompanied proliferation in the hypothalamus was
prevented with mitotic inhibition through the treatment with Ara-C [58].
Metabolic studies have also identified time-dependent, sex-dependent, and areadependent neurogenic effects of high fat diet in the adult hypothalamus (Figure 1.6) [55, 133].
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Lee et al., administered BrdU during the first 3 days of a 32-day HFD treatment and discovered
decreased numbers of adult-born BrdU+ mature neurons in the ARC when compared to control
diet animals [55]. A low protein diet had an even more intense effect [55]. The study of newborn
neurons in the ME of female mice identified heightened proliferation with both HFD and low protein
diet when compared to control diet, but no difference in male mice [55]. Additional studies on the
role of caloric restriction (CR) during or following HFD revealed changes in proliferation of BrdU+
adult-born cells, wherein HFD followed by CR increased total proliferation in one study [133], but
decreased ME proliferation in females (with no effect in males) in another [55]. However, the
animals used in these studies as well as the length of the diet and CR were not identical, making
it difficult if not impossible to draw direct comparisons. Finally, an analysis of gene expression
following CR revealed Igf1r upregulation by 2-5-fold, which has previously been identified to
induced tanycyte proliferation, indicating a possible role for tanycyte-driven CR-derived
neurogenesis in the adult hypothalamus [331]. It is also important to note that HFD induces
inflammatory responses [331], whereas CR reduces inflammation. The increased proliferation
resulting from HFD treatment could be a combination of neurogenesis, gliogenesis, cell repair, or
microglial activation and proliferation [331].

1.5.2 Role of the Immune System and Glial Cells in Adult Hypothalamic Plasticity
While neurons within the hypothalamus relay information across hypothalamic nuclei and
throughout the body, the glial cell populations within the hypothalamus also retain important
metabolic function yet are often overlooked. NG2+ GPCs in the mediobasal hypothalamus
express the stem cell marker Sox2, proliferate, and give rise to oligodendrocytes [49].
Interestingly, lineage tracing studies also reveal newborn NeuN+ neurons in the adult mouse brain
derived from NG2+ cells, implicating a neurogenic and gliogenic role for these cells [130]. NG2+
glia are also critical for the proper function of neurons within the ARC, with leptin responsive
neurons relying on direct contact with NG2+ cells to respond to this circulating hormone [131].
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Here, ablation of NG2+ glia in the ME via Ara-C treatment prevented neurons in the ARC from
responding to leptin, resulting in significant body weight gain through increased food intake.
Interestingly, this group had previously discovered that NG2 glia will regenerate completely
following mitotic inhibition [130]. Indeed, the role of these glial cells appears to be critical for brain
function in the context of leptin sensitivity.
Tanycytes, radial glial cells of the ventral third ventricle, are known to respond to dietary
changes via the creation of newborn neurons within the hypothalamus [51, 52, 332]. After a high
fat diet, young adult mice showed reductions in neurogenesis in the ARC, and female mice also
had increased neurogenesis in the ME [55]. These newborn neurons within the ME were traced
from Nestin+ cells and were determined to likely be progeny of tanycytes in proximity to the ME,
as tanycytes are one of the few Nestin+ cell types in this niche. In addition, irradiation of the ME
attenuated weight gain in female mice fed an HFD, resulting in significantly lower weight gain than
their HFD-sham counterparts, providing evidence that adult-born neurons in the median eminence
respond to HFD with increased body weight [55]. Interestingly, this effect was not seen in male
mice, indicating that adult hypothalamic neurogenesis may be a sexually dimorphic method of
body weight regulation and energy storage. See Appendix A for information on signaling pathways
related to BMPs and their effects on adult plasticity and hypothalamic neurogenesis
Microglia are the resident immune cells of the brain and spinal cord (Section 1.1.3.3).
These specialized cells can influence adult neurogenesis during both basal and HFD-induced
inflammatory conditions wherein microglia are activated in the hypothalamus [333, 334]. Both
food intake and energy expenditure are regulated at the axis of microglial activation and
hypothalamic plasticity. As identified by Jin et al., microglial activation alters POMC neuron activity
through changes to their inputs [335]. These changes to microglia had whole body effects
including anorexia-derived weight loss [335]. In addition, hypothalamic inflammation if not reduced
can eventually lead to neuronal apoptosis [336]. Interestingly, hypothalamic inflammation first
occurs as a result of HFD in the mediobasal hypothalamus, which contains the ME, a key
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proliferative niche of the hypothalamus [337]. In response, microglia will activate within the ARC
and produce inflammatory cytokines [338]. To further support the importance of carefully
comparing HFD-induced neurogenesis studies, it has been observed that 1wk HFD induces
inflammation within the hypothalamus, which is then reduced after 2 weeks, and then again
increased after 4 weeks [337]. Finally, although microglial activation in the adult brain is not
specific to the hypothalamus, the hypothalamus exhibits microglial activation before other brain
regions. For these reasons, it is crucial that future studies and the analysis of previous studies
are sure to compare the hypothalamic microglial response and plastic effects of involved
interventions only across similar treatments.
Microgliogenesis occurs throughout the adult brain. However, although hypothalamic
inflammation is well studied, the role of microglial proliferation in this context has only just been
realized. In addition to the regulatory roles played by microglia during HFD, these cells will also
proliferate within the hypothalamus, specifically in the ARC after a 3-week HFD treatment [339].
Blocking mitosis of microglia (as well as other proliferative cells) via Ara-C resulted in reduced
feeding, weight gain, and adiposity. The mitotic inhibition of microglia was paired with decreased
proinflammatory cytokine expression indicating a reduction in inflammation [339]. These results
must call into question previous hypothalamic neurogenic studies that utilize the number of
BrdU+ or EdU+ cells to determine ‘neurogenesis’, as both NG2+ cells and microglia are a
proliferative cell type within this niche.
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Figure 1.6. Effect of CR and HFD on Proliferation and Plasticity in the Hypothalamus.
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Chapter 1 Acronym List
aANSCs – Activated adult neural stem cells
AgRP – Agouti-related peptide
AHN – Adult hippocampal neurogenesis
Ara-C – Cytosine arabinoside
ARC – Arcuate nucleus
ASC – Adult stem cell
ASCL1 – Achaete-scute homolog 1
aSVZ – anterior subventricular zone
BBB – Blood-brain barrier
BCSFB – Blood-CSF-barrier
BDNF – Brain-derived neurotrophic factor
BLBP – Brain lipid binding protein
BMP – Bone morphogenetic protein
BrdU – Bromodeoxyuridine
CNTF – Ciliary neurotrophic factor
CNS – Central nervous system
CP – Choroid plexus
CPEC – Choroid plexus epithelial cell
CSF – Cerebrospinal fluid
DCX – Doublecortin
DG – Dentate gyrus
EdU – 5-ethynyl-2’-deoxyuridine
EGFR – Epidermal growth factor receptor
ESC – Embryonic stem cell
GABA – Gamma aminobutyric acid
GBCs – Globose basal cells
GCL – Granule cell layer
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GFAP – glial fibrillary acidic protein
GLAST – glutamate aspartate transporter
GPC – Glial precursor cell
HBCs – Horizontal basal cells
HFD – High fat diet
hTERT – human TERT
HSC – Hematopoietic stem cell
IGF-1 – Insulin-like growth factor 1
LVCPsec – Lateral ventricle choroid plexus secretome
MASH1 – Mammalian ASCL1 homolog
MBP – Myelin basic protein
ME – Median eminence
mtDNA – mitochondrial DNA
mTERT – mouse TERT
Myrf – Myelin regulatory factor
NeuN – Neuronal nuclear protein
NF-KB – nuclear factor kappa B
NG2 – Chondroitin sulfate proteoglycan NG2
NGF – Nerve growth factor
NMDA – N-methyl-D-aspartate
NPY – Neuropeptide Y
NVU – Neurovascular unit
OB – Olfactory bulb
OE – Olfactory epithelium
OPC – Oligodendrocyte progenitor cell
OSN – Olfactory sensory neuron
PDGFRa/B – Platelet-derived growth factor alpha/beta
POMC – Pro-opiomelanocortin
PSA-NCAM – polysialylated-neural cell adhesion molecule
pSTAT3 – phosphorylated signal transducer and activator of transcription 3
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pSVZ – posterior subventricular zone
qASC – Quiescent adult stem cell
qANSC – Quiescent adult neural stem cell
Rax – Retina and anterior neural fold homeobox transcription factor
RMS – Rostral migratory stream
SGZ – Subgranular zone
Shh – Sonic hedgehog
TAC – Transit amplifying cell
TERC – Telomerase RNA component
TERT – Telomerase reverse transcriptase
Tfam – Mitochondrial transcription factor A
V-SVZ – Ventricular-subventricular zone
V3V – Ventral third ventricle
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CHAPTER 2:

TELOMERASE REVERSE TRANSCRIPTASE (TERT)-EXPRESSING CELLS MARK A
NOVEL STEM CELL POPULATION IN THE ADULT MOUSE BRAIN

Abstract
Telomerase reverse transcriptase (TERT) is expressed by quiescent adult stem cells
(qASC) in numerous adult murine and human tissues but has never been explored in the adult
brain. Here, we demonstrate that TERT+ cells in the adult mouse brain represent a novel
population of multipotent qASCs. TERT+ cells were localized to numerous classical
neuro/gliogenic niches including the ventricular-subventricular zone, hypothalamus and olfactory
bulb, as well as newly discovered regions of adult tissue plasticity such as the meninges and
choroid plexus (ChP). TERT+ cells expressed neural stem cell markers such as Nestin and Sox2,
but not markers of activated stem/progenitor cells, nor markers of mature neuronal or glial cells.
TERT+ qASCs also rarely expressed the proliferation marker Ki67, further confirming a quiescent
phenotype. When cultured, TERT+ cells behaved like brain stem cells by forming neurospheres.
Lineage tracing of TERT+ cells in adult transgenic mice revealed large-scale expansion of TERT+
progeny and differentiation in multiple brain regions to diverse cell types. Lineage-traced cells
expressed markers of mature neurons, oligodendrocytes, astrocytes, ependymal cells, and
choroid epithelial cells, thus demonstrating the striking multipotency of this stem cell population
in basal tissue turnover. Together, these data demonstrate that TERT+ cells represent a new
population of multipotent stem cells that contribute to basal brain plasticity and regeneration.
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Introduction
The adult mammalian brain retains cellular plasticity and the ability to regenerate certain
cell types, but adult neurogenesis is thought to occur only in restricted patterns and discrete
niches of the adult brain [340]. Adult neurogenesis is well-studied in the ventricular-subventricular
zone (V-SVZ) of the lateral ventricles and subgranular zone (SGZ) of the dentate gyrus (DG) in
the hippocampus. However, numerous other adult brain niches have also demonstrated adult
plasticity and capacity for neurogenesis. In the adult mammalian brain, the V-SVZ contains
quiescent adult neural stem cells (qANSCs) known as Type B1 cells (reviewed in [134]). These
cells can become activated and asymmetrically divide into self-renewing B1 cells and transit
amplifying cells (TACS), also known as Type C cells. TACS then further divide to produce
neuroblasts (Type A cells), which migrate rostrally within the rostral migratory stream (RMS) to
the olfactory bulb (OB), where they differentiate into mature neurons that integrate into the neural
circuitry [19]. In humans, V-SVZ-derived progenitors appear to migrate to the striatum instead of
the OB [341]. Within the SGZ, quiescent radial glial-like stem cells (Type 1 cells) produce
intermediate progenitor cells (Type 2 cells) via symmetric or asymmetric cell division. These cells
produce adult-born neuronal cells that express doublecortin (DCX). DCX+ cells then migrate into
the granule cell layer where they differentiate into mature DG neurons (reviewed in [342]). By
contrast, in regions such as the hypothalamus and cortex, the cell types and mechanisms involved
in adult neuro/gliogenesis are less well understood [343].
In the absence of a specific and unique marker for quiescent adult stem cells (qASCs) in
the brain, explorations have relied on a combination of cellular markers. Sex determining region
Y-box 2 (Sox2), glutamate aspartate transporter 1 (GLAST), and glial fibrillary acidic protein
(GFAP) are often used to identify ANSCs in V-SVZ and SGZ.

Further complicating these

analyses, each of these markers is also expressed by other cell types throughout the brain,
reducing their specificity. For example, GFAP and GLAST are expressed by mature glial cells in
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addition to stem cells. Here, we propose that telomerase reverse transcriptase (TERT), the
catalytic subunit of the enzyme telomerase, is a more specific and novel marker for a population
of multipotent qASCs in numerous niches of the adult mouse brain.
TERT has previously been identified as a marker for slowly cycling or quiescent intestinal
stem cells, as well as adult tissue stem/progenitor cells found in the testes, bone marrow, heart,
thymus, spleen, liver, kidney, endometrium, heart, bone and adipose [268, 283-285, 287, 344348]. However, until now TERT had never been investigated as a marker of ASCs in the brain.
In both mice and humans, telomerase activity is high in the brain during development, but is
dramatically reduced in the postnatal brain [255, 259]. In mice, telomerase activity declines in the
brain before adulthood, except in specific neurogenic regions such as the V-SVZ and OB [268,
269, 349]. Numerous studies have pointed to TERT as a putative stem cell marker in the adult
brain. For example, telomerase activity has been localized to cellular fractions containing Type A,
B, and C neural progenitor cells (NPCs) from the adult mouse V-SVZ [269]. Differentiation of
embryonic stem cells into astrocytes or neurons induces loss of telomerase activity [301, 303]. As
mice age, they exhibit decreased TERT expression in the V-SVZ, which is accompanied by
reduced proliferation and neurogenesis [350], consistent with a decline in the stem cell pool.
Evidence for the importance of telomerase activity in neurogenic niches is supported by
decreased levels of V-SVZ neurogenesis in mice with telomerase RNA component (TERC)
deletion. In these mice, the stem cells in the V-SVZ are affected, while the proliferative ability of
more committed/differentiated cells, such neuroblasts, remained unaffected [350]. Finally, tissue
degeneration and decreased V-SVZ neurogenesis was reversed following TERT reactivation in
TERT-ERT2 mice [304]. Together, these findings suggested that TERT plays an essential role in
adult stem cell maintenance and in adult neurogenesis.
We now demonstrate for the first time that TERT+ cells in the adult mouse brain represent
a rare, quiescent stem cell population, and that these cells possess the multipotent capability to
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proliferate upon activation and to regenerate multiple brain regions by differentiating into
numerous mature cell types
Materials and Methods
Mice
All procedures were approved by the University of Maine and Ohio State University IACUC. Mice
were maintained on a 12 hr light/dark cycle, and food and water was provided ad libitum. Tg(TertGFP)22Brlt (mTERT-GFP) mice were described previously [284]. For lineage tracing studies,
mTert-rtTA:: otet-Cre:: R26Rflox(mTmG) mice were generated by crossing mTERT-rtTA mice [287] to
otet-Cre:: R26Rflox(mTmG) mice, which were generated by our lab by crossing B6.Cg-Tg(tet0cre)1Jaw/J mice (The Jackson Lab) to B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo mice
(The Jackson Lab). Recombination was induced via 2 mg/ml doxycycline (Sigma Aldrich) in 50
mg/ml sucrose water over the course of 2-21 days as indicated. To chase, doxycycline water was
removed, and normal water was provided. Both male and female animals were utilized for most
experiments (see Results section for specifics).

Immunostaining
Mice were anesthetized via intramuscular injection of 320 mg/kg body weight Ketamine and 24
mg/kg body weight Xylazine in 0.9% saline and then sacrificed via transcardial perfusion with 1X
PBS followed by Histochoice Fixative, after loss of motor and ocular reflexes. Brains were postfixed overnight at 4°C, then placed in 15% sucrose at 4°C for 2d, followed by 30% sucrose at 4°C
for 2d. Brains were then divided into coronal or sagittal sections using adult mouse brain matrices
and then frozen in optimal cutting temperature compound and stored at -20°C until slicing. Brains
were sliced on a CM1950 or CM3050 S cryostat (Leica) at -20°C. Two slices of 7-10µm size were
adhered to each slide. Slides were stored at -20°C until used for immunostaining, at which point
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they were warmed up to room temperature and post-fixed with ice-cold acetone for 15min. Slides
were washed for 5min in 1X IHC Select TBS Rinse Buffer shaking at 60rpm at room temperature
(RT) between each step. Permeabilization for staining of nuclear antigens was performed with
0.3% Triton X-100 for 10min at RT. Permeabilization for staining of cytoplasmic antigens was
performed with 0.3% Tween-20 for 10min at RT. Antigen retrieval was performed by microwaving
slides in 1X DAKO Antigen Retrieval Solution on low for 10 minutes twice. Slides were then
incubated in 0.3% Typogen Black in 70% EtOH for 20min at RT, blocked for 20 min at 37°C with
Millipore Blocking Reagent, and incubated with primary antibody diluted in antibody diluent
overnight at 4°C. Antibody concentrations are listed in the Key Resource Table. The next day,
sections were incubated in Alexa Fluor secondary antibodies for 10m at RT, then counter-stained
with 100ng/mL DAPI for 5min. Epifluorescence images were captures on Nikon E400 microscope
with a Hamamatsu Flash 2.0. Confocal images were captures on either SP8 (Leica), Stellaris 5
(Leica), or LSM 900 (Zeiss) for co-expression analysis.

FACS
To obtain single cell suspensions of adult mouse brains, mice were sacrificed via CO2 followed
by cervical dislocation. Brains were isolated and washed with artificial cerebrospinal fluid (ACSF)
(Ecocyte). Brains were then diced with a razor blade in a petri dish containing ice-cold ACSF with
1mg/mL pronase (Millipore-Sigma) until brain pieces were uniform sizes. Brains were then
transferred to loosely capped 50mL falcon tubes placed in shaking water incubator (37°C and
90rpm) for 60-75min until cloudy. Every 5 minutes tubes were vortexed and then returned to
shaking incubator. Samples were then centrifuged at 1600rpm for 4 minutes and supernatant
decanted. Samples were then treated with ACSF with 5% fetal bovine serum (FBS) for 15 minutes
while shaking at 90 rpm and 37°C. Trituration of each sample was performed with pasteur pipettes
of 600μm, 300μm, and 150μm openings. Samples were centrifuged at 300 x g for 10min and
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supernatant decanted. Debris removal solution (Miltenyi) was utilized to remove debris and myelin
from the samples. In experiments where CD45 antibody was utilized for FACS, cells were then
treated with 1X PBS with 0.5% BSA and 2% FBS for 20 min at 4°C, spun at 1800rpm for 5min,
resuspended in 1X PBS with 5% FBS and 5mM EDTA with antibodies for 20min at 4°C, and then
washed twice with 1X PBS with 0.5% BSA and 2% FBS. Cells were resuspended in ACSF with
10% FBS and stored on ice until sorting. Cells were sorted for endogenous membrane GFP
fluorescent signal or Alexa Fluor 700 signal from CD45 antibody via BD FACSAria II (Jackson
Laboratory, Bar Harbor, ME) or BD FACSAria III (OSUMC, Columbus, OH). Cells were sorted
into Trizol (Ambion) and frozen at -80°C for qRT-PCR experiments or Neurosphere Basal Medium
supplemented with Proliferation Supplement (STEMCELL Technologies), heparin, FGF2, and
EGF (STEMCELL Technologies) for in vitro neurosphere culturing experiments according to
methods from [351].

Neurosphere Formation Assay
Cells were sorted into 96-well low-attachment plates containing NeuroCult Basal Media (Mouse
and Rat) (STEMCELL Technologies) with Proliferation Supplement (STEMCELL Technologies),
20ng/mL hrEGF (STEMCELL Technologies), 10ng/mL hrbFGF (STEMCELL Technologies), and
0.002% Heparin (w/v) (STEMCELL Technologies). Both GFP+ and GFP- cells were grown at
37°C with 5% CO2 and 90% relative humidity for 14 days. Media was changed every 5-7 days.
Cells were imaged every three days for a total of 22 days.

EdU Labeling
Neurospheres were removed from 96-well plates and pipetted into 8-well Seahorse XF HS
miniplates (Agilent) coated with 15 µg/mL poly-L-ornithine and 10µg/mL laminin. Plates were spun
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at 200 x g for 2 minutes until cells were adhered. Cells were incubated in 5µM EdU (ThermoFisher
Scientific) in NeuroCult proliferation media with EGF and FGF for 24hr. Media was removed and
cells were fixed with 4% PFA (pH 7.4) for 15min. Cells were washed twice with 3% BSA in PBS,
then permeabilized with 0.5% Triton X-100 in PBS for 20min at RT. Cells were washed once with
3% BSA in PBS. Cells were incubated in Click-iT EdU reaction buffer for 30 minutes at RT
(ThermoFisher Scientific). Cells were then washed once with 3% BSA in PBS followed by 1x PBS
and incubated in 5µg Hoeschst 33342 for 30min at RT. Finally, cells were washed with 1X PBS,
then imaged. After imaging, representative images were used for cell counting. Here, images from
each of the 405, GFP, and 647 (EdU) channels were opened in FIJI (v1.543k). For each: images
were converted to 8-bit, the threshold was adjusted, particles were analyzed with the parameters
of size (inch^2): 0.001 – infinity, circularity 0.00-1.00, and the cell number was identified.

RNAscope
RNAscope was performed using the RNAscope Multiplex Fluorescent v2 Assay (ACD Bio). Slides
with sagittal adult mouse brain sections from mice perfused with Amresco Histochoice Tissue
Fixative and put through a sucrose gradient (15% to 30%) were frozen in OCT and sliced at 7um
on a Leica Cryostat. Slides were washed in 1x PBS for 5min, then post-fixed in 4% PFA (pH 7.4)
in 1X PBS at RT for 15min. Slides were washed in 1X PBS for 1min, and then dehydrates with
5min incubations of 50% EtOH, 70% EtOH, and 100% EtOH at RT. Tissues were dried on the
benchtop for 5min. 5 drops of Hydrogen Peroxide (ACD Bio) was applied to each tissue and
incubated for 10min at RT, then slides were washed with DI water for 5min, twice. Slides were
boiled in antigen retrieval solution (ACD) at 100C for 15min, then rinsed with DI water for 5
minutes, twice. Slides were dehydrated in 100% EtOH for 5min at RT, then dried on the benchtop
for 5min at RT. Pap-pen barriers were drawn around each tissue, and then slides were placed
into a Hybridization Oven set at 40C with 5 drops of Protease III solution each, for 30min. Slides
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were washed in DI water for 5min, twice. Probes were hybridized by adding 4 drops of the TERT
probe, positive control probes, or negative control probes, and then incubating at 40C for 2hr.
Slides were washed in 1X Wash Buffer for 2 min, then slides were washed in the same manner
between each of the following steps. Tissues were incubated at 40C with each of FL v2 AMP1,
AMP2, and AMP3 for 30min, 30 min, and 15min, respectively. For each channel, tissues were
then incubated in FL v2 HRP (for that channel) for 15min at 40C, then FL v2 HRP blocker for
15min at 40C. Finally, slides were washed in 1x wash buffer, 4 drops of DAPI solution was added
to each tissue for 30sec, and then cover slips with 1 drop of mounting medium were applied.

Intracerebroventricular administration of Ara-C
When mice reached 13 weeks of age, 2mg/ml doxycycline were administered in the drinking water
for a 4-week pulse to mark mTERT expressing cells with GFP. 6 days prior to doxycycline
removal, they received cytosine-β-D-arabinoside (2%; Ara-C) in 0.9% saline, or 0.9% saline alone
into the right lateral ventricle via a mini-osmotic pump (ALZET) with cannulas implanted. Brain
cannulation occurred at the following coordinates: anterior/posterior (A/P), -0.5mm; medial/lateral
(M/L), -1.1mm; dorsal/ventral (D/V), -2.5mm (relative to Bregma and the surface of the brain; M/L
coordinates are directed laterally to the right). After 6 days of Ara-C infusion, the mice were
perfused and the brains were collected. *i.c.v. administration was performed by Jake Willows and
Noelle Leon-Palmer.

Statistical Analysis
All plots represent mean ± SEM. Statistical calculations were carried out in Excel or GraphPad
Prism 9.0, utilizing the ANOVA or Student’s T-test as indications of significance. For all figures,
*p<0.05, **p<0.01.
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Results
TERT+ cells in the brain of adult mTert-GFP direct reporter mice are localized to the V-SVZ and
novel plastic regions
In the adult brain, prior work has demonstrated that adult stem/progenitor cells reside
mainly within three anatomical regions: the V-SVZ, SGZ, and hypothalamus. To characterize the
location and quantity of mTERT-GFP+ cells in the adult mouse brain, we examined a neurogenicenriched area of the adult brain from mTert-GFP direct reporter mice [284]. This area contained
the V-SVZ, SGZ, and hypothalamus (Figure 2.1A). Immunofluorescent analysis of all TERT-GFP+
cells revealed localization to some classical neurogenic niches as well as newly identified plastic
niches (Figure 2.1B). TERT+ cells were detected at low numbers, as expected for qASCs. Most
TERT+ cells were identified in the V-SVZ, LV ChP, D3V, D3V ChP, hypothalamus, and meninges,
although other brain regions contained TERT+ cells as well (Figure 2.1B). No TERT+ cells were
identified in the hippocampus (Figure 2.7). Interestingly, there were significantly more TERT+
cells per brain section, per mouse in the meninges when compared to the V-SVZ (Figure 2.1B,
2.2A). An analysis of TERT+ cells across 9 Bregma coordinates throughout the neurogenic
enriched brain area (Figure 2.1A) identified that TERT+ cells were found at the same number
throughout the neurogenic enriched brain area (Figure 2.1C). No difference was observed in the
number of TERT+ cells per brain region across Bregma (Figure 2.1D). Fluorescence activated
cell sorting (FACS) of TERT-GFP+ cells from full mTert-GFP brains revealed that only 0.1-0.3%
of brain cells were TERT+ (Figure 2.2A). Taken together, TERT+ cells are found at low numbers
throughout plastic niches of the adult mouse brain.
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Figure 2.1. TERT+ cells in the adult mTert-GFP mouse brain are quiescent stem cells
localized to both well-studied and novel regions of adult brain plasticity.
(A) Mouse brain illustration of the neurogenic-enriched brain area used for immunostaining with
arrows indicating coronal planes used for TERT-GFP+ cell analysis.
(B) Quantification of TERT + cells per region identified via immunostaining in adult mTert-GFP
mouse brains. Cell quantification is graphed as the number of TERT+ cells per niche, per mouse.
Dots represent individual animals. 8-20 coronal brain sections per mouse were analyzed from
N=5 males and N=6 females at 12-weeks of age.
(C) Quantification of TERT+ cell numbers across Bregma coordinates through the neurogenic
enriched brain area. Cell quantification is graphed as the sum of TERT+ cells across n=2 coronal
brain sections per depth, per mouse. Dots represent individual animals. N=6-11 mice per depth.
(D) Quantification of TERT+ cells per region across Bregma coordinates through the neurogenic
enriched brain area. Cell quantification is graphed as the sum of GFP+ cells per brain region
across n=2 brain sections for each of N=6-11 mice.
(E) Quantification of co-staining for TERT-GFP and Ki67 in mTert-GFP mouse brains. Cell
quantification is graphed as the average number of cells per brain region, per mouse, across n=16
brain sections for each of N=5 males and 5 females.
(F) Co-immunostaining of TERT+ cell in the V-SVZ with the proliferation marker Ki67. White arrow
indicates TERT+Ki67+ cell. Red arrow indicates TERT-Ki67+ cells (N=5 males, 5 females, n=16
brain sections per animal).
(G) Representative image of co-immunostaining with Ki67 in the meninges of mTert-GFP mice.
Green or red “+” or “-” indicates that the cells in indicated area were GFP+/GFP-, or Ki67+/Ki67-,
respectively. Dots indicate individual animals. (N=4 males, 4 females, n=16 brain sections per
animal).
(H-I) Representative neurosphere formation of FACS-sorted GFP+ cells grown with EGF and FGF
with fluorescence analyzed on Day 9 (H) and Day 22 (I) (N=6).
J) EdU incorporation in TERT+ cells cultured with EdU for 24 hours at Day 9 (N=3 of 4 samples).
K) Quantification of GFP+EdU+ cells across the total number of EdU+ cells (N=3).
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Scale bars are 25µm. Insets show 4x digital magnification of indicated area. Bar graphs show
mean cells per brain section, per animals ± SEM with individual data points per animal. Grouped
bar graphs show GFP+ cells per mouse, per brain section, at each depth ± SEM. Significance
was determined via one-way ANOVA (*P < 0.05, **P < 0.01). V-SVZ: ventricular-subventricular
zone, LV: lateral ventricle, ChP: choroid plexus, D3V: dorsal 3rd ventricle, Hypo: hypothalamus,
Me: meninges, ACA: anterior cingulate area, BF: brightfield, EdU: 5-ethynyl-2´-deoxyuridine.
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Figure 2.2: TERT+ cells in the adult mouse brain are rare, mostly quiescent, and include a
subpopulation of CD45+ immune cells.
(A) Representative fluorescent activated cells sorting (FACS) plot of GFP+ cells from sorted adult
mTert-GFP full mouse brains (N=16 males, 9 females). P3: GFP+, P4: GFP-. PE-Texas Red-A
used to gate for autofluorescence.
(B) Quantification of total proliferative TERT+ cells across all tissues in the neurogenic enriched
brain area stained for Ki67 from 10 mTert-GFP animals. (N=5 males, 5 females, n=8 sections per
brain).
(C-D) Representative images of TERT+CD45+ (C) and TERT+CD45- (D) cells identified via
immunofluorescence in the adult mTert-GFP mouse brain (identified in N=5 of 5 males, 5 of 5
females, n=8 brain sections per mouse).
(E) Quantification of co-staining for TERT-GFP and CD45 in mTert-GFP mouse brains. Cell
quantification is graphed as the average number of cells per brain region across n=8 brain
sections for each of N=5 males and 5 females.
(F) Quantification of total proliferative TERT+ cells across all tissues in the neurogenic enriched
brain area stained for Ki67 from 10 mTert-GFP animals. (N=5 males, 5 females, n=8 sections per
brain).
(G-I) Representative fluorescent activated cell sorting (FACS) plots showing identification of
CD45- cells (G) followed by isolation of TERT-GFP+ cells from GFP- control brains (H) or full
mTert-GFP full mouse brains (I) (N=6 males).
(J) FACS sorted GFP- cells from mTert-GFP animals do not express GFP (N=2 males).
(K) Proliferative 3T3-F4421A cells as a positive control for the EdU assay.

TERT+ cells in the adult mTert-GFP mouse brain are largely quiescent
Quiescent populations of stem cells are expected to slowly divide in order to prevent
exhaustion of the stem cell pool. In adult murine brains where extended periods of stem cell
proliferation have occurred, such as with aging, the stem cell pool becomes exhausted, resulting
in reduced proliferation and neurogenesis [352]. Previously, it has been reported that TERT+ adult
tissue stem cells in the intestines are slowly cycling and rarely express the proliferation marker
Ki67 [284, 285]. Expression of TERT may act to restore telomere length after cell division and
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prevent senescence into adulthood, which is a characteristic of stem cells. To assess the
proliferative capacity of TERT+ cells in the adult mouse brain, we co-immunostained with the
proliferation marker Ki67 in the neurogenic-enriched area of the adult brain in adult mTert-GFP
mice [284]. TERT+Ki67- cells were identified in all brain regions of interest, while TERT+Ki67+
cells were found in the V-SVZ, hypothalamus, meninges, and other areas (Figure 2.1E).
TERT+Ki67+ cells were not found in the LV ChP, D3V, or D3V ChP (Figure 2.1E). The majority
of TERT+ cells analyzed across all brain sections were Ki67-negative, with only 14.9% of TERT+
cells expressing Ki67 (Figure 2.1E, 1.8B). We observed TERT+Ki67+ (Figures 2.1F, 2.1G’),
TERT+Ki67- (Figure 2.1G’’), and TERT-Ki67+ cells (Figure 2.1G’’’), indicating that TERT
expression is not cell-cycle specific, yet is rarely expressed by actively dividing cells. Taken
together, TERT+ cells in the adult mouse brain are quiescent but have the ability to proliferate
across various plastic niches.

TERT+ cells constitute immune and non-immune populations and form neurospheres in culture
Previous studies have identified subpopulations of TERT+ cells in various murine tissues
as CD45+ immune cells originating from bone marrow [283, 285]. To determine whether TERT+
cells in the adult murine brain included a population of CD45+ immune cells, we performed
immunostaining and identified both TERT+CD45+ and TERT+CD45- cells throughout the adult
mouse brain (Figures 2.2C-F). Analysis of the total number of TERT+ cells across all brain
sections examined revealed that 53.6% of TERT+ cells expressed CD45 (Figure 2.2F).
Quantification of co-staining per region, per mouse, identified both CD45+ and CD45- TERT+
cells throughout most major TERT+ areas of the brain, although no TERT+CD45+ cells were
identified in the hypothalamus (Figure 2.2E). FACS analysis of mTert-GFP brains where CD45+
cells were gated separately, revealed that 99% of brain cells were CD45- and that of these CD45cells, only 0.1% were GFP+ (Figures 2.2G-I).
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The ability of neural stem cells to form neurospheres in culture is a standard assay for
characterizing their behavior [353]. To analyze the neurosphere-forming capabilities of a pure
population of TERT+ stem cells from the brain, TERT+CD45- cells were sorted by FACS (to
eliminate TERT+ immune cells) and plated into neurosphere growth media containing epidermal
growth factor (EGF) and basic fibroblast growth factor (bFGF) (following the standard culture
methods of [351]). The strategy for isolation of GFP+CD45- cells is outlined in Figures 2.2G-I.
TERT+ cells did form classical neurospheres in culture (Figure 2.1H). GFP- cells sorted from
mTert-GFP animals were used as controls (Figure 2.2J). Individual cells retained GFP expression
in culture, while neurospheres exhibited a loss of GFP expression in culture over time (Figures
2.1H-I), likely due to the activation by the presence of growth factors in the culture media.
Activation of TERT+ cells was further demonstrated through the incorporation of EdU over a 24hour period (Figure 2.1J; N=3 of 4 animals, n=1 well per animal). 49.5% ± 5.6 of EdU+ cells were
GFP+ (Figure 2.1K).

TERT+ cells express markers of quiescent stem cells but not of activated stem cells or
intermediate neuronal progenitors.
There is currently no single, specific marker for qASCs in the adult brain. This is due to
the fact that all previously identified stem cell markers are also expressed by various non-stem
cell types [354]. For this reason, we investigated the expression profile of the stem cell markers
Sox2, Nestin, and EGFR in TERT+ cells. Co-immunostaining was performed in adult mTert-GFP
mouse brains. The neuronal lineage in both the V-SVZ and SGZ, consisting of qASCs which
differentiate into neurons, is shown in Figure 2.3A with typical gene expression markers shown
for reference (Figure 2.3A). Immunofluorescent staining for Sox2 co-expression in the
neurogenic-enriched area of brains of adult mTert-GFP mice revealed populations of
TERT+Sox2+ and TERT+Sox2- cells throughout all major TERT+ niches except for the V-SVZ
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and D3V, which housed no TERT+Sox2+ cells (Figures 2.3B-D). Analysis of the total number of
TERT+ cells across all brain sections examined revealed that 33.3% of TERT+ cells expressed
Sox2 (Figure 2.4A). Immunostaining with Nestin uncovered 1 TERT+Nestin+ cell (Figure 2.3E)
and 9 TERT+Nestin- cells (Figure 2.3F) showing 10% of TERT+ cells were Nestin+ (Figure 2.3EF, 2.4B). These results indicate that a subset of TERT+ cells express various known stem cell
markers, such as Sox2 and Nestin.
While subsets of TERT+ cells expressed Sox2 and Nestin, many TERT+ cells did not. To
determine whether these were activated stem cells or differentiated cell types, we performed coimmunostaining with markers of activated stem cells as well as immature and mature neuronal
cell types. The activated adult stem cell marker EGFR, which is also expressed by aASCs, TACS
(V-SVZ), and Type II cells (DG), was never expressed by TERT+ cells in any brain region (Figures
2.3H-I, 2.4C). Additionally, TERT+ cells never expressed the more differentiated neuroblast
marker DCX or the mature neuron marker neuronal nuclear protein (NeuN) (Figures 2.4D-G).
Bone morphogenetic protein (BMP) receptor 1A (BMPR1A) is a protein that in the V-SVZ and
SGZ allows for stem cells to respond to neuro/gliogenic BMP signals (reviewed in [355]). We did
identify 1 TERT+ ASC with rare BMPR1A expression (Figure 2.4H). Taken together, these results
show that TERT+ cells express quiescent and activated ASC markers, but are not activated
intermediate neuronal progenitors or differentiated neuronal cell types.
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Figure 2.3. TERT+ cells express markers of quiescent stem cells, but not of activated
stem cells, neuronal precursors, or mature neurons.
(A) Schematic depicting neuronal lineage markers from qASCs to mature neurons in the adult
mouse brain. Markers with red text were stained for in this figure. SGZ-specific markers are
denoted (SGZ). Curved arrows indicate the ability to proliferate, straight arrows indicate the ability
to differentiate.
(B-C) Representative images of Sox2 staining in the adult mTert-GFP mouse brain. TERT+Sox2+
cells were identified in N=4 of 8 males and 3 of 9 females, n=4-8 brain sections (B). TERT+Sox2cells were identified in N=4 of 8 males and 6 of 9 females, n=4-8 brain sections (C).
(D) Quantification of immunofluorescent co-staining analysis of the stem cell marker Sox2 in adult
mTert-GFP mice. Cell quantification is graphed as the average number of cells per brain region
across n=4-8 brain sections from N=8 males and N=9 females at 12 weeks of age.
(E-F) Representative images of Nestin staining in the adult mTert-GFP mouse brain. The rare
TERT+Nestin+ cell was identified in N=1 of 10 mice (N=1 of 4 males and 0 of 6 females), n=4-6
brain sections (E). TERT+Nestin- cells were identified in N=5 of 10 mice (N=3 of 4 males and 2
of 6 females), n=4-8 brain sections (G).
(G) Quantification of immunofluorescent co-staining analysis of the stem cell marker Nestin in
adult mTert-GFP mice. Cell quantification is graphed as the average number of cells per brain
region across n=4-8 brain sections from N=4 males and N=6 females at 12 weeks of age.
(H) Representative image of EGFR staining in the adult mTert-GFP mouse brain. TERT+EGFRcells were identified in N=8 of 10 mice (3 of 4 males, 5 of 6 females), n=4-6 brain sections.
(I) Quantification of immunofluorescent co-staining analysis of the stem cell marker Nestin in adult
mTert-GFP mice. Cell quantification is graphed as the average number of cells per brain region
across n=4-6 brain sections from N=4 males and N=6 females at 12 weeks of age.
Insets show indicated area at 3x digital zoom. White arrows indicate co-stained cells, green
arrows indicate cells that express only TERT. Scale bars are 100µm except Figure H (50µm).
Grouped bar graphs show mean cells per mouse, per brain section, at each brain region ± SEM.
All images taken on SP8 or LSM 900 confocal microscopes. V-SVZ: ventricular-subventricular
zone, LV: lateral ventricle, ChP: choroid plexus, COA: cortical amygdalar layer, ME: median
eminence.
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Figure 2.4: TERT+ cells express markers of quiescent stem cells, but not of activated stem
cells, neuronal precursors, or mature neurons.
(A-C) Quantification of total TERT+ cells across all tissues in the neurogenic enriched brain area
stained for Sox2 (A), Nestin (B), or EGFR (C) from 10 mTert-GFP animals. (N=4-8 males, 6-9
females, n=4-8 sections per brain).
(D-G) Representative images of TERT+ cells within the brain co-stained with DCX (D) with
quantification across total TERT+ cells (E), or NeuN (F) with quantification across total TERT+
cells (G; for each marker, N=5 males, 5 females, n=4 sections per brain assessed).
(F) Brain section containing TERT+BMPR1A+ cell along D3V. 1 TERT+BMPR1A+ cell was
identified across N=5 males, 5 females, n=8 sections per brain assessed.
Scale bars are all 100μm. Insets show indicated area at 2x digital zoom. LV: lateral ventricle, D3V:
dorsal third ventricle

TERT+ cells do not express markers of glial progenitors or glia in the brains of TERT-GFP direct
reporter mice
Adult gliogenesis, the generation of adult-born astrocytes and oligodendrocytes, occurs
throughout the brain in a less restricted pattern than adult neurogenesis, due in part to the mitotic
nature of mature astrocytes [356]. Since TERT+ cells were identified in neurogenic and nonneurogenic regions of the brain and expressed markers of adult stem cells but not differentiated
neuronal cell types, we subsequently performed immunostaining for markers of glial precursor
cells (GPCs) and mature glia. GPCs, which express neuron-glial antigen 2 (NG2), are found
throughout the adult brain and have been described as arise from Sox2+ and Nestin+ stem cells
[357]. Figure 2.5A depicts the changes gene expression across glial cell differentiation. Coimmunostaining revealed no co-expression of TERT with the GPC marker NG2, the
oligodendrocyte-lineage marker oligodendrocyte transcription factor 2 (OLIG2), nor the astrocytelineage marker GFAP (Figures 2.5B-H). Images using the OLIG2 antibody in the V-SVZ confirmed
labeling of mTERT-GFP with OLIG2+ cells (Figure 2.6A). These data indicated that TERT+ cells
in the murine brain are not glial-committed precursors, mature astrocytes, or mature
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oligodendrocytes. As GFAP is expressed by both astrocytes and ANSCs in the V-SVZ and SGZ
[19], we had initially hypothesized that some TERT+ cells would be GFAP+. However, we saw no
co-expression of TERT and GFAP in any brain region across numerous cohorts. Taken together,
TERT+ cells in the adult mouse brain cannot be characterized as glial progenitors or mature glia.
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Figure 2.5. TERT+ cells do not express markers of glial-committed progenitors or mature
glia.
(A) Schematic depicting glial lineage markers from glial-committed progenitors to mature glial cell
types in the adult mouse brain. Markers with red text were stained for in this figure.
(B-C) Immunostaining in the brains of adult mTert-GFP mice for the glial precursor cell marker
NG2 identified no TERT+NG2+ cells (N=5 males, 5 females, n=4 sections per brain analyzed).
(D-E) Immunostaining in the brains of adult mTert-GFP mice for the progenitor/ mature
oligodendrocyte marker OLIG2 identified no TERT+Olig2+ cells (N=5 males, 5 females, n=4
sections per brain analyzed).
(F-H) Immunostaining in the brains of adult mTert-GFP mice for the marker of immature/ mature
astrocytes as well as qANSCs identified no TERT+GFAP+ cells (N=5 males, 5 females, n=4
sections per brain analyzed).
Insets show indicated area at 3x digital zoom. Scale bars are 100µm. MEAav: media amygdalar
nucleus, anteroventral part, Me: meninges, TU: tuberal nucleus, LV: lateral ventricle, V-SVZ:
ventricular-subventricular zone. Grouped bar graphs show mean cells per mouse, per section at
each brain region ± SEM.
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Figure 2.6: TERT+ cells do not express markers of glial-committed progenitors or mature
glia.
(A) Schematic of a coronal mouse brain indicating area of Fig. 3B (Allen Brain Atlas).
(B) Positive control region for OLIG2 expression in the adult mouse brain. Scale bar is 100μm.
LV: lateral ventricle, V-SVZ: ventricular-subventricular zone.
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TERT+ stem cells trace to multiple areas of the adult mouse brain in a lineage-tracing mouse
model
Based on the premise that TERT+ cells are qASCs, we tested the hypothesis that TERT+
cells would proliferate, differentiate, and migrate within the adult mouse brain using an inducible
lineage tracing system [358]. Lineage tracing allows for an indelible tag such as the
bioluminescent luciferase or the fluorescent protein GFP to be expressed by each TERT+ cell
during a ‘pulse’ of the tetracycline derivative, doxycycline. If a cell population is labeled in this
way, a ‘chase’ period after drug administration will allow for lineage tracing of these cells as they
migrate, proliferate, or differentiate into mature cell types. Lineage tracing was performed with
mTert-rtTA::oTet-Cre::R26R-mTmG

(mTert-mTmG)

animals

[287].

In

these

animals,

recombination after doxycycline administration resulted in loss of membrane tomato expression
and activation of membrane (m)GFP expression through the doxycycline-inducible Tet-On system
(Figure 2.7A). To better understand large-scale changes occurring throughout major TERT+ brain
regions (i.e. proliferation and migration), various pulse-chase experiments were compared and
three different pulse-chase durations were utilized in these studies: a 2-day pulse, 0-day chase,
a 3-week pulse, 11-day chase, and a 3-week pulse, 14-week chase (Figure 2.7B). The 2-day
pulse, 0-day chase was the shortest possible time required for mGFP induction and was used to
compare to direct reporter mice [359]. The 3-week pulse, 11-day chase was chosen because
adult-born neurons are created in approximately 2-4 weeks in the SGZ, V-SVZ, and hypothalamus
[34, 58, 360-362] The 3-week pulse, 14-week chase was utilized to show long-term effects of
TERT+ cell proliferation, migration, and differentiation in the adult brain similar to the IVIS-CT
images.
Lineage tracing over the 3-week, 11-day pulse-chase period revealed expansion of mTertdriven mGFP signal throughout various brain regions when compared to mTert-GFP direct
reporter mice (Figures 2.7C-R; see Figure Legend for N, n values). Immunostaining of mTert-

82

GFP brains revealed TERT+ cells in proximity to the walls of the lateral ventricles (Figure 2.7C).
The expansion of this signal in the LV after a 3-week pulse, 11-day chase in mTert-mTmG animals
appears to be minimal, as traced mGFP+ cells were also found at low numbers (Figure 2.7D). It
is possible that TERT+ cells in the V-SVZ do not often give rise to V-SVZ or RMS cells under
basal conditions, but instead respond to injury, metabolic, or other plasticity promoting cues.
In the OB of mTert-GFP mice, TERT+ cells were identified in the periglomerular layer
(PGL; Figure 2.7E). Contrary to the low numbers of mGFP+ cells observed in the LV after lineage
tracing, high mGFP+ cell numbers were observed in the PGL and the olfactory nerve layer (ONL)
of the OB after a 3-week, 11-day pulse-chase, indicating proliferation and differentiation activity
of the qASCs in this niche (Figure 2.7F). Traditional V-SVZ neurogenesis leads to the formation
of adult-born neurons via migration of TACs and neuroblasts through the RMS into the GCL of
the OB. In accordance with the low number of Tert-GFP+ and lineage traced mGFP+ cells in the
V-SVZ (Fig. 4G-H), we also observed low numbers of mGFP+ cells within the GCL. These mGFP+
cells did not show a neuronal phenotype, indicating a possibly gliogenic pathway within or into
the OB (Figure 2.8A). Progenitors and immature neurons that migrate to the OB via the RMS will
integrate into the GCL more often than the PGL and ONL [24]. Although lineage tracing revealed
mGFP+ cells within the RMS (Figure 2.8B), we never observed lineage traced cells with a
neuronal morphology within the GCL that is typical of traditional V-SVZ-derived neurogenesis
(Figure 2.8C). Instead, mGFP+ cells were found at low numbers in the mitral layer of the OB with
similar morphology to the mGFP+ cells in the GCL (Figure 2.8E). It is therefore likely that adult
neurogenesis from TERT+ stem cells in the olfactory epithelium (OE), as observed by luciferase
signal after lineage tracing (Figures 2.7D and 2.7E) fueled the expansion of mGFP expression in
the PGL and ONL [24].
In the hypothalamus, adult neurogenesis regulates energy balance and metabolism via
the development of new adult-born proopiomelanocortin (POMC)+ and neuropeptide Y (NPY)+
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neurons, as well as hypothalamic glial differentiation [58]. Metabolic interventions such as high
fat diet increase neurogenesis in the median eminence (ME) of female mice while decreasing
neurogenesis in the arcuate nucleus (ARC) of both male and female mice [55]. Additionally,
treatment with the metabolic cytokine ciliary neurotrophic factor (CNTF), which causes weight
loss in obese rodents and humans, increases cell proliferation in feeding centers of the murine
hypothalamus, which is reversed with coadministration of the mitotic inhibitor cytosine-beta-darabinofuranoside (Ara-C), indicating that hypothalamic neurogenesis affects whole body energy
balance [55, 58]. Immunofluorescent analysis revealed that the hypothalamus contained TERT+
cells in mTert-GFP direct reporter animals (Figure 2.7G). Interestingly, TERT+ cells were also
identified nearby to the tanycyte region of the third ventricle (3V; Figure 2.8D). Tanycytes are
radial glial-like cells that line the ventricles and are implicated in glucose-sensing and stem-like
behavior [51]. Also, in the hypothalamus, we identified TERT+ cells in the ARC which contains
POMC and NPY neurons (Figure 2.7G). Compared to direct reporter mice, a larger number of
cells in the ARC and ME of the hypothalamus expressed mGFP after lineage-tracing, suggesting
TERT+ cell contribution to tissue turnover in this niche (Figure 2.7H). This large-scale expression
of mGFP when compared to the mTert-GFP hypothalamus (Figure 2.7G) may be attributed to the
membrane expression of large cells such as traced neurons, astrocytes, and microglia, which all
proliferate in the adult mouse hypothalamus, whereas the mTERT-GFP direct reporter animals
express a fainter fluorophore that is not membrane-expressed.
Interestingly, in the hippocampal DG, no TERT+ cells were ever identified (Figure 2.7I).
Lineage tracing also revealed no mGFP signal in any hippocampal region in mTert-mTmG
animals after a 3-week pulse,11-day chase (Figure 2.7J).
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Figure 2.7: Lineage tracing reveals that mTert+ cells give rise to a heterogeneous
population of cells in multiple plastic regions of the brain.
(A) Depiction of mTert-rtTA::oTet-Cre::R26R(mTmG) mouse model.
(B) Illustration of major pulse-chase timings utilized across both lineage-tracing mouse lines.
(C-J) Representative images of TERT+ cells from immunofluorescent analysis across classical
neuro/gliogenic brain regions in direct reporter mice versus mTert-mTmG mice after a 3-week,
11-day pulse-chase. Images taken of mTert-GFP brains in the LV (C), OB (E), hypothalamus (G),
and hippocampus (I) (N=2-11 of 11 mice showed this signal [N=2-5 of 5 males, 0-6 of 6 females],
n=4-20 sections per brain analyzed). Representative images of adult mTmG lineage tracing mice
after a 3-week, 11-day chase in the LV (D), OB (F), hypothalamus (H), and hippocampus (J);
N=6-10 of 10 mice showed this signal; 3-4 of 4 males, 3-6 of 6 females, n=1-23 sections per brain
analyzed).
(N-U) Immunofluorescent analysis across novel neuro/gliogenic regions in mTert-GFP (K,M,O,Q);
N=2-6 of 6-10 mice showed this signal [N=1-3 of 3-5 males, 1-3 of 3-5 females], n=8-12 sections
per brain analyzed) and mTmG mice after a 3-week pulse, 11-day chase (L,N,P,R; N=8-11 of 11
mice showed this signal [N=4 of 4 males, 4-7 of 7 females], n=1-19 sections per brain analyzed).
Scale bars are 100µm. Insets show indicated area at 3x digital zoom. LV: Lateral Ventricle, PGL:
periglomerular layer, MiL: mitral layer, 3V: third ventricle.

86

87

Figure 2.8: Lineage tracing reveals that TERT+ cells give rise to a heterogeneous
population of cells in multiple plastic regions of the brain.
(A) Representative image of TERT+ cells in the OB of mTert-GFP animals, specifically the GCL
(A’) and PGL (A’’) of mTert-GFP brains (identified in N=2 of 5 mice [N=2 of 3 males, 0 of 3
females], n=8-14 sections per brain assessed).
(B) Representative image of mGFP+ cell within the GCL of mTert-mTmG mice after a 3-week,
11-day lineage tracing experiment (identified in N=8 of 10 mice [N=3 of 4 males, 5 of 6 females],
n=13-23 sections per brain assessed).
(C) Representative image of mGFP+ cell within the RMS of mTert-mTmG mice after a 3-week,
11-day lineage tracing experiment (identified in N=3 of 10 mice [N=2 of 4 males, 1 of 6 females],
n=1-5 sections per brain assessed).
(D) mGFP+ cells within the MiL after lineage trace (identified in N=2 of 10 mice [N=1 of 4 males,
1 of 6 females], n=13-22 sections per brain assessed.
(E) Hypothalamic TERT+ cell within the tanycytic layers of the third ventricle (3V) (identified in
N=1 of 11 mice [N= 1of 5 males, 0 of 6 females], n=4-20 sections per brain assessed).
(F-I) Representative images of mGFP+ cells following a 3-week, 11-day pulse-chase in the
cerebellum identifying Bergmann glia (F), granule cells G), basket cells (H), and Purkinje neurons
(I) (seen in N=8-11 mice [N=4 of 4 males, 4-7 of 7 females], n=4-19 sections per brain assessed).
Scale bars are 100μm.
J-K) TERT mRNA identified through RNAscope in the lateral ventricle and RMS (J) and
hippocampus (K) of an adult WT BL/6 mouse (N=1).

TERT+ stem cells expand after lineage tracing in novel neuro/gliogenic niches of the adult mouse
brain
TERT+ cells were also identified in brain regions where plastic potential has been
observed but remains poorly understood. These regions, which included the cerebellum,
meninges, and ChP, contain proliferative stem cells with the ability to differentiate [153, 363-365].
Within the cerebellum TERT+ cells were identified in direct reporter mice (Figure 2.7K). While
TERT+ cells were sparse within the cerebellum, lineage tracing resulted in a large-scale
expansion of mGFP signal throughout various cell types and regions of the cerebellum not seen
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in mTert-GFP animals (Figures 2.7K and 2.7O). We confirmed traced cell types in the cerebellum
that had the morphological identity of Bergmann glia (Figure 2.8E), granule cells (Figure 2.8F),
basket cells (Figure 2.8G) and Purkinje neurons (Figure 2.8H). When compared to the rare
TERT+ cells in mTert-GFP mice, the increased number of TERT-traced cells with the clear
morphological identity of mature cell types within the cerebellum indicate TERT+ cells give rise to
mature cell types.
The meninges also harbored TERT+ cells in mTert-GFP mice (Figure 2.7M). Lineage
tracing revealed mGFP+ expression increased compared to direct reporter expression in the
meninges (Figure 2.7N). These patterns were observed within the ChP as well (Figures 2.7O and
2.7P). These brain regions sit at the blood-brain barrier and blood-cerebrospinal fluid (CSF)
barrier interface and play a major role in immune cell trafficking [366]. The ChP produces CSF,
which in turn coordinates neurogenesis via the production of growth factors throughout the
ventricular regions of the brain, including the lateral and third ventricles, and hypothalamus [135,
367]. Finally, In the OE, mTert-GFP animals showed low numbers of TERT+ cells (Figure 2.7Q).
After a 3-week, 11-day lineage tracing experiment, mGFP+ cells were found at higher numbers
throughout the OE compared to the direct reporter animals (Figure 2.7R), supporting the idea that
newborn olfactory sensory neurons (OSNs) in this niche may be observed within the olfactory NL
and PGL. Taken together, TERT+ cells give rise to adult-born cells in most, but not all classical
and newly discovered neurogenic brain regions.

Lineage tracing of TERT+ cells increased mGFP expression with the pulse-chase duration
Expansion of the mGFP+ cell labeling over increasing pulse-chase times was observed in
the OB, from the 2-day pulse, 0-day chase to the 3-week pulse, 14-week chase. It is important to
note that these changes occur primarily in the ONL and PGL (Figures 2.9A-C). The fact that
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TERT+ cells exist within the OB in direct reporter animals indicates the possibility of TERT+ cell
proliferation within the OB instead of primarily via migration, however, the extent of GFP
expression after a pulse-chase in the PGL and NL implies that this is in combination with
neurogenesis in the OE so this may be an additional anatomical source of OB GFP signal. mGFP+
cell expansion was also identified in the cerebellum between the 2-day pulse, 0-day chase and
3-week pulse, 14-week chase (Figures 2.9D-E), but fluorescent intensity was reduced into the 3week, 14-week pulse-chased cerebellum (Figure 2.9E). Within the hypothalamic ARC a trend was
observed towards increased fluorescent intensity between 2-day pulse, 0-day chase and the other
treatments (Figures 2.9G-H). The thalamus also showed a trend towards increased mGFP signal
intensity between animals treated with a 2-day pulse, 0-day chase and 3-week pulse, 11-day
chase (Figures 2.9H-I). Over all three pulse-chases, we rarely observed mGFP traced cells in the
V-SVZ and RMS (Figures 2.10A-B).
Intracerebroventricular (i.c.v.) treatment with the mitotic inhibitor cytosine-beta-darabinofuranoside (Ara-C) resulted in a reduction of DCX+ cells along the lateral ventricle wall/VSVZ (Figures 2.10C-E) but did not result in changes to the fluorescent intensity of lineage-traced
mGFP expression in cells in the LV ChP (Figure 2.10F). Ara-C treatment did not significantly
decrease mGFP expression in the OB, indicating that the mGFP signal within the OB likely does
not originate from the V-SVZ (Figure 2.10G).
FACS analysis of a lineage-traced brains following a 3-week pulse, 11-day chase
identified that mGFP cells accounted for 3.8% of the full adult mouse brain and formed
neurospheres in culture, much higher numbers than what was observed in the mTERT-GFP direct
reporter mice (Figure 2.10H), consistent with our immunostaining observations. These cells
exhibited neurosphere formation as well (Figure 2.10H).
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Figure 2.9: Lineage tracing reveals numerous brain regions with high basal plasticity and
differentiation of TERT+ precursors that increase with pulse-chase time. mTert-mTmG
mouse brains were immunostained following a: 2-day pulse, 0-day chase (N=5 males, 5 females);
3-week pulse, 11-day chase (N=4 males, 8 females); or 3-week pulse, 14-week chase (N=6
females).
(A-N) Representative images of each of the OB (A), OB PGL (B), cerebellum (C), hypothalamus
(D), and thalamus (E). Representative images of sagittal-view brain regions of interest were
obtained from the Allen Brain Atlas. Quantification of mean fluorescent intensity of mGFP
expression (± SEM) per mouse across lineage tracing in the OB PGL (C), cerebellum (E),
hypothalamus (G), and thalamus (I). For each brain region imaged, N=4-10 mice, n=1 section per
brain. Dots represent mean fluorescent intensity of individual animals (N=4-10; *P < 0.05, **P <
0.01, ****P < 0.001).
All scale bars are 100µm. All images taken at the same sagittal depth. Dotted lines indicate the
PGL identified in the OB.
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2.10: Lineage tracing of TERT+ cells revealed low numbers of traced cells in certain adult
brain niches, which were unaffected by mitotic inhibition. Lineage traced cells were able
to form neurospheres, and did not show increased expression of activation or
differentiation markers.
(A-B) Representative images of each of the V-SVZ (A), and RMS (B). Representative images of
sagittal-view brain regions of interest were obtained from the Allen Brain Atlas. mTert-mTmG
mouse brains were immunostained following either a: 2-day pulse, 0-day chase (N=5 males, 5
females), 3-week pulse, 11-day chase (N=4 males, 8 females), or 3-week pulse, 14-week chase
(N=6 females).
(C-D) Representative image of the LV of a vehicle treated mouse (C) and Ara-C treated mouse
(D). For both, N=4 mice, n=1 section per brain assessed. Dotted lines indicate areas of the VSVZ and RMS where DCX expression is observed under basal conditions.
(E) Fluorescent intensity of DCX signal in the V-SVZ of Ara-C or vehicle treated mice (N=4 mice,
n=1 section per brain assessed).
(F-G) Fluorescent intensity of GFP signal in the LV ChP (G) or OB (H) of Ara-C or vehicle treated
mice quantified by frame of vision (N=2-4 mice, n=1 section per brain assessed).
(H) FACS analysis of 3-week pulse, 11-day chase (J; N=4) lineage-traced mouse brains and the
ability of GFP+ cells to form neurospheres in culture. P3: GFP+, P2, P4: GFP-. PE-Texas Red-A
used to analyze membrane tomato signal.
Scale bars all 200μm except for D and E, which are 100μm. Bar graphs show mean +/- SEM.
Dots indicate individual animals. ***P = 0.005.

TERT cells give rise to immature and mature neuronal cell types in lineage-tracing animals
In order to identify the cell types arising from lineage-traced TERT+ populations across
the adult mouse brain, we co-stained mGFP+ cells from mTert-mTmG lineage traced mice with
markers of activated ASCs, TACS, neuroblasts, and neurons. The brain regions where images
were taken are represented in Figure 2.11A. The neuronal differentiation pathway is again shown
in Figure 2.11B for reference. In the V-SVZ, the activation marker EGFR never co-localized to
lineage traced mGFP+ cells after a 2-day, 0-day pulse-chase, nor the 3-week, 11-day pulsechase, and only co-localized rarely with mGFP+ cells from 3-week, 14-week lineage-traced mTert-
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mTmG animals (Figure 2.11C). While these data indicate that TERT+ cells often do not become
activated, it does suggest that some animals may incur activation of TERT+ cells in the V-SVZ
under certain situations and over longer time periods.
After a 3-week, 11-day lineage trace, mGFP+ cells in the ventricular lining and V-SVZ
were negative for the stem cell marker Sox2 (Figure 2.12A). Interestingly, mGFP+Sox2+ cells
were found in the midbrain (Figure 2.12B) and in the RMS after a 3-week, 11-day pulse-chase
(Figures 2.11D and 2.8C). A subpopulation of mGFP+ cells in the RMS were DCX+ neuroblasts
(Figure 2.11D). mGFP+ cells found in proximity to the RMS were DCX- and lacked the neuroblast
phenotype (Figure 2.12C), indicating they may not be migrating neuronal precursors. The
activation marker EGFR was co-expressed by lineage-traced mGFP+ cells in the brainstem after
a 3-week, 11-day pulse-chase (Figure 2.12D). Finally, although no mGFP+ cells were found in
the SGZ of the hippocampus after a 2-day, 0-day pulse-chase, nor following the 3-week, 11-day
pulse-chase, we did observe 1 mGFP+ cell cluster in the DG of the hippocampus after the 3week, 14-week pulse-chase (Figure 2.12E). This cluster of cells in the DG was EGFR+ (Figure
2.12E). Taken together, mGFP+ cells in the V-SVZ, RMS, and DG have the capacity to express
markers of ASCs or progenitor cell types, indicating a cell type that has the potential to become
activated in neurogenic brain regions, but TERT+ expression in these classical niches is far lower
than in non-classical niches of the brain.
Lineage-traced cells co-expressed the mature neuron axonal marker NCAM in the
olfactory bulb (Figure 2.11E). NCAM is expressed only in the ONL and PGL, and marks all PGL
compartments due to expression of NCAM in olfactory sensory neurons [368]. mGFP signal was
highly expressed in the ONL, but did not fill all PGL compartments after either a 3-week, 11-day
nor after a 3-week, 14-week pulse-chase (Figure 2.11E). Unexpectedly, about half of female
animals showed low or no mGFP signal in the ONL and PGL after a 3-week, 11-day pulse-chase,
whereas all of the males had bright signal (Figure 2.12F). This was a rare display of sexual
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dimorphism in these mouse models. The mature neuron marker TUJ1 was expressed by mGFP
cells in the midbrain, identifying these cells as mature neurons (Figures 2.11F). Lineage-traced
cells in the cerebellum also expressed TUJ1 and showed morphology indicative of mature
neurons (Figure 2.11G). Taken together, it is clear that TERT+ cells give rise to a variety of
neuronal cell types throughout the brain, which we confirmed by co-staining with mature cell
markers, in both classic and non-classic neurogenic regions.
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Figure 2.11. Lineage tracing of TERT+ cells revealed immature and mature neuronal cell
types throughout the adult mouse brain, confirming the multipotency of TERT+ ASCs.
(A) Sagittal mouse brain indicating the region each image was captured C-G (Allen Brain Atlas).
(B) Schematic depicting neuronal lineage markers; quiescent stem cell to mature neuron. Markers
with red text were stained for in this image.
(C) Co-staining of lineage tracing mice after a 3-week, 14-week pulse-chase with the activated
marker (EGFR). Both mGFP+EGFR+ (C’, white arrow) and mGFP+EGFR- (C’’, green arrow) cells
were identified. No other mGFP+ cells expressed EGFR in the V-SVZ (N=5 males, 5 females with
2-day, 0-day pulse-chase, n=2 sections per brain; N=4 males, 4 females with 3-week, 11-day
pulse-chase, n=2 sections per brain; N=6 females with 3-week, 14-week pulse-chase, n=2
sections per brain).
(D) Immunostaining of mTert-mTmG brains after a 3-week, 11-day pulse-chase stained with the
neuroblast marker DCX in the RMS (seen in N=1 of 4 mice [N=1 of 2 males, 0 of 2 females], n=2
sections per brain analyzed)
(E) Representative image of co-immunostaining of OB stained with the olfactory sensory neuron
marker NCAM after 3-week, 11-day pulse-chase (seen in N=4 of 5 mice [N=2 of 2 males, 2 of 3
females], n=2 sections per brain).
(F-G) Representative images of co-immunostaining with the mature neuron marker TUJ1 in the
brainstem (F; N=2 of 4 mice [N=1 of 2 males, 1 of 2 females]) and cerebellum (G; N=3 of 4 mice
[N=2 of 2 males, 1 of 2 females]) after a 3-week, 11-day pulse chase.
Scale bars are 100µm. Co-stained cells are indicated with white arrows. Cells that express mGFP
only are indicated with green arrows. Insets show 4x digital magnification of indicated area. RMS:
rostral migratory stream, MoL: molecular layer, GCL: granule cell layer, V-SVZ: ventricularsubventricular zone.
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Figure 2.12: Lineage trace of TERT cells leads to labeling of immature and mature neuronal
cell types throughout the adult mouse brain.
(A-B) Representative images of 3-week, 11-day pulse-chased mTert-mTmG mouse brains
stained for the stem cell marker Sox2 in the V-SVZ (A; N=2 of 2 females, n=2 sections per brain
assessed) and midbrain (B; N=2 of 2 males, 2 of 2 females, n=2 sections per brain assessed).
(C) Representative image of mGFP+DCX- cell in proximity to RMS after 3-week, 11-day pulsechase (cells identified in N=2 of 4 males, n=1-5 sections per brain assessed).
(D) Co-immunostaining with EGFR after 3-week, 11-day pulse-chase in the brainstem (N=1 of 2
males, n=2 sections per brain assessed).
(E) TERT+EGFR cell identified within the DG after a 3-week, 14-week pulse-chase. 1 mGFP+
cell was found within the DG across 78 brain sections in 3-week, 14-week pulse-chased animals
(N=1 of 6 females, n=13 sections per brain analyzed). No mGFP+ cells were identified in the DG
in 2-day, 0-day or 3-week, 11-day pulse-chased animals (N=4 males, 6-8 females, n=2 sections
per brain analyzed).
(F) Representative image from a subset of female mice that showed little to no signal within the
PGL or NL layers of the OB co-stained with the olfactory sensory neuron marker NCAM (N=3 of
10 mice [N=0 of 4 males, 3 of 6 females], n=2 sections per brain assessed).
(G) mGFP signal in the OB NL and PGL co-stained with Vimentin (N=7 of 10 mice [N=4 of 4
males, 3 of 6 females], n=2 sections per brain assessed). All images taken in sagittal plane. Scale
bars are 100μm. Insets show 2x digital magnification. Arrows indicate expression of GFP (green),
other indicated marker (magenta), or co-staining (white).

TERT cells give rise to various non-neuronal cell types including glia
After a 3-week, 11-day pulse-chase, mGFP+NG2+ cells were identified in the cerebellum
(Figure 2.13C). These cells were therefore likely either GPCs or oligodendrocyte-restricted
progenitors, whereas NG2+ cells in the meninges were not mGFP+ (Figure 2.14A). Lineagetracing also revealed mGFP+OLIG2+ oligodendrocyte-lineage cells in a variety of brain regions,
including the cerebellum, RMS, midbrain, and IoC (Figures 2.13D-2.13E and 2.14B-C).
mGFP+GFAP+ cells in the astrocyte-lineage were observed in dense regions of the ventral
hypothalamus (Figure 2.13F). Lineage-traced mGFP+ cells were identified lining all the ventricles
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of the adult mouse brain and expressed ependymal markers Vimentin and GFAP (4th ventricle
shown in Figures 2.13G-2.14D). While rare, TERT-traced cells also expressed the microglial
marker Iba1, indicating that TERT+ qASCs can differentiate into microglia in the adult mouse
brain (Figure 2.14E). In addition to glial cell types, lineage tracing revealed mGFP+ mature ChP
epithelial cells expressing AQP1 (Figure 2.14E). Taken together, TERT+ cells give rise to various
glial cell types, in addition to neuronal cell types, throughout the adult mouse brain.
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Figure 2.13. Lineage tracing of TERT+ cells revealed immature and mature glial cell types
throughout the adult mouse brain, confirming the multipotency of TERT+ ASCs.
(A) Sagittal mouse brain indicating areas of images C-G (Allen Brain Atlas).
(B) Schematic depicting neuronal lineage markers of glial-committed progenitors through mature
astrocytes and oligodendrocytes. Red text indicates markers stained in this figure.
(C-G) Co-staining of 3-week 11-day pulse-chased lineage tracing mice with the glial progenitor
marker NG2 (C), the oligodendrocyte marker Olig2 (D-E), the hypothalamus (F), and the 4th
ventricle (G) (N=4-5 of 5 males, 5-6 of 6 females showed this signal, n=2 sections per brain
analyzed).
Scale bars are 100µm. White arrows indicate cells that co-express markers of interest. Insets
show 2x digital zoom of indicated area. RMS: rostral migratory stream, MoL: molecular layer,
GCL: granule cell layer, BV: blood vessel. 4V: 4th Ventricle
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Figure 2.14: TERT+ cells give rise to numerous non-neuronal cell types, including glia,
following lineage tracing
(A) Representative image of co-immunostaining with NG2 in 3-week, 11-day pulse-chased mTertmTmG lineage tracing mice (N=5 of 5 mice [N=2 of 2 males, 3 of 3 females], n=2 sections per
brain assessed).
(B-C) Representative OLIG2 co-staining with GFP in 3-week, 11-day pulse-chased mTert-mTmG
mouse brains in the midbrain (B; N=3 of 4 mice [N=2 of 2 males, 1 of 2 females], n=2 sections
per brain assessed) and IoC (C; N=4 of 4 mice [N=2 of 2 males, 2 of 2 females], n=2 sections per
brain assessed).
(D) Representative co-staining of the astrocytic and ependymal marker GFAP in the 4V of 3-week,
11-day pulse-chased mTert-mTmG brains (identified in N=2 of 10 mice [N=2 of 4 males, 0 of 6
females], n=2 sections per brain assessed). Scale bars are 100μm. Insets show 2x digital zoom
of indicated area. White arrows identify co-staining.

Discussion
Although adult neurogenesis was first discovered in avian brains in 1984 [369] and murine
brains in 1992 [370, 371], the first evidence of human adult neurogenesis was as recent as 1998
[11]. The current understanding is that stem cells that can give rise to new mature neurons in the
adult mammalian brain are restricted to certain neurogenic niches. Recently, these views have
been challenged by the identification of stem cells that can give rise to neurons and glia in
numerous other brain regions, such as the ChP [153], meninges [365], cerebellum [363], and
more [343]. Here we report the identification of a rare, multipotent population of TERT+ qASCs in
the adult murine brain. These TERT+ cells are distinct from GFAP+/Nestin+/Sox2+ cells, often
termed quiescent adult neural stem cells (qANSCs) found within the SGZ or V-SVZ. While
GFAP+/Sox2+/Nestin+ cells in the adult mouse brain are restricted to differentiation to neurons,
astrocytes, and oligodendrocytes, TERT+ cells are truly multipotent and can differentiate into
various subtypes of neurons, astrocytes, oligodendrocytes, ependymal cells, and choroid plexus
epithelial cells. TERT+ qASCs are also less restricted anatomically than classical GFAP+
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qANSCs, and we observe them in the basal state in numerous plastic brain regions. Due to the
relative quiescence and multipotency of TERT+ cells, it is possible that previously described
ANSCs in SVZ and SGZ may also be a mix of quiescent and activated stem cells and committed
progenitors.
Despite the identification of molecular markers expressed by ANSCs in prior research, a
specific and unique marker for qASCs in the adult mammalian brain had not yet been identified.
Nestin, GFAP, GLAST, Sox2, and other markers have been proposed to mark slowly cycling
multipotent stem cells, but each of these also marks multiple non-stem cell types throughout the
brain. Nestin marks endothelial and meningeal cell types, GFAP and GLAST mark mature glia,
and Sox2 is widely expressed throughout the brain. For these reasons, there is controversy in the
field regarding the phenotype and localization of true qASCs in the brain [163]. TERT was an
appealing candidate given the numerous prior studies investigating TERT+ qASCs in multiple
tissues and organs. We now believe that TERT represents a more unique and specific marker of
adult qASCs in the brain, as demonstrated by the low frequency of TERT+ cells in direct reporter
mice and the ability of these cells to contribute to tissue turnover of mature numerous cell types
as demonstrated in lineage tracing mice.
As discussed, a large percentage (53%) of TERT+ cells in the adult mouse brain express
the immune cell marker CD45 (Figure 2.2). While TERT does mark a population of CD45+
immune cells in the brain these cells are likely circulating lymphocytes, as the majority of TERT+
CD45+ cells were identified in the ChP and meninges, brain regions with high immune infiltration.
Human TERT (hTERT) is expressed by lymphocytes isolated from thymus, tonsil, and peripheral
blood [372]. Therefore, TERT+CD45+ co-expressing cells may be infiltrating immune cells from
the periphery via the bloodstream and glymphatic system. Previous studies have investigated the
transdifferentiation of bone marrow derived TERT+CD45+ cells and concluded that
TERT+CD45+ cells do not transdifferentiate into stroma, epithelium, and endothelium in the
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endometrium [373]. Thus, TERT+CD45+ cells likely represent a committed or mature cell type
that retains TERT expression, instead of a plastic cell type capable of renewing adult tissue like
we describe here. Since CD45+ lymphocytes are post-mitotic, they are unlikely to contribute in
any meaningful way to the lineage tracing observations in this study. It remains a possibility that
a population of TERT+ cells are CD45-low microglia, which have mitotic properties. Further
studies should investigate the role of TERT+ microglia in adult brain plasticity.
TERT+ cells represent a potentially heterogeneous population due to variable expression
of CD45, Ki67, Nestin, and Sox2 observed in TERT-GFP+ cells. TERT was originally
hypothesized to be expressed only by proliferative cells, since the telomerase enzyme, which is
composed of TERT and a telomerase RNA component, prevents telomere shortening during
chromosomal replication, thus allowing for continued cell division [374]. However, in other adult
murine tissues such as the intestine, where TERT+ stem cells are low in number and rarely
express Ki67, TERT clearly marks a population of adult tissue stem cells that are slowly cycling
and quiescent. TERT may therefore carry out non-canonical functions in quiescent stem cells;
indeed, tight mitochondrial control of the balance of glycolysis and oxidative phosphorylation is
required in stem cells and TERT is understood to influence mitochondrial function distinct from its
role in telomere extension [375]. The discovery of mostly non-proliferating, regenerative,
multipotent TERT+ stem cells in the intestine, bone marrow, liver, adipose, long bone, kidney,
heart, and now brain, is strong collective evidence for TERT as a marker of quiescent adult tissue
stem cells [283-288, 344, 347, 348].
The ability of TERT+ cells to form neurospheres in vitro further supports these cells identity
as neural stem cells, as the formation of neurospheres is a characteristic response, whereby
proliferative stem cells can respond to cues such as the growth factors found in neurosphere
culture media that activate the stem cells. As TERT+ cells appear to be quiescent in vivo, it is
likely that the loss of GFP observed over time in neurospheres in vitro occurred due to activation
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by EGF and bFGF in the culture media, leading to a proliferative and neurosphere-forming
phenotype. Although TERT+ cells were activated in culture and could proliferate, as determined
via EdU incorporation assays, TERT neurospheres were small, rarely reaching 50um. It is for this
reason that no secondary sphere formation assays were assessed, although further experiments
should be performed to determine whether TERT+ cells have the potential to grow enough for
secondary sphere assays.
mTert-GFP direct reporter mice express GFP under the control of 4.4kb fragments of the
mTert promoter region [284]. These cells express high levels of Tert mRNA transcripts as well as
variable levels of GFP [284]. Analysis of this protein has been hindered by the lack of a specific
TERT antibody. While the caveat remains that TERT-GFP+ cells could only be expressing the
Tert mRNA and not translating to the TERT protein, prior studies have identified TERT-GFP+
cells exhibit telomerase activity, indicating the presence of functioning TERT protein within these
cells [284]. mTert-rtTA::oTet-Cre::Rosa-mTmG mice have been validated previously as well in
bone [287]. These TERT mouse models have also been utilized and validated in numerous prior
tissue stem cell studies [283-285, 287, 288, 344, 347].
Although the V-SVZ and SGZ are classical neurogenic niches, there remains debate about
how much the neurogenic capacity in these regions in rodent models translates to the adult human
brain, as there are substantial discrepancies between human and mouse adult neurogenesis in
both the V-SVZ and SGZ [376]. It is not yet fully understood where adult-born neurons from the
human V-SVZ travel, as the human RMS remains elusive, however, some research indicates
progeny of human V-SVZ ANSCs are destined for the striatum rather than the OB, which is much
smaller in humans than mice [341]. In the human hippocampus, neurogenesis analysis relies
heavily upon the presence of immature neurons, proliferative cells, and label retaining cells [11,
190, 194, 195, 197, 200]. Whether these immature neurons are derived from a population of stem
cells within the niche, were created earlier in life as a pool of committed progenitors, or migrate
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to the hippocampus from other brain regions, is currently unresolved. Additionally, depending on
the analysis, adult human brains demonstrate rare or nonexistent hippocampal neurogenesis
[196, 198, 199]. The underlying reason for the addition of these adult-born neurons in the striatum,
and whether adult hippocampal neurogenesis in the DG persists past a few months into adult
human life is still contested [190, 199, 201, 377-380]. Finally, it must be noted that while mTert
mRNA expression and telomerase activity in the adult brain has been observed in mice [299]. In
humans, while TERT expression has been observed [267, 298, 381], there is no evidence of
human telomerase activity in the brain [298, 382]. In fact, human telomerase activity is decreased
in the brain to undetectable levels after the 16th week of gestation [382].
It is possible that the most well-described adult neurogenic niches are mostly populated
with committed neural progenitors and not multipotent qASCs, or they may represent a non-TERT
separate pool of stem cells. This is supported by the rarity of TERT+ cells within the V-SVZ in
both mTert-GFP and lineage tracing mice. Indeed, as we observed few TERT-traced cells within
the RMS and GCL of the OB, it is likely that the V-SVZ/OB neurogenic axis does not populate the
GCL with adult-born neurons as do GFAP+ cells within the V-SVZ. Previous studies have
described the V-SVZ in TERT KO mice, wherein neurogenesis was significantly reduced [304].
TERT+ cells likely contribute to the neurogenesis in this region, although the process by which
this occurs remains unknown. Our observations of TERT in the hippocampus in our two mouse
models indicated that TERT+ cells may play a minimal role in adult neurogenesis in the SGZ. We
only observed rare EGFR+ lineage-traced clusters of cells in the SGZ, even after a 3-week pulse,
14-week trace experiment in mTert-mTmG animals. The rarity of these events paired with the lack
of TERT+ cells seen throughout the SGZ in mTert-GFP direct reporter mice, indicates that TERTdriven hippocampal neurogenesis may occur rarely, or at an extremely slow rate in the basal
state. There is evidence that TERT overexpression in the hippocampus of Tert-/- mice improves
the reduced dendrite outgrowth of DCX+ intermediate progenitors within the DG [305]. These
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results indicate a role for TERT in the hippocampus. This paper utilizes TERT overexpression in
a TERT KO mouse, which differs from our basal animals. The authors of this paper utilize TERT
overexpression to reintroduce TERT expression in the brains of TERT KO mice, but by doing so
may be introducing TERT expression to cells which may not express TERT under a basal state,
which may explain the differences observed between the role of TERT expression and DCX+
intermediate progenitors and the lack of TERT in the DG observed by us. TERT+ cells and their
progeny may be a rare quiescent stem cell population within these niches that do not proliferate
or differentiate under basal conditions, in contrast to the intermediate progenitor cell types such
as DCX+ neuroblasts. The lack of TERT+ cells in the DG and rarity of lineage tracing to
hippocampal cell types do not support a role for TERT within the hippocampus during basal states.
However, as both the V-SVZ and DG are areas of the brain that respond to various external
stimuli, the potential for TERT effects in the hippocampus should be taken into consideration in
further studies.
TERT+ cells and lineage-traced expansion of TERT+ cells and their progeny were
identified through the adult mouse brain outside of the classical neuro/gliogenic niches, but within
niches with prior evidence of adult neuro/gliogenesis. Lineage tracing revealed an increased
number of GFP+ cells (meaning they derived from TERT+ precursors) compared to TERT direct
reporter animals, across brain regions that included the meninges, ChP, cerebellum, brainstem,
and thalamus. The presence of a rare population of TERT+ qASCs in these regions that gave rise
to large numbers of multiple cell types clearly demonstrated that adult neuro/gliogenesis occurs
in a far less restricted manner than previously believed. During development, neuroblasts migrate
from the early postnatal V-SVZ to the medial prefrontal cortex, striatum, nucleus accumbens, and
IoC. The cerebellum contained rare TERT+ cells in mTERT-GFP mice, but after lineage tracing,
a large number of various mature cerebellar cell types were observed. While the cerebellum is
known to harbor Sox2+ stem-like cells, the expansion of mature cell types from this stem cell
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population is less than the V-SVZ or DG. Therefore, it was surprising to see such high levels of
neuro/gliogenesis in the cerebellum after lineage tracing.
In the hypothalamus, a more recently identified neuro/gliogenic niche of the adult mouse
brain, we identified expansion of mGFP+ cell signal within the ME and ARC. These cells did not
co-express any glial cell markers. While these cells may have been neurons, which were created
or expanded upon lineage tracing, these cells remain to be identified. In the hypothalamus, adultborn neurons and glia have been produced within the ARC and ME although the stem cell
population that produces these cells is currently unknown. Additionally, this niche contains
proliferative NG2+ glia and Olig2+ oligodendrocyte progenitor cells, which may contribute to the
observed expansion of lineage traced mGFP+ signal.
Based on our data, we hypothesize that maintenance of a TERT+ population of ASCs in
the brain is necessary to retain neurogenic and gliogenic potential throughout adulthood.
Dysfunction in the maintenance of this population may play a role in the cognitive deficits seen in
aging and neurodegenerative diseases. For example, TERT KO animals show decreased V-SVZ
neurogenesis and stem cell numbers in adults, implicating TERT in stem cell renewal and niche
function [304]. Consistent with this hypothesis, analysis of telomerase activity in the V-SVZ after
injury shows that TERT+ cells may be injury-responsive [269]. In other adult tissues, TERT+ cells
respond to injury by significantly increasing turnover and it is possible that these cells may not
proliferate at high levels under homeostatic conditions, even in proliferative brain regions [285,
286]. The fact that telomerase activity in the V-SVZ is induced after injury may explain why low
numbers of TERT+ cells and lineage-traced cells were observed in the V-SVZ during a basal
state, as injury may be required for these cells to become activated.
In summary, we have identified a quiescent, multipotent stem cell population in the adult
mouse brain which expresses TERT. These cells are located in various regions of the adult mouse
brain and give rise to numerous adult-born mature cell types in the basal state of tissue turnover
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and regeneration. Surprisingly, only a small population of TERT+ cells and their progeny were
found in the traditional V-SVZ, RMS, and OB neurogenic niches, while no population of TERT+
cells existed in the SGZ. We hypothesize that the low number of GFP+ and mGFP+ cells identified
in these classically neurogenic niches indicates that TERT+ cells may be a separate population
of ASCs in the adult mammalian brain, or that they could have given rise to the stem/progenitor
cells that have been previously studied in adult neurogenesis in these niches, earlier in
development. It is also possible that these classical niches house activated stem cells or
committed progenitors, but not qASCs, if TERT marks the sole qASC population in the brain.
Intriguingly, TERT+ qASCs express only a subset of the markers previouly used for ANSCs, which
could be because they are a true multipotent stem cell and not a purely neural/glial committed
stem cell.
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CHAPTER 3

SINGLE-CELL RNA SEQUENCING OF TERT LINEAGE-TRACED CELLS IN THE BRAIN
REVEALS A ROLE OF TERT-DERIVED CELLS IN THE PROCESS OF NEUROPROTECTION
AND NEURAL PLASTICITY IN RESPONSE TO CALORIC RESTRICTION

Abstract
Caloric Restriction (CR) as a dietary intervention extends lifespan and modulates adult
neurogenesis throughout the adult brain, including the dentate gyrus (DG) of the hippocampus
and the olfactory bulb (OB). However, the hypothalamus, which is another major neurogenic niche
of the adult brain, and which coordinates energy balance throughout the body, has not been
extensively studied in the context of CR. As neurogenesis within the hypothalamus is required for
ciliary neurotrophic factor (CNTF)-induced weight loss and high-fat diet (HFD)-induced weight
gain, it is understood that hypothalamic neurogenesis is vital for energy balance and metabolism.
To understand the role of CR in adult hypothalamic neurogenesis, we performed single cell RNA
sequencing (scRNAseq) using cells lineage traced from telomerase reverse transcriptase
(TERT)-expressing cells in the adult mouse brain. TERT is expressed by a subset of adult stem
cells (ASCs) that give rise to adult-born neurons and glia throughout the brain. CR treatment on
adult mTert-rtTA::oTet-Cre::Rosa-mTmG lineage tracing animals revealed a decrease in TERTtraced cell signal within the median eminence (ME) of the hypothalamus, with no change in the
arcuate nucleus (ARC), when compared to unrestricted diet (UR)-treated animals. CR treatment
also revealed an increase in the neuroprotective gene brain lipid binding protein (BLBP) in TERTtraced cells after 1 month of CR. As neuroprotection is a classical response to inflammation, we
then studied the role of TERT+ cells in the inflammatory process of aging. TERT+ cell numbers
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varied with aging across neurogenic niches but remained a similar percentage of the full brain.
However, TERT-traced cell signal increased significantly with aging, although label retention
decreased. Aging was also required for the expression of BLBP in TERT-traced cells in the 4th
ventricle. CR treatment in aged mice did not induce expression of neuroprotective or immune
markers BLBP or Iba1 in TERT-traced cells within the hypothalamus. In all, lineage tracing of
TERT+ ASCs in the adult mouse brain reveals hypothalamic changes in response to CR and fullbrain changes in neuro/gliogenesis with aging.

Graphical Abstract

TERT-traced cell signal is reduced in the median eminence of the hypothalamus
following caloric restriction, though the cell types responsible remain unknown. Green
areas indicate the presence of membrane GFP (mGFP) after a pulse-chase in mTert-rtTA::oTetCre::Rosa-mTmG animals (left). Faded cell types identified via question marks identify
populations of cells that may be TERT-traced and reduced with CR in the ME (right).
Abbreviations: TERT: telomerase reverse transcriptase, mGFP: membrane GFP, ARC: arcuate
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nucleus, ME: median eminence, 3V: 3rd ventricle, CR: caloric restriction, OLG: oligodendrocyte,
OPC: oligodendrocyte progenitor cell, GPC: glial precursor cell

Introduction
The mammalian hypothalamus produces adult-born neurons and glia through the
processes of adult neuro/gliogenesis, as an adaptive response to respond to environmental
stressors [59]. Under normal conditions, proliferation, and differentiation of quiescent adult stem
cells (qASCs) and glial precursor cells (GPCs) in the hypothalamus produces adult-born neurons
and glia [49, 58]. Both treatment with ciliary neurotrophic factor (CNTF), which reduces food intake
and decreases body weight, or high-fat diet (HFD), increases hypothalamic neurogenesis and
leads

to

adult-born

orexigenic

neuropeptide

Y

(NPY)-expressing

and

anorexigenic

proopiomelanocortin (POMC)-positive neurons [383, 384]. Ablation of neurogenesis in the
hypothalamus via mitotic inhibition prevents the weight loss associated with CNTF treatment
[384]. Prevention of HFD-induced hypothalamic neurogenesis results in excessive obesity [55].
Taken together, hypothalamic neurogenesis is an important functional process in the adult brain,
with full-body impacts.
HFD is a risk factor for diseases such as diabetes [385] and has multiple impacts on the
mammalian brain, including in the neurogenic processes in the dentate gyrus (DG) of the
hippocampus, where both acute and chronic HFD in the adult hippocampus reduce neurogenesis
and ASC proliferation [386-388]. In the hypothalamus, HFD produces variable effects on adult
neurogenesis depending on length of treatment, sex, and hypothalamic region [55]. In the median
eminence (ME), neurogenesis increases with a 3-week HFD, while neurogenesis is decreased in
the arcuate nucleus (ARC) [55]. Increased hypothalamic neurogenesis has been identified after
as little as 3 days of HFD in adult mice [383]. Interestingly, these changes are associated with
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hypothalamic reactive gliosis, which occurs prior to diet-induced obesity and results in neuronal
apoptosis [337].
Caloric restriction (CR) is defined as a reduction in average daily caloric intake without
malnutrition [389]. CR extends lifespan and appears to be a conserved metabolic response, as it
has been identified to improve the lifespan of worms [390], mice [391], non-human primates [392394], and humans [395, 396]. CR processes associated with aging include decreased metabolic
rate and reduced oxidative damage [397]. In the adult brain, CR is correlated with increased
neurogenesis and expression of brain-derived neurotrophic factor (BDNF) in the hippocampus
[398-401]. The neurogenic effects of CR in the DG are observed between 2 weeks and 8 months
and are therefore similar between acute and chronic treatment [398, 399]. In the V-SVZ and
olfactory bulb (OB), CR increases neurogenesis in a time-dependent manner through the actions
of acyl-ghrelin, indicating a connection between CR-induced plasticity and metabolic processes
[402, 403]. In the adult mouse hypothalamus, CR in conjunction with HFD decreases adult
hypothalamic proliferation specifically within the ME [55]. CR following HFD increases the number
of label-retaining cells in adult mice, although these cells were not identified as neuronal [133]
and may have resulted from the microglial proliferation in the hypothalamus that accompanies
HFD [132, 404]. While further studies are required to understand the role of CR in the
hypothalamus, gene expression analysis revealed decreased expression of insulin and ghrelin in
an age-dependent manner, indicating that pathways which govern adult neurogenesis in
response to CR in the V-SVZ and DG are also present in the hypothalamus [331].
Inflammation in the adult brain is characterized by activation of microglia, specialized
macrophages seeded in the brain and spinal cord during development [405]. Microglia-driven
inflammation decreases adult neurogenesis in the hippocampus [406-408]. In this niche,
inflammation results in microglial phagocytosis of immature newborn neurons [409, 410] and
neuroblasts [406, 411]. These effects are mirrored in the hypothalamus where the pro-
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inflammatory HFD treatment is associated with microglial activation and neuronal death in adult
mice [337, 404]. Acute HFD (3 days to 3 months) results in a period of proliferation in the
hypothalamus [55, 133, 336, 337, 383], which is associated with increased microglial proliferation
and activation [337, 404]. Chronic HFD (4 months to 8 months) leads to decreased neurogenesis
in this niche paired with cell death [383, 412]. Indeed, a 4-month HFD induced IKKB/NF-KBcontrolled apoptosis and impaired neuronal differentiation [412]. Interestingly, while both acute
and chronic HFD are associated with hypothalamic inflammation, they exhibit opposite effects on
neurogenesis. Unlike HFD, CR inhibits inflammation in humans [411, 413] and rodents [414], as
both short-term and long-term CR decrease microglial activation [402]. While microglial activation
is reduced with CR, glial activation appears to decrease in response to CR in some studies [415,
416] and decrease in others [417]. In the hypothalamus, CR reduces microglial activation after
lipopolysaccharide (LPS) treatment [418]. These effects may be due to the decrease in
expression of the inflammatory cytokines IFN-y, IL-6, and TNF-a [419-422] and the increase in
BDNF and insulin growth factor 1 (IGF-1) expression [423-425].
Aging is associated with increased inflammation [426, 427] and decreased neurogenesis
in the SGZ [428, 429], V-SVZ [430], and hypothalamus [431]. Age-related changes in
neurogenesis can be attributed to inflammation [432], breakdown of the blood-brain barrier [433]
and blood cerebrospinal fluid (CSF) barrier, and changes in the composition of the CSF [135].
Due to the anti-aging effects of CR in mice and humans, it is hypothesized that CR may reduce
the effects of aging on neurogenesis. Indeed, CR attenuates the age-associated changes in
mouse brains [434] including microglial activation [435]. CR may slow age-associated
inflammation via the process of neuroprotection [436]. Neuroprotection is conferred in part by the
expression of neurotrophins, which work to prevent neuronal apoptosis. Neurotrophins increased
with CR include BDNF, neurotrophin-3 (NT-3), and glial cell line-derived neurotrophic factor
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(GDNF) [400, 401, 423, 424, 437]. In fact, there is evidence that neurogenesis is enhanced in
response to CR through the actions of BDNF [437].
The role of CR on adult hypothalamic neurogenesis remains less completely understood
than the ‘classic’ neurogenic niches of the V-SVZ and DG. This is in part due to the lack of specific
and unique markers of qASCs, and the questions that surround the process of neuronal
differentiation in the hypothalamus [49]. Recent work has localized telomerase reverse
transcriptase (TERT)-expressing qASCs to the adult mouse hypothalamus (Chapter 2). Lineage
tracing of TERT+ cells in the adult mouse brain revealed the expansion of lineage-traced cells
throughout the ARC and ME of the hypothalamus (Chapter 2). To understand the role of CR on
hypothalamic neurogenesis we performed single cell RNA-sequencing (scRNAseq) on cells
lineage traced from telomerase reverse transcriptase (TERT)-rtTA::oTet-Cre::Rosa-mTmG adult
mice in the brain and further analyzed the relationship between TERT-traced cells and markers
of neurogenesis and neuroprotection. TERT has been identified as a marker for qASCs in the
adult mouse brain (Chapter 2).
Here, we describe the relationship between CR and neuroprotective gene expression by
TERT-traced cells in the adult mouse brain, highlighting the importance of these adult-born cells
in responding to metabolic intervention in the adult brain. Neuroprotective genes RBM3, CIRBP,
and BLBP are upregulated in TERT-traced cells in response to CR in adult mTert-mTmG::oTetCre::Rosa-mTmG mice across various mature cell types. In addition, we identify the expansion of
TERT-traced cells in the ME of the adult hypothalamus is reduced with CR. Overall, mature cell
types traced from TERT+ stem cells in the brain clearly respond to metabolic cues and must be
considered in future hypothalamic plasticity studies.
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Materials and Methods
Mice
All procedures were approved by the Ohio State University IACUC. Mice were maintained on a
12 hr light/dark cycle, and food and water was provided ad libitum. mTert-rtTA:: otet-Cre::
R26Rflox(mTmG) mice were generated by crossing mTERT-rtTA mice [2] to otet-Cre:: R26Rflox(mTmG)
mice, which were generated in our lab by crossing B6.Cg-Tg(tet0-cre)1Jaw/J mice (The Jackson
Lab) to B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo mice (The Jackson Lab) (Jensen &
Beaulieu). Recombination was induced via 2 mg/ml doxycycline (Sigma Aldrich) in 50 mg/ml
sucrose water. To chase, doxycycline water was replaced with normal drinking water. Both male
and female animals were utilized. For caloric restriction, animals were single caged and basal
food intake was determined by weighing food daily over 7 days. For each of the calorie restricted
animals, an amount of chow equal to 30% less than the average initial food intake was given per
day. All unrestricted diet animals were given pair-fed chow. Ad libitum (ad lib) animals had
unlimited access to food. Food intake was measured daily, and body weight was recorded twice
per week throughout the study.

Body Composition Analysis
One day prior to perfusion animals underwent analysis of fat, lean, free water, and total water
masses using the EchoMRI 3-in-1 body composition analyzer at the Ohio State University Small
Animal Imaging Core. No anesthesia or special preparation was required.

Brain Dissociation, FACS, and Sample Collection
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To obtain single cell suspensions of adult mouse brains, mice were sacrificed via CO2 followed
by cervical dislocation. Brains were isolated and washed with artificial cerebrospinal fluid (ACSF)
(Ecocyte). Brains were then diced with a razor blade in a petri dish containing ice-cold ACSF with
1 mg/mL pronase (Millipore-Sigma) until brain pieces were uniform sizes. Brains were then
transferred to loosely capped 50 mL falcon tubes placed in a shaking water incubator (37°C and
90 rpm) for 60-75 min until cloudy. Every 5 minutes the tubes were vortexed and then returned to
the shaking incubator. Samples were then centrifuged at 1600 rpm for 4 min and supernatant
decanted. Samples were then treated with ACSF with 5% fetal bovine serum (FBS) for 15 min
while shaking at 90 rpm and 37°C. Trituration of each sample was performed with pasteur pipettes
of 600 μm, 300 μm, and 150 μm openings. Samples were centrifuged at 300 x g for 10 min and
supernatant decanted. Debris removal solution (Miltenyi) was utilized to remove debris and myelin
from the samples. Cells were resuspended in ACSF with 10% FBS and stored on ice until sorting.
Cells were sorted for endogenous membrane GFP fluorescent signal on a Kraken- BD Fortessa
machine at the Nationwide Children’s Hospital Flow Core. Cells were sorted into 1X PBS (Ca2+
and Mg2+ free) containing 0.04% w/v BSA. Cells were spun at 150 x g for 3 min and pellets were
resuspended in 60 uL 1X PBS (Ca2+ and Mg2+ free) containing 0.04% w/v BSA. Samples were
transferred to the Ohio State University Genomics Shared Resource, where cell number and
viability were analyzed via hemocytometer.

Preparation of RNA-seq Libraries
For scRNAseq experiments, the following reagents were used: Chromium Next GEM Single Cell
3’ Kit v3.1, 16 rxns (PN-1000268), Chromium Next GEM Chip G Single Cell Kit, 16 rxns (PN1000127), Dual Index Kit TT Set A, 96 rxns (PN-1000215) were used according to the
manufacturer’s instructions for the GEM Single Cell 3’ Kit v3.1, 16 rxns (PN-1000268).
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EdU Administration
EdU in 0.9% NaCl was injected at 50mg/kg via intraperitoneal (i.p.) injections 18 days prior to
perfusion using an EdU click reaction kit (Baseclick; BCK-EdU647).

Immunostaining
Mice were anesthetized via peritoneal injection of 320 mg/kg body weight Ketamine and 24 mg/kg
body weight Xylazine in 0.9% saline and then sacrificed via transcardial perfusion with 1X PBS
followed by Histochoice Fixative, after loss of motor and ocular reflexes. Brains were post-fixed
overnight at 4°C, then placed in 15% sucrose at 4°C for 2 d, followed by 30% sucrose at 4°C for
2 d. Brains were then divided into coronal or sagittal sections using adult mouse brain matrices
and then frozen in optimal cutting temperature compound (Sakura) and stored at -20°C until
slicing. Brains were sliced on a CM1950 cryostat (Leica) at -20°C. Two slices of 7µm were
adhered to each slide. Slides were stored at -20°C until used for immunostaining, at which point
they were warmed up to room temperature and post-fixed with ice-cold acetone for 15 min. Slides
were washed for 5 min in 1X IHC Select TBS Rinse Buffer shaking at 60 rpm at room temperature
(RT) between each step. Permeabilization for staining of nuclear antigens was performed with
0.3% Triton X-100 for 10 min at RT. Permeabilization for staining of cytoplasmic antigens was
performed with 0.3% Tween-20 for 10 min at RT. Antigen retrieval was performed by microwaving
slides in 1X DAKO Antigen Retrieval Solution on low for 10 min twice. Slides were then incubated
in 0.3% Typogen Black in 70% EtOH for 20 min at RT, blocked for 20 min at 37°C with Millipore
Blocking Reagent, and incubated with primary antibody diluted in antibody diluent overnight at
4°C. Antibody concentrations are listed in the Key Resource Table. The next day, sections were
incubated in Alexa Fluor secondary antibodies for 10 min at RT, then counter-stained with
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100ng/mL DAPI for 5 min. Epifluorescence images were captured on Nikon E400 microscope
with a Hamamatsu Flash 2.0. Confocal images were captured on a Stellaris 5 (Leica) for coexpression analysis.
Optical Clearing of Brain Sections
Adult male mTert-rtTA::oTet-Cre::Rosa-mTmG mice and Cre-, negative control mice were
transcardially perfused with 1X PBS and 4% PFA after a 3-week, 11-day doxycycline pulse-chase.
Brains were excised fully intact and post-fixed in 4% PFA overnight at 4oC and then again for 1hr
at room temperature. Brains were washed in 1X PBS for an hour two times at room temperature
and then cut into 1,000μm thick sagittal sections using a 500 μm brain block and placed back into
5 mL microcentrifuge tubes containing 1X PBS and proceeded to methanol pre-treatment as
described by (Renier, N., 2014). Next, samples were incubated in 1X PBS/0.2% TritonX-100/20%
DMSO/0.3M glycine at 37°C overnight on orbital shaker and then blocked in 1X PBS/0.2%
TritonX-100/10% DMSO/6% donkey serum at 37°C for 3 days on an orbital shaker. Samples were
then washed in 1X PBS/0.2% Tween-20 with 10µg/ml heparin for 1h twice at 37°C and then
incubated in 1X PBS/0.2% Tween-20/10µg/ml heparin/5% DMSO/3% donkey serum containing
a 1:500 concentration of rabbit anti-GFP Alexa Fluor 488 at 37°C on an orbital shaker for 2 days.
Samples were then washed in 1X PBS/0.2% Tween-20 with 10µg/ml heparin for 1 hour at 37°C
on orbital shaker, 3 times, and then once a day for 2 days. Tissues were then cleared with the
iDISCO method detailed in Renier et al., 2014. Cleared brains were refractive index matched with,
and imaged while submerged in, dibenzyl ether which is corrosive to most objective lenses and
most plastics. To mitigate this, we took a glass bottom dish and coated any interior plastic with
quick drying silicone elastomer (Kwik-Sil). Cleared brains were imaged on a Lecia Stellaris 5
confocal microscope with a white light laser (ex. 495, em. 505-600) intensity set to 20%. Images
were captured with a 10X dry objective at 1024x1024 resolutions with pinhole set to 1 AU. Line
scan speed was set to 600 Hz and lines were averaged 3 times per frame. Photons were captured
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with Power HyD S detectors; gain set to 20%. Images were captured as Z-stacks; a total range
of 500 μm with a 6 μm step-size (84 images per stack) Z-stacks were tiled together to form a
complete image of each brain slice. These were then Z-maximum intensity projected into a
comprehensive 2D image.

Fiji Analysis
Z-maximum intensity projections were opened in ImageJ (NIH, http://imagej.nih.gov/ij). For EdU+
cell counting, images were converted to 8-bit (Image -> Type -> 8-bit), thresholded (Image ->
Adjust -> Threshold), and individual cells were quantified (Analyze -> Analyze Particles). For GFP
fluorescence quantification, a region of interest (ROI) was identified (full brain was used for ROI),
background subtraction was performed (Process -> Subtract Background), and images were
measured (Analyze -> Measure) for fluorescent intensity.

Statistical analysis
All statistical analyses in this study were performed via student’s t-test, as analyses were
performed across two groups (aged vs. young or CR vs. UR). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.005,
****P ≤ 0.001.
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Results
Caloric Restriction Induces Neuroprotective Changes in TERT-traced Cells
TERT+ qASCs in the adult mouse brain are multipotent and give rise to neurons, glia,
ependyma, choroid plexus epithelial cells (CPECs) and other mature cell types. Due to the multifaceted signaling changes affecting various cell types following CR, we hypothesized that single
cell RNA sequencing (scRNAseq) of TERT-traced cells would reveal key signaling pathways by
which these cells coordinated changes in neurogenesis and plasticity. Mice were administered
CR or unrestricted (UR) diet for 33 days during a doxycycline pulse-chase (Figures 3.1A, B). CR
resulted in a decreased change in percent body weight from initial after 15 days of caloric
restriction (Figure 3.1C). Brains were then used for FACS isolation of GFP+ cells, followed by
scRNAseq of samples from both CR and UR treated animals (Figure 3.1D, E). There were no
significant differences in the cell number (Figure 3.1F), concentration of cDNA per sample (Figure
3.1G), or nucleotide concentration per library between CR and UR samples (Figure 3.1H). Cluster
analysis and differential expression between CR and UR animals was performed by Kaitlyn
Hajdarovic (Brown University) and are not shown in this dissertation. UMAP analysis of TERTtraced cells isolated from mTert-rtTA::oTet-Cre::Rosa-mTmG brains revealed TERT-traced
arachnoid barrier cells, astrocytes, choroid plexus cells, dendritic cells, endothelial cells,
microglia, macrophages, neurons, olfactory ensheathing glia, oligodendrocytes, and pericytes.
Differential analysis of transcript expression across treatments identified both transcripts that were
upregulated with CR and transcripts that were downregulated with CR (data analyzed by Kaitlyn
Hajdarovic). The transcripts RBM3, CIRBP, and BLBP, which are all associated with
neuroprotection, were all upregulated with CR. Cell-type specific differential expression analysis
revealed CR-directed upregulation of BLBP in astrocytes, CIRBP in microglia, olfactory
ensheathing glia, and oligodendrocytes, and RBM3 in choroid cells, microglia, olfactory
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ensheathing glia, and oligodendrocytes (data analyzed by Kaitlyn Hajdarovic). Taken together,
CR directs the expression of neuroprotective transcripts in TERT-traced cells across multiple cell
types.
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Figure 3.1 - Caloric Restriction Induced Neuroprotective Changes in TERT-traced Cells
A) Experimental timeline of caloric restriction concomitant with doxycycline pulse-chase in adult
mTert-rtTA::oTet-Cre::Rosa-mTmG mice.
B) Daily food intake from D7-D40 of CR/UR-treated mice averaged per mouse (N=5 mice per
group).
C) Average change in percent body weight from initial per group (N=5 mice per group).
D) Experimental design of scRNAseq of TERT-traced cells and downstream analysis (N=4 mice
per group).
E) FACS plots detailing isolation of TERT-traced GFP-labeled cells from the adult mouse brain
(N=5 mice per group).
F) Number of cells used for scRNASeq library preparation per sample (N=4 mice per group).
G) cDNA concentration per sample (N=4 mice per group).
H) Nucleotide concentration per library (N=4 mice per group).
Graphs show mean ± SEM. *P<0.05; **P<0.01, ***P<0.005, ****P<0.001.

Caloric Restriction-Induced Reduction in Adiposity and Increased Thermogenesis is Associated
with Changes in TERT-traced Signal in the ME
CR-directed neurogenic modulation occurs throughout multiple plastic niches of the adult
mouse brain, including the SGZ, V-SVZ, OB, and hypothalamus. In the hypothalamus, CR
reduces proliferation in the ME, which has full-body implications as ME proliferation is required
for weight gain on HFD. As scRNAseq did not elucidate the brain regions in which the identified
TERT-traced cells were found, a replicate study was performed to identify changes in TERTtraced cells throughout the hypothalamus. Here, mice underwent a CR or UR intervention as
discussed in Figure 3.1 (Figures 3.2A, B). CR once again resulted in a decreased change in
percent body weight from initial (Figure 3.2C), in part due to a reduction in the weight of
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perigonadal white adipose tissue (pgWAT; Figure 3.2D). Body composition analysis via EchoMRI revealed decreased body weight with CR paired with decreased fat mass and adiposity
(Figure 3.2E). These findings were paired with a trend towards increased lean mass in CR-treated
mice and a significant increase in leanness (Figure 3.2E). There were no significant changes in
free water or hydration ratio between groups (Figure 3.2E). Thermal imaging of interscapular
brown adipose tissue (iBAT) revealed an increase in thermogenesis in CR-treated mice who lost
at least 20% BW when compared to UR mice or CR-treated mice who did not lose 20% BW
(Figure 3.2F). In the hypothalamus, TERT-traced GFP+ cells were localized to the arcuate
nucleus (ARC) and median eminence (ME) (Figures 3.2G, H). There was no difference in GFP
fluorescent intensity in the mGFP expression of the full hypothalamus with CR when compared
to UR-treated mice (Figures 3.2G-I). Similarly, there was no difference in the GFP fluorescent
intensity within the ARC of animals treated with CR or UR (Figures 3.2G’-H’; 3.2J). However, CR
significantly reduced the expression of GFP fluorescent intensity in the ME (Figures 3.2G’’-2H’’;
3.2K). Taken together, CR improved the metabolic profile of adult mTert-rtTA::oTet-Cre::RosamTmG, which was associated with reduced TERT-traced mGFP signal in the ME, but not ARC.
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Figure 3.2 - Caloric Restriction-Induced Reduction in Adiposity and Increased
Thermogenesis was Associated with Changes in TERT-traced Signal in the ME
A) Experimental timeline of caloric restriction concomitant with doxycycline pulse-chase in adult
mTert-rtTA::oTet-Cre::Rosa-mTmG mice.
B) Daily food intake from D7-D40 of CR/UR-treated mice averaged per mouse (N=6-8 per group;
N=2-3 female, N=4-5 male).
C) Average change in percent body weight from initial per group (N=6-8 per group).
D) Weight of adipose tissues per mouse at euthanasia (N=6-8 per group).
E) Body composition analysis via Echo-MRI of body weight, fat mass, adiposity (%fat), lean mass,
leanness (%lean), Free H2O, and hydration ratio per mouse (N=6-8 per group).
F) Thermal imaging analysis of iBAT across CR mice with body weight loss <20%, CR mice with
body weight loss >20%, and UR mice (N-6-8 per group).
G-H) Representative immunofluorescence of mGFP signal through the ARC and ME of the
hypothalamus in coronal brain sections of UR (G) and CR mice (H). Insets are shown in G’, G’’
and H’, H’’ (N=3 mice per group).
I-K) Quantification of mGFP fluorescent intensity within the full hypothalamus (I), ARC (J), and
ME (K; N=3 mice per group, n=2-4 brain sections per brain).
Insets show indicated area at 3x digital zoom. Scale bars are 100µm. Graphs show mean ± SEM.
*P<0.05; **P<0.01, ***P<0.005, ****P<0.001.

BLBP Expression is Unaffected by Caloric Restriction and is not Expressed by TERT-traced Cells
in Ventricular Niches
Increased BLBP expression in TERT-traced astrocytes after CR supports a
neuroprotective phenotype, as BLBP expression is increased in astrocytes during reactive
astrogliosis. In addition, the expression of BLBP in astrocyte-like cells has been associated with
stemness of such BLBP+ cells, both in embryogenesis and adulthood. BLBP expression was
examined through immunostaining of coronal brain sections to identify changes in BLBP
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expression with caloric restriction in the neurogenic hypothalamus (Figures 3.3A-B) and V-SVZ
(Figures 3.4A-B). Heightened fluorescent intensity of BLBP fluorescence may have resulted from
CR when compared to UR in the hypothalamus and V-SVZ, but a low N-value prevented the
analysis of this comparison (Figure 3.3C, 3.4C). However, there appeared to be no co-expression
of BLBP in TERT-traced cells within the ME after either treatment (Figure 3.3D, E). In the ARC,
where mGFP signal appears diffuse and often cannot be localized to specific cells, there was
possible overlap of mGFP with BLBP, although the specific cells where co-localization may have
occurred cannot be determined (Figure 3.3F, G). While co-expression of BLBP with mGFP has
been identified in the lateral ventricle choroid plexus (Figure 3.4A), no co-expression of BLBP and
mGFP occur within the neurogenic V-SVZ in either treatment (Figures 3.4A, B, D). In the 4th
ventricle BLBP was expressed by ependymal cells (Figures 3.4E-G). However, BLBP was not
expressed by TERT-traced cells in this niche (Figure 3.4G). Overall, while BLBP mRNA
expression was increased in TERT-traced astrocytes with CR, no difference in BLBP expression
was observed with CR in the V-SVZ or hypothalamus in adult animals, and co-expression with
TERT-traced cells in neurogenic niches could not be identified.
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Figure 3.3 – BLBP Expression was Unaffected by Caloric Restriction and was not
Expressed by TERT-traced Cells in Ventricular Niches
A-B) Representative immunofluorescence of mGFP and BLBP throughout the hypothalamus in
coronal brain sections of UR (A) and CR mice (B; N=2-3 mice per group, n=1-2 sections per
brain).
C) Quantification of the fluorescent intensity of BLBP in the hypothalamus (N=3 mice per group,
n=1-2 sections per brain).
D-E) Representative immunofluorescence of mGFP and BLBP in the ME of UR (D) and CR mice
(E; N=3 mice per group, n=1-2 sections per brain).
F-G) Representative immunofluorescence of mGFP and BLBP in the ME or UR (F) and CR mice
(G; N=3 mice per group, n=1-2 sections per brain)
Insets show indicated area at 3x digital zoom. Scale bars are 100µm. Graphs show mean ± SEM.
*P<0.05; **P<0.01, ***P<0.005, ****P<0.001.
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Figure 3.4 - TERT-traced cells in the V-SVZ and 4th Ventricle Rarely Expressed BLBP
A-B) Representative immunofluorescence of mGFP and BLBP in the V-SVZ and CP in UR (A)
and CR animals (B; N=2-3 mice per group, n=1-2 slices per brain).
C) Quantification of BLBP fluorescent intensity within the V-SVZ and CP (N=2-4 mice per group,
n=1-2 slices per brain).
D) Representative image of BLBP expression within the V-SVZ at 63x (N=2-4 mice per group,
n=1-2 slices per brain)
E-G) Representative immunofluorescence of mGFP and BLBP in the 4th Ventricle of sagittal
mouse brain sections of UR (E) and CR mice (F-G; N=3-6, n=1-2 sections per brain)
Insets show indicated area at 2x digital zoom. Scale bars are 100µm. Graphs show mean ± SEM.
*P<0.05; **P<0.01, ***P<0.005, ****P<0.001.

No Effect was Observed on Proliferation within the V-SVZ or Hypothalamus in Response to CR
Proliferation of both stem and intermediate progenitor cells occurs throughout neurogenic
regions of the mouse brain each day. While there have been many studies of cell survival and
label retention with BrdU, few studies have examined basal proliferation at the time of perfusion.
Additionally, no literature exists regarding the proliferative capacity of TERT-traced cells in the
adult mouse hypothalamus. The number of proliferative cells in the V-SVZ was unchanged in CR
mice when compared to UR (Figure 3.5A-C). Proliferation in the hypothalamus was rare, with
most hypothalamic tissues containing no Ki67+ cells with either dietary treatment (Figure 3.5DE). Additionally, while one set of proliferating cells were identified within the ME of one animal,
the nature of the mGFP signal in the hypothalamus of mTert-rtTA::oTet-Cre::Rosa-mTmG animals
prevented the clear identification of these cells as mGFP+ or mGFP- (Figure 3.5F). Within the VSVZ and choroid plexus (ChP) of the lateral ventricles no TERT-traced cells were Ki67+ (Figure
3.5G), although Ki67+ cells were present in both areas. Taken together, this CR treatment did not
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affect V-SVZ proliferation and TERT-traced cells are not proliferative after this pulse-chase period
in the V-SVZ or hypothalamus.
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Figure 3.5 - Proliferation remained unchanged throughout the V-SVZ and Hypothalamus
after CR
A-B) Representative immunofluorescence of mGFP and Ki67 in the V-SVZ
C) Quantification of Ki67 cell number in the V-SVZ (N=3 mice per group, n=1-2 sections per brain).
D-E) Representative immunofluorescence of mGFP and Ki67 in the hypothalamus in UR (D) and
CR mice (E; N=3 mice per group, n=1-2 sections per brain).
F) Immunofluorescence of mGFP and Ki67+ cells in the ME (N=2 of 6 mice showed this signal,
n=2 sections per brain).
G) Immunofluorescence of mGFP and Ki67+ cells in the V-SVZ and CP (N=6 of 6 mice; N=3 CR,
N=3 UR showed this signal, n=2 sections per brain)
Scale bars are 100µm. Graphs show mean ± SEM. *P<0.05; **P<0.01, ***P<0.005, ****P<0.001.

Aging Increases TERT-traced Cell Signal in the Adult Mouse Brain
Aging reduces the number of proliferative stem and intermediate progenitor cells in the
mouse and human brains. These changes are associated with cognitive decline and breakdown
of critical regulatory barriers, such as the blood-brain barrier (BBB) and blood-cerebrospinal fluid
barrier (BCSFB). The relationship between the BBB in the ME and the BCSFB in the hypothalamic
third ventricle is therefore of critical importance regarding hypothalamic neurogenesis. To
determine the effects of TERT lineage tracing and the relationship to proliferation and label
retention in the adult mouse brain, young and aged mTert-rtTA::oTet-Cre::Rosa-mTmG mice were
exposed to a 3-week doxycycline pulse, followed by an 11-day chase (Figure 3.6A). These mice
were also injected with EdU on day 14 of the doxycycline pulse (Figure 3.6A). Animals were
perfused following the doxycycline pulse-chase and a 1mm sagittal brain slice was cleared
following the iDISCO protocol for each brain. Analysis of label retention through the quantification
of EdU+ cells after the EdU ‘chase’ period revealed a decrease in the number of EdU+ cells with
aging (Figure 3.6B). Interestingly, mGFP expression was significantly increased with aging
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(Figure 3.6C). Representative images of the midsagittal slices used for these analyses reveal the
expression of mGFP in the cerebellum, pontine reticular nucleus, median raphe nucleus, third
ventricle, and olfactory bulb in aged brains, but only the third ventricle and olfactory bulb in young
brains (Figures 3.6D, E).
Although TERT-traced mGFP expression increases with aging after a pulse-chase in
mTert-rtTA::oTet-Cre::Rosa-mTmG animals, the number of TERT+ cells in the adult mouse brain
remains unchanged (Figure 3.6A-B). Immunostaining of coronal brain slices from the neurogenic
enriched brain area (Figure 3.6A) revealed that while TERT+ cell numbers increased in some
regions, the number of TERT+ cells decreased in other regions (Figure 3.6A). Overall, TERT+
cells accounted for approximately 0.3% of the adult mouse brain, the same percentage as the
aged mouse brain (Figure 3.6B). Immunostaining on thin sections of mTert-rtTA::oTet-Cre::RosamTmG mice that underwent a 3-week doxycycline pulse, followed by an 11-day chase with EdU
administration on day 14 (Figure 3.5A), revealing a high likelihood of increased expression of
mGFP within the 4th ventricle and cerebellum with aging (Figures 3.5F-H). Here, only N=2 young
animals could be assessed, preventing statistical analysis. To support these results, a replicate
cohort of mTert-rtTA::oTet-Cre::Rosa-mTmG young and aged animals where animals did not
receive EdU was assessed (Figure 3.6C). In these animals, decreased numbers of EGFR+
activated ANSCs (aANSCs) and TACS were observed with aging in the V-SVZ (Figure 3.6D),
indicating a reduction in neurogenesis with aging in these mice similar to previously published
results. mGFP expression in the cerebellum trended towards an increase with aging (Figure 3.6E)
in support of our results in aged versus young mice from the previous experiment (Figure 3.5FH). Interestingly, BLBP co-expression was observed in TERT-traced cells lining the 4th ventricle
of aged brains (Figure 3.5I), identifying that TERT-traced ependymal cells of the 4th ventricle
express BLBP with aging, but not in young brains exposed to CR or ad lib diet (Figure 3.6E-G).
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Figure 3.6 - Aging Increased TERT-traced Cell Signal in the Adult Mouse Brain
A) Experimental outline of EdU analysis of mTert-rtTA::oTet-Cre::Rosa-mTmG mice.
B) Quantification of the number of EdU+ cells throughout the adult and aged mouse brain (N=34 mice per group, n=1 cleared slice per brain).
C) Quantification of the fluorescent intensity of GFP throughout the adult and aged mouse brain
(N=3-4 mice per group, n=1 cleared slice per brain).
D-E) Immunofluorescent analysis of mGFP and EdU in the young (D) and aged (E) mouse brain
(N=3-4 mice per group, n=1 cleared slice per brain)
F-G) Representative immunofluorescence of mGFP in thin slices of the cerebellum (N=2-4 mice
per group, n=1-2 slices per brain).
H) Quantification of mGFP fluorescent intensity in thin slices of the 4th ventricle (N=2-4 mice per
group, n=1-2 slices per brain).
I) Co-expression of mGFP with BLBP in ependymal cells of the 4th ventricle (N=3-4 per group,
n=2 slices per brain).
Insets show indicated area at 2x digital zoom. Scale bars are 100µm unless denoted otherwise.
Graphs show mean ± SEM. *P<0.05; **P<0.01, ***P<0.005, ****P<0.001.
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Figure 3.7 - Aging Modified TERT+ Cell Numbers and TERT-traced Cell Numbers Across
Brain Regions
A) Quantification of TERT+ cells identified through immunofluorescence analysis of mTert-GFP
mouse brain sections (N=6-10 mice per group, n=6-11 sections per brain).
B) FACS plots of full mTert-GFP mouse brains from adult and aged mice (N=7-25 mice per age)
C) Experimental outline of replicate lineage tracing experiment in aged and young mice.
D) Representative immunofluorescence of mGFP and EGFR in the V-SVZ of mTert-rtTA::oTetCre::Rosa-mTmG mice with a 3-week pulse, 11-day chase with quantification of the number of
EGFR+ transit amplifying cells (TACs) per mouse (N=3-6 mice per group, n=1 section per brain).
E) Representative immunofluorescence of mGFP in the cerebellum of mTert-rtTA::oTetCre::Rosa-mTmG mice with a 3-week pulse, 11-day chase with quantification of the fluorescent
intensity per mouse (N=4 mice per group, n=1-2 sections per brain).
Insets show indicated area at 2x digital zoom. Scale bars are 100µm. Graphs show mean ± SEM.
*P<0.05; **P<0.01, ***P<0.005, ****P<0.001.

TERT-traced Microglia are Observed in the Aged Mouse Brain, but are Unaffected by CR
Aging is associated with changes in microglial shape and function, as well as full-brain
inflammatory status. Behavioral changes also occur with aging, including cognitive decline.
Caloric restriction in aged rodents has been identified as a treatment for the behavioral effects of
aging through the reversal of age-associated expression of the inflammatory interleukin-6 (IL-6)
[438]. To examine the relationship between aging and CR on TERT lineage tracing in the mouse
brain, caloric restriction was performed on young and aged mTert-rtTA::oTet-Cre::Rosa-mTmG
animals as per previous experimental plans (Figure 3.1A, 3.2A; Figure 3.8A). Body weight was
significantly decreased in both young and aged mice when compared to UR controls (Figure
3.8B). Brain clearing of UR aged mice revealed similar TERT-traced mGFP+ signal in the
cerebellum and 3rd ventricle when compared to CR aged mice (Figure 3.8C-D). However, CR-
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treated animals showed reduced expression of mGFP in the olfactory glomerular and nerve layers
(Figure 3.8C-D). Immunostaining was subsequently performed with sagittal sections of ad lib or
CR-treated mice at each age group to identify the presence of TERT-traced microglia. In the
hypothalamus, Iba1, a marker of microglial cells, was largely never co-expressed by TERT-traced
cells with aging with ad lib or CR treatment (Figures 3.8E-F). However, 1 Iba1+mGFP+ cell was
identified in the ME of ad lib aged mice (Figure 3.8G). Iba1+mGFP+ cells were also identified
throughout the brain in the cortex (Figure 3.8H), meninges (Figure 3.9A), and thalamus (Figure
3.9B). While these cells were too rare for a quantitative comparison between ad lib and CR
animals, the presence of mGFP+Iba1+ cells supported the results from the scRNAseq of separate
microglial populations of TERT-traced cells (data analyzed by Kaitlyn Hajdarovic). Overall, CR
with aging decreased TERT-traced signal in the OB but was not associated with changes in Iba1
in these cells. Taken together, the co-expression of Iba1 in TERT-traced cells throughout various
brain regions points to a role of TERT+ cells and their progeny in the process of age-related
inflammation.

142

143

Figure 3.8 – TERT-traced Microglia were Observed in the Aged Mouse Brain, but were
Unaffected by CR
A) Daily food intake from D7-D40 of CR/UR-treated mice averaged per mouse (N=3-6 mice per
group).
B) Average change in percent body weight from initial per group (N=3-6 mice per group).
C-D) Immunofluorescent analysis of mGFP and EdU in aged UR (C) and aged CR mice (D; N=26 mice per group, n=1 section per brain).
E-F) Representative immunofluorescent image of BLBP expression in sagittal slices of the aged
mouse brain with ad lib diet (E) or CR (F; N=3-6, n=1-2 sections per brain)
G-H) Iba1 expression in sagittal slices of the aged mouse brain with UR (E) or CR (F; N=3-6, n=12 sections per brain)
Insets show indicated area at 2x digital zoom. Scale bars are 100µm unless denoted otherwise.
Graphs show mean ± SEM. *P<0.05; **P<0.01, ***P<0.005, ****P<0.001.
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Figure 3.9 - TERT-traced Cells Expressed the Microglial Marker Iba1 in the Meninges and
Thalamus
A-B) mGFP+ cells co-express Iba1 in the ME (C; N=1), cerebral cortex (D; N=1), meninges (E;
N=1), and thalamus (F; N=1).
Insets show indicated area at 2x digital zoom. Scale bars are 100µm.

Discussion
Adult neurogenesis throughout the mouse and human brains remains incompletely
understood, in part due to the lack of specific and unique markers for adult stem cells in the brain
[163]. In the mouse brain, the V-SVZ and SGZ are highly proliferative niches that are home to
ANSCs, which produce adult-born neurons and glia throughout adulthood [340]. While a
population of stem cells has been identified in these niches in mice, the study of neurogenesis in
the adult human brain has been hindered by debate regarding the potential of the human brain to
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produce adult-born neurons and glia beyond childhood [190, 196, 198, 199]. It remains a
possibility that a population of quiescent and multipotent stem cells exist within these niches within
the mouse and human but have not yet been identified. The identification of these qASCs will also
answer questions regarding plasticity in additional neuro/gliogenic niches of the adult brain,
including the hypothalamus. Currently the hypothalamus is known to house various stem-like cell
types, including alpha and beta tanycytes, and Olig2+Sox2+ OPCs, although the cell types that
differentiate into newborn neurons and glia during basal conditions in vivo remain unknown [49].
In addition, the production of adult-born neurons and glia in the niche hint towards a qASC
population, although definitive evidence remains to be collected towards this cell type. We have
previously shown the potential for TERT+ cells in the mouse brain to be this cell type.
A lineage-tracing study of mTert-rtTA::oTet-Cre::Rosa-mTmG mice followed by
scRNAseq of TERT-traced cells labeled with mGFP reveals the differentiation of TERT+ cells to
neurons, microglia, astrocytes, oligodendrocytes, choroid plexus epithelial cells (CPECs),
endothelial cells, and more. There was no difference in the number of cell types identified with
CR compared to animals with UR. However, differential analysis of bulk and cell-specific gene
expression between CR and UR animals revealed an increase in neuroprotective genes with CR.
This matches with previous studies that correlate CR with increased neuroprotection and
neurogenesis in the adult mouse brain [401, 402, 418]. This study identifies Rbm3 and Cirbp as
significantly upregulated with CR in TERT-traced microglia, OEGs, and oligodendrocytes. In the
adult mouse brain, Rbm3 promotes neuronal differentiation and neural progenitor proliferation,
while decreasing neuronal apoptosis, following hypoxic ischemia [439]. Primary neural progenitor
cells isolated from the SGZ of adult mice support the role of RBM3 as neuroprotective, as RBM3
KO animals showed significantly fewer proliferation events when compared to WT animals [440].
CIRBP prevents apoptosis in neural stem cells and prevents differentiation in vitro [441]. In the
mouse hippocampus, CIRBP increases in response to both cold exposure and brain ischemia
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[442]. CIRBP has also been shown to attenuate apoptosis through the ERK and MAPK pathways
[443, 444].
Cold exposure reduces inflammation and induces anti-apoptotic effects by inhibiting
caspase-depenent and caspase-independent pathways [445]. This treatment is also largely antiinflammatory, as it also reduces neutrophils and activated microglia, ROS [446], and proinflammatory cytokines [447] in the adult mouse brain. Interestingly, both RBM3 and CIRBP are
expressed during cold exposure, indicating a role for these genes in this anti-inflammatory and
pro-neuroprotective intervention [448-450]. In the central nervous system (CNS), cold exposure
reduces the severity of EAE by reducing neuroinflammation through large-scale changes in
macrophages and dendritic cells [451]. Taken together, the increased expression of both RBM3
and CIRBP in multiple cell types with caloric restriction are likely performing anti-inflammatory
and neuroprotective effects in the adult mouse brain, although further studies are required to
determine the pathways utilized.
BLBP is expressed by radial glial cells in the embryonic ventricular zone and postnatal
brain [452]. In the V-SVZ, BLBP is expressed by GFAP+ B cells as well as Hes5+ proliferative
progenitors [453], although whereas GFAP and Hes5 are expressed by more quiescent B cells
(Type 1 and Type 2), BLBP is expressed by Type 2 and Type 3 B-cells [453]. Similar to the qANSC
markers GFAP and GLAST, BLBP is also expressed by cells within the astrocyte lineage of adult
animals [454]. In the present study we analyzed TERT-traced cells with common markers of both
qASNCs and astrocytes to confirm that there were no qANSC cells within our astrocyte cluster.
This provided evidence for the increased expression of BLBP with CR to be specific to astrocytes.
BLBP expression in astrocytes in the adult CNS is often concurrent with reactive astroglia [454456]. The process of reactive gliosis includes upregulation of GFAP, vimentin, and nestin,
morphological changes including cytoskeletal hypertrophy, and can result in glial scars forming
from proliferating scar astrocytes in proximity to tissue lesions [454, 457]. Indeed, BLBP
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expression is identified in proliferative astrocytes resulting from demyelination and cortical stab
injuries [458]. In addition, BLBP expression in astrocytes is correlated with remyelination through
activation of oligodendrocyte progenitor cells in multiple sclerosis (MS), and expression of BLBP
in astrocytes decreases with disease progression [454]. In rat glioma cells as well as cultured
astrocytes, proliferation is induced with BLBP [458, 459]. Taken together, BLBP upregulation in
astrocytes within TERT-traced cells likely indicates a reactive phenotype for these cells in
response to this treatment.
CR decreased the mGFP signal intensity from TERT-traced cells in the ME of the
hypothalamus, but not the ARC. This pattern reflects the findings of Lee et al., [55], where CR
during HFD reduced label retention in the ME, but not the ARC of adult mice. Interestingly,
neurogenesis (Hu+BrdU+/Hu+ cells) was not identified to be significantly affected by HFD in the
ME in that study. Instead, label retention was significantly altered, as the ratio of BrdU+ nuclei
over total nuclei decreased with CR [55]. This group was unable to identify the cell types
responsible for the changes occurring with CR, although there are several possibilities. Other cell
types found in the ME include tanycytes, glial precursor cells (GPCs), astrocytes,
oligodendrocytes, OPCs, and microglia [50, 53]. Gliogenesis encompasses the processes of
astrogliogenesis, oligodendrogenesis, and microgliognesis, and likely accounts for the observed
increase in proliferation after CR during HFD [55]. In the current study, co-staining experiments
have not identified the TERT-traced cell population within the ME, as these cells were largely
negative for markers of microglia (Iba1), tanycytes (Vimentin), neurons (NeuN), and astrocytes
(GFAP). What then are TERT-traced cells in the ME and why do they decrease with CR?
Furthermore, is the decrease in mGFP signal in the ME indicative of cell death of TERT-traced
cells, reduced proliferation or differentiation of TERT-traced cells, or changes in the morphology
of these TERT-traced cells?
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In the ARC and ME the mGFP signal from TERT-traced cells appears to spread out across
the entirety of these regions. For this reason, it is unlikely that only one cell type would lead to the
mGFP expression observed, as cells such as microglia, astrocytes, or OPCs are spread nearly
uniformly throughout the hypothalamus. For this reason, it remains a possibility that the mGFP
signal observed originates from neurons within the ARC. This would explain the high density of
mGFP signal within this brain region after a lineage trace. However, NPY/AgRP and POMC
neurons within the ARC reach into the paraventricular nucleus (PVN) and lateral hypothalamus
(LH), and there is no evidence for mGFP signal within this brain region in CR or UR treated
animals. As the mGFP expression occurs throughout the full cell membrane, we would expect
mGFP to be identified within the cell body, as well as axons and dendrites, and as none are
observed within the PVN, we cannot conclude that the mGFP+ cells in the ARC and ME are
NPY/AgRP and POMC neurons.
However, there are other neuronal subtypes in the ARC which extend axons into the ME,
including dopamine/tyrosine hydroxylase neurons, gonadotropin-releasing hormone (GnRH)
neurons, and growth hormone-releasing hormone (GHRH) neurons [460-462]. Of great
importance to the analysis of the results in this study is the identification of axonal degeneration
in the ME in response to aging [463]. Perhaps axons reaching into the ME from ARC neurons are
degenerating in response to CR in the adult mouse brain, resulting in decreased mGFP signal in
the ME. Future studies should identify whether ARC-ME neuron subtypes in these animals
express mGFP after a lineage tracing experiment (Figure 3.7). While it is possible that the mGFP+
signal observed in these regions originates from neurons whose axons and dendrites reside within
the ARC and ME, future studies could be clouded by the fact that the cell bodies of these neurons
may be found outside of these regions or even the hypothalamus. The hypothalamus is connected
through long-range neuronal pathways to the hippocampus and amygdala, receives input through
various bodily systems, and through the periventricular axon system and neuropeptidergic
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hypothalamic network (Figure 3.10). Therefore, there is a distinct possibility that the mGFP
observed in the hypothalamus in mTert-rtTA::oTet-Cre::Rosa-mTmG animals after a pulse-chase
experiment is expressed by neuronal cell types with cell bodies outside of the hypothalamus (see
Conclusions and Future Directions for more on the possible axonal connections between the
olfactory epithelium and hypothalamus).
Initially, the qASC population in the adult hypothalamus was hypothesized to be tanycytes,
radial glial cells that line the hypothalamic third ventricle [95]. Support of this hypothesis was
identified in the in vitro formation and multipotent differentiation of neurospheres derived from
these cells [96]. Lineage tracing studies of tanycytes further supported the formation of adult-born
neurons and glia from these cells [3, 6, 96]. The newborn cells were identified within the ARC and
ME, several cell layers away from the tanycytes. The growing consensus hinted at a cell type that
could produce adult-born cells that would migrate down the tanycyte process into the
hypothalamic parenchyma [97]. However, due to the promiscuity of the promoters utilized for
lineage tracing studies and the differences between in vitro and in vivo tanycyte function, these
studies have not conclusively identified tanycytes as adult stem cells in this niche. In fact, Rax+
tanycytes were recently identified as non-proliferative in a basal state [3].
Instead, both Olig2+Sox2+ OPCs and NG2+ GPCs have been identified in the
hypothalamic parenchyma as a population of progenitor cells. NG2+ GPCs in the ME are
proliferative in adult mice under basal conditions and indicate an active progenitor cell population
within this niche [94]. While Zilka-Falb et al. and others describe NG2+ cells as oligodendrocyte
progenitors due to the ability of NG2+ cells to differentiate into mature oligodendrocytes in vitro
and after transplantation, NG2+ cells throughout the mammalian brain are largely GPCs which
can produce adult-born astrocytes or oligodendrocytes [98]. Therefore, it cannot be ruled out that
the NG2+ cell population in the ME produces both astrocytes and oligodendrocytes in this niche.
Furthermore, OPCs in the ME have recently been found to undergo variable proliferation and
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differentiation depending on nutritional state [464]. NG2+ cells in the ME have also been identified
to maintain dendritic processes of ARC neurons in the ME, indicating other roles of these GPCs
outside of proliferation and differentiation [99]. It is important to note that tanycytes can contribute
to injury-induced tissue repair, however, it is likely that under basal conditions hypothalamic
plasticity is regulated by other cell types in this niche.
Basal proliferation in the hypothalamus occurs at lower levels than the classical
neurogenic niches of the V-SVZ and DG. The high proliferative capacity of the intermediate
progenitor cells in these niches allows for thousands of newborn neurons to be produced daily.
Proliferation occurs more rarely in the hypothalamus, with a recent study identifying approximately
1.5 Ki67+ cells/ mm2 in 40um-thick sections of 8-week-old C57BL/6J mice [465]. In contrast, Ki67+
cells in the SGZ of 50um-thick sections from 8-week-old mice were found at approximately 500
Ki67+ cells/ mm2 [466]. This matches with our results which showed minimal numbers of Ki67+
cells in any hypothalamic region, and points to the importance of other methods of studying adult
neurogenesis in the hypothalamus.
Aging reduces adult neurogenesis in all brain regions. Interestingly, aged mTertrtTA::oTet-Cre::Rosa-mTmG animals that underwent a 3-week pulse of doxycycline followed by
an 11-day chase showed increased fluorescent intensity of GFP across cleared sagittal brain
slices when compared to young adult mice (Figure 3.5C-E). A study of EdU+ label-retaining cells
that had incorporated EdU on day 14 of the doxycycline pulse revealed a decrease in EdU+ cells
by the end of the study in aged animals (Figure 3.5B), modeling previous research on adult
neurogenesis in aging. Further evidence for the decrease in neurogenesis with aging in lineagetracing mice was illustrated through the decrease in EGFR+ aANSCs and TACs in the V-SVZ
(Figure 3.6D). It can therefore be concluded that these animals respond to aging with a decrease
in proliferation.
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It is curious that we would see an increase in the mGFP signal of TERT-traced cells across
the mouse brain through clearing of sagittal brain sections (Figures 3.5C-E). Importantly, the
increase in mGFP expression across the mouse brain was not fully due to increased mGFP
expression in the regions of low mGFP expression in young mice, such as the olfactory bulb or
LVCP. Instead, large numbers of mGFP+ cells were identified in brain regions such as the PVN,
MRN, and other regions within the midbrain and brainstem (Figures 3.5D-E). It therefore remains
possible that TERT-traced cells within these regions become more proliferative with aging, or that
TERT expression is induced by more cells within these brain regions with aging. Further studies
are required to determine the number and proliferative capacity of TERT+ cells in these brain
regions, although we have shown that TERT+ cell numbers can vary significantly between young
and aged mTert-GFP mice (Figure 3.6A).
The timing of EdU administration in this study must also be taken into consideration.
Doxycycline was administered to adult or aged animals for 3 weeks, followed by an 11-day chase,
with a single injection of EdU at day 14 of the doxycycline. 14 days into the doxycycline pulse,
TERT+ cells will have already been marked and begun activating, proliferating, migrating, and
differentiating. For this reason, the EdU administration may label proliferative cells that are no
longer TERT+ but are lineage-traced from TERT+ cells which would include intermediate
progenitor cell types such as neuroblasts, which have been observed in TERT-tracing
experiments previously (Chapter 2). In addition, the administration of EdU only once during this
experiment likely prevented the labeling of most TERT+ cells, as only approximately 15% of
TERT+ cells express Ki67 in the adult mouse brain (Chapter 2). The results of EdU+mGFP+ coexpression, while currently undiscovered, must be considered in this light.
To study the role of TERT+ cells in the adult and aged mouse brain to produce adult-born
microglia, as identified through scRNAseq, sagittal brain sections were stained with the microglial
marker Iba1. While Iba1 expression was identified throughout all brain regions in both adult and
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aged mice, TERT-traced Iba1+ microglia were rare in all brain regions. These cells were identified
once per every few brain sections and did not compose any significant population of microglia
(Figure 3.9). Due to the increase in Rbm3 and Cirbp in TERT-traced microglia in the adult mouse
brain with CR (data analyzed by Kaitlyn Hajdarovic), we hypothesized that TERT-traced microglia
would have a neuroprotective function in the aged mouse brain with CR treatment. While TERTtraced microglia were identified in both treatments in aged animals, including within the
hypothalamus, the low number of microglia observed prevented quantification of TERT-traced
microglia. Further studies should be done to identify the levels of Rbm3 and Cirbp in TERT-traced
Iba1+ microglia, but current analysis is hindered by low cell counts.
Overall, this study highlights the role of TERT+ qASCs in the adult mouse brain to respond
to the neurogenic and anti-inflammatory process of CR, including within the hypothalamus.
scRNAseq uncovered a role of TERT-traced cell types throughout the brain to respond to CR by
inducing a neuroprotective phenotype through the expression of Blbp, Rbm3, and Cirbp. We have
also identified a loss of mGFP signal in the ME with CR, indicating a loss of TERT-traced cells in
this niche. Currently, the TERT-traced cells within the ME remain unclear, as the ME contains
various proliferative and stem-like cell types, including Olig2+Sox2+ OPCs and NG2+ GPCs, as
well as tanycytes, as well as mature cell types including oligodendrocytes, astrocytes, and axons
from neurons in the ARC. Furthermore, an interesting dichotomy was discovered between the
decrease in proliferative potential and increase in mGFP signal from TERT-traced cells within the
aging brain. Further studies are required to understand the role of TERT-traced microglia in the
adult brain. While there have been some studies pointing towards the expression of TERT by
microglial cell types, it remains possible that TERT+ cells can produce CR-responsive microglia.
The implications of these cells in the adult and aged mouse brain to respond to inflammatory
signals by producing neuroprotective transcripts may unveil a valuable role of TERT+ cells and
their progeny in the mouse brain.
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Figure 3.10 – Axonal degeneration may result in TERT-traced mGFP+ GnRH, TH, and/or
GHRH neurons in response to CR. Abbreviations: ARC: arcuate nucleus, ME: median
eminence, 3V: 3rd ventricle, CR: caloric restriction, OLG: oligodendrocyte, OPC: oligodendrocyte
progenitor cell, GPC: glial precursor cell. Green, fluorescent outline indicates expression of mGFP
in neurons.
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Figure 3.11 – Hypothalamic-centric axonal connectivity in the adult mouse brain. Dotted
arrows indicate movement of hormones and nutrients. Solid arrows indicate neuronal
connection of brain regions.
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Chapter 4

OVERALL CONCLUSION AND FUTURE DIRECTIONS

Overall Conclusions
These studies have identified TERT+ cells in the adult mouse brain as qASCs which form
neurospheres and proliferate in vitro and which express stem cell markers, but not markers of
activated or mature cell types in vivo. TERT+ cells in adult mouse brains differentiate into mature
cell types in both classical and novel neuro/gliogenic niches. Furthermore, we have identified
TERT+ as well as TERT-traced intermediate progenitor cells and mature cell types labeled with
mGFP throughout various brain regions (Figure 4.1) in mTert-rtTA::oTet-Cre::Rosa-mTmG mice.
Multiple populations of TERT-traced cells adopt a neuroprotective transcriptional profile following
CR treatment implicating these cells in functional roles in response to changes in energy balance.
CR results in a significant reduction in mGFP signal in the ME, a brain region known to undergo
changes in proliferation and neurogenesis with dietary intervention. Finally, a higher amount of
mGFP signal is identified through the brains of aged lineage-traced mice when compared to
adults, pointing to the possibility of differences in proliferation and/or TERT expression with aging.
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Figure 4.1 - Map of TERT+ stem cells and TERT lineage-tracing in anatomical niches of
the adult brain. DR: direct reporter, Trace: lineage tracing mouse line after a lineage-trace with
doxycycline, PGL: periglomerular layer, MiL: mitral layer, GCL: granule cell layer, RMS: rostral
migratory stream, ICj: Islands of Calleja, STR: Striatum, THA: thalamus, ML: molecular layer.

Future Directions
The role of TERT-directed neurogenesis in the olfactory epithelium in hypothalamic
neurogenesis and energy balance
The current lack of a specific and unique marker for qANSCs in the adult brain has
hindered our understanding of adult neural plasticity. The reliance on markers that overlap with
other cell types and tools which mark proliferating cell types has yielded information on the
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process of neurogenesis but has left out critical information on the first steps of the process
regarding the stem cells that produce these adult-born intermediate and mature cell types.
One such brain region where adult neurogenesis is well understood from a ‘classical’
angle is the OB, where V-SVZ-derived neuroblasts differentiate into adult-born olfactory granule
neurons. Due to the lack of evidence of adult-born neurons or an RMS in the human brain, other
options should be explored. We identified TERT+ cells in the olfactory bulb throughout the PGL,
MiL, and GCL, while lineage tracing resulted in a vast majority of the resulting TERT-traced cells
in the PGL layer. The phenotype and expression of NCAM in these cells is evidence that these
are axons from OSNs in the OE. Further analysis of the OE revealed TERT+ and TERT-traced
cells within this niche (Chapter 2, Figure 4). Much is known regarding the role of stem cells in the
OE and the production of OSNs that interact with the OB in both mice and humans. However, as
is the case in the brain, the specific qASC population in the OE is unidentified. There are
significant similarities in the stem cell populations in the OE and the brain including the expression
of stem cell markers Nestin and Sox2 and therefore, much can be learned from the neural tissue
of the OE. For this reason, a more complete understanding of the role of adult neurogenesis in
the OE should be investigated.
The following experiments can be performed to better understand the role of TERT+ cells in
neurogenesis within the OE.
Discover the cell types and molecular mechanisms involved in TERT+ cell activation and
neurogenesis in the olfactory epithelium
•

Experiment 1 (mechanisms of TERT cell action with and without stimulation): scRNAseq
& IF analysis of pathway transcripts of interest
o

Questions: What are TERT+ ASCs? What markers do they express? What cells
do TERT+ cells create? How are these cells different after neurogenic stimuli
(CR)? How is TERT-mediated adult neuro/gliogenesis affected by neurogenic CR?
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Which pathways can we validate from scRNAseq via IF? What are the cellular
processes utilized by various mGFP cells?
o

Hypothesis: TERT+ cells will express various SC markers and produce multilineage progeny and CR will induce increased neurogenesis in the hypothalamus
and areas of proliferation/ differentiation and will also express high levels of growth
factors of interest (Noggin, EGF, FGF, etc.)

•

Experiment 2 (in vitro mechanisms of TERT cell action): Seahorse/ cell culture with TERT+
cells and administration of various compounds (BMP4, EGF, FGF)
o

Questions: Do TERT+ cells have metabolic characteristics of qASCs? How do
TERT+ cells respond to various neuro/gliogenic stimuli? Which pathways can we
validate from scRNAseq via Seahorse?

o

Hypothesis: TERT+ cells will have robust mitochondrial profiles with great capacity
for survival under ischemic conditions; additionally, they will show decreased
glycolysis after treatment with noggin, EGF, FGF2, and other activating factors.

•

Experiment 3 (in vivo mechanisms of TERT cell action): in vivo administration followed by
IF/ WB/ qRT-PCR
o

Questions: What are the effects of in vivo administration of growth factors/
signaling molecules/ other on TERT cell activation, quiescence, proliferation,
differentiation, and more in different brain regions?

o

Hypothesis: Compounds that led to changes in TERT proliferation and
differentiation from scRNAseq, Seahorse, or cell culture, will cause changes in
TERT+ cell and TERT+ cell progeny in the adult mouse brain

•

Experiment 4 (TERT+ cell types and effects after regeneration): IF of mTert-GFP and
mTert-rtTA (pulse-chased) brains and OE (with and without intranasal treatment with
ZnSO4, which destroys OSNs)
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o

Questions: How does OE/OB cell ablation affect mGFP TERT progeny? What cell
types are TERT+ cells in the OE? What are the effects of OE/OB cell ablation on
mGFP signal in other brain regions?

o

Hypothesis: TERT+ cells in the OE will show markers of HBCs and GBCstem cells
and will regenerate the OE after injury (as well as in basal conditions at different
levels). TERT+ cells in the OE will express proteins expected in the BMP pathway/
other pathways discovered via scRNAseq/ Seahorse.

Determine whether OSNs from TERT+ cells in the OE communicate with the hypothalamus
to control energy balance and metabolism
In addition to better understanding TERT+ cells, we can utilize TERT+ cells in the OE to
better understand the relationship between olfaction, the hypothalamus, and metabolic status.
Nearly half of Americans are obese, increasing our population’s chances of heart disease, stroke,
type 2 diabetes, and metabolic syndrome [1]. Obesity results from various environmental,
physical, and neurological variables. The hypothalamus of the brain regulates signaling to and
from the liver, adipose, and stomach to regulate both food intake as well as energy expenditure.
Plasticity within this brain region has been identified in the form of neurogenesis, gliogenesis, and
synaptic plasticity and can modulate energy input as well as energy output. However, because
hypothalamic neurogenesis has only recently been discovered, our understanding of the dynamic
processes within the adult hypothalamus are incomplete [2].
Creation or destruction of of adult-born of olfactory sensory neurons (ONSs) within the
olfactory epithelia (OE) and subsequent olfactory changes can modify food intake, adipose
thermogenesis and browning, and full body glucose homeostasis [3]. It is understood that neurons
within the olfactory bulb communicate with the hypothalamus, but their effect on hypothalamic
plasticity remains unknown [4]. We have recently discovered telomerase reverse transcriptase
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(TERT) expressing cells in the adult mouse brain give rise to newborn ONSs in the OE as well as
unknown cell types in the hypothalamus. Importantly, destruction of OSNs in the OE via zinc
sulfate leads to loss of TERT+ progenitors in the hypothalamus after a lineage-trace (Figure 4.2)

Figure 4.2 - Lineage tracing followed by ZnSO4 OSN ablation revealed loss of hypothalamic
mGFP signal in adult mTert-rtTA::oTet-Cre::Rosa-mTmG mice.
A-B) Representative image of immunostaining of OB mGFP signal after ZnSO4 intranasal
treatment (A) or vehicle (B; N=1-3 mice per treatment, n=1-2 tissues per brain)
C-D) Hypothalamic mGFP signal after ZnSO4 intranasal treatment (C) or vehicle (D; N=1-3 mice
per treatment, n=1-2 tissues per brain).
Scale bars are 100um.
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We hypothesize that adult born OSNs that arise from TERT+ cells in the OE communicate
with the hypothalamus to induce energy balance changes in the adult body (Figure 4.3). This
research will uncover previously unknown hypothalamic energy pathways from the OE and
olfactory bulb that have been shown to influence metabolic changes. Unlike other approaches
that do not investigate the interconnected olfactory and hypothalamic pathways, our approach will
allow us to identify how these olfactory signals induce plastic changes within the hypothalamus
and study the newborn cells. The proposed work addresses a current obesity epidemic, and
specific experiments are detailed below.

•

Experiment 5 (Hypothalamic & full-body effects of ZnSO4 in OE): Analysis will be
performed on hypothalamus; IF for mGFP signal to determine if loss of signal is changes
in proliferation vs. changes in axonal outgrowth from OE/OB/olfactory cortex
o

Questions: What are the effects of OE/OB cell death OR regeneration on mGFP
signal in the hypothalamus? What are the effects of OE/OB cell death OR
regeneration on energy balance and metabolism (BAT, WAT, Liver, glucose/
insulin, etc.)

o

Hypothesis: OE cell death will lead to decreased olfaction and improved metabolic
state through decreased hypothalamic TERT related signaling/ neurogenesis and
metabolic tissue changes, while allowing for OE regeneration will show opposite
effects.

•

Experiment 6 (OE/OB-Hypo retrograde tracing): in vivo administration of cholera toxin
from hypothalamic nuclei, staining for neurons in OE/OB that also express cholera toxin
after trace period
o

Questions: Are mGFP cells in the hypothalamus in direct communication with
mGFP+ cells in the OE/OB?
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o

Hypothesis: OE/OB cells that express mGFP or OE/OB cells that are in proximity
to mGFP cells will express cholera toxin fluorophores after retrograde trace from
the ARC or ME of the hypothalamus.

Figure 4.3 - Working Model: TERT ASCs in the OE coordinate hypothalamus-adipose SNS.
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1. Introduction
Bone morphogenetic proteins (BMPs) are multi-functional growth factors belonging to the
Transforming Growth Factor-β (TGF-β) superfamily [467]. BMPs were first discovered in the
1960’s, and while initially believed to only be involved in bone formation, BMPs are now
understood to be involved in numerous cell regulatory processes. These include cell growth,
proliferation, differentiation, migration, and apoptosis, as well as the development and life-long
function of various tissues and organs such as the brain [468-471]. Knockouts of many BMPs are
lethal during embryogenesis and often result in marked defects or pathologies, which can include
decreased metabolic health and obesity [472, 473]. BMP signaling is critically important for the
development and maintenance of the central nervous system (CNS) and peripheral nervous
system (PNS) [474]. In adulthood, previous studies by us and others have highlighted the roles
of BMP7 and BMP8b, as well as BMP receptor 1A (BMPR1A), in reducing body weight by
modulating signaling, appetite, and sympathetic outflow to adipose depots [472, 475, 476].
2. The Basics of BMP Signaling

212

BMP signaling is initiated at the cell surface by the binding of a BMP ligand to type I or
type II transmembrane serine/ threonine kinase receptors forming a tetrameric receptor complex
[469, 477]. After ligand binding, the type II receptor dimer phosphorylates the type I receptor
dimer, activating the downstream signaling cascades [478]. The mode of ligand binding and
tetrameric receptor formation differs between BMPs. BMP2 and BMP4 have a higher affinity for
type I receptors, leading to the recruitment of type II receptors, while BMP6 and BMP7 bind type
II receptors and recruit type I receptors [478-480]. BMP type II receptors can also form tetrameric
complexes prior to ligand binding to affect downstream signaling [479]. In fibroblasts where BMP
type II receptors were mutated to prevent preassembled receptor complexes, BMP2 treatment
preferentially activated SMAD1 signaling, at the expense of the p38 Mitogen-Activated Protein
Kinase (MAPK) pathway in vitro [481].
BMP ligands each bind preferentially to certain type I and type II receptors, with higher
affinities for three type I BMP receptors: BMPR1A (ALK3), BMPR1B (ALK6) and ActR1A (ALK2),
and three type II receptors: BMPRII, and the activin receptors ActRIIA, and ActRIIB [482-487].
BMPR1A, BMPR1B, and BMPRII are specific to BMP2, BMP4, BMP5, BMP6, BMP7, BMP8, and
BMP8b ligands, but activin receptors have the ability to bind activin ligands and to a lesser degree
BMP3, BMP9, BMP10, BMP12, BMP13, BMP14, and BMP15 [488]. BMP binding affinity may
play a role in regulating signaling. BMP7 binds BMPR1B with higher affinity than BMPR1A, while
BMP4 binds both type I receptors with the same affinity [487, 489]. Other receptors in the TGF-β
superfamily, including ALK1, ALK4, and ALK5 have the ability to bind BMPs, but the binding
occurs less frequently [470, 490].
The SMAD pathway is the canonical signaling pathway downstream of BMP receptor
phosphorylation. The SMAD nomenclature is derived from the homologues for SMAD, SMA (small
worm phenotype) in Caenorhabditis elegans (C. elegans) and MAD (Mothers Against
Decapentaplegic) in Drosophila melanogaster (D. melanogaster) [491, 492]. Activation of the
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SMAD pathway begins with phosphorylation of a receptor activated SMAD (R-SMAD) by a type I
BMP receptor. R-SMADs include SMAD1, SMAD5, and SMAD8/9. Phosphorylated R-SMADs will
then bind to SMAD4, a co-mediator SMAD (co-SMAD) and translocate to the nucleus where the
complex can act as a transcription factor [493]. This process can be modulated by inhibitory
SMADs (I-SMADs), including SMAD6 and SMAD7, which bind to co-SMAD to prevent nuclear
binding and downstream processing [493]. SMAD4 has been used to explore the role of BMPs,
including in the CNS, as SMAD4 knockout models halt downstream BMP-SMAD signaling [493].
BMP signaling pathways in the CNS have been well studied during development [494,
495]. Much remains to be studied regarding BMP signaling pathways in the adult brain, including
specific cell types and discrete brain regions where BMP signaling occurs. In the subventricular
zone (SVZ) of the lateral ventricles, a region with well-described adult neurogenesis, the presence
of p-SMAD1/5/8 signaling is correlated to the presence of BMP2, BMP4, BMP6, and BMP7, as
well as Noggin, BMPRII and SMAD4. Additionally, SMAD4 KO from stem cells and glia in the
SVZ, as well as infusion of the inhibitor Noggin, led to major changes in proliferation and
neurogenesis, indicating the utilization of the SMAD signaling pathway in the regulation of adult
brain plasticity [496, 497]. BMP-related downstream SMAD signaling is also observed in the
hippocampus of the adult murine brain, another region with high adult neural plasticity, where
differences in pSMAD1/5/8-positive progenitor cells are linked to age-associated changes in BMP
ligand expression [498]. Non-canonical BMP signaling occurs in the brain as well, as
intracerebroventricular (i.c.v.) administration of BMP7 to adult mice induced a central rapamycinsensitive mTOR-p70S6 kinase pathway in the hypothalamus [476]. In this study, BMP7 treatment
of hypothalamic neuronal cells resulted in increased pSMAD1/5/8 and phosphorylated Ribosomal
Protein S6 Kinase (p-p70S6K) protein levels in vitro (Fig. A2A) [476]. While the role of these
signaling pathways in various processes are incompletely understood, it is clear that BMP
signaling induces both canonical and non-canonical signaling in the adult brain.
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The effects of BMPs are also regulated across different tissues through the inherent
diversity of the many BMP ligands (BMP1-15) [490], the regulation of the extracellular matrix
(ECM) environment, the specificity of the downstream signaling pathways activated, and the
action of endogenous antagonists. BMP antagonists include Noggin [497, 499, 500]. It is
important to note that Noggin is endogenously expressed throughout the mouse [497] and rat
[501] adult CNS, including the neuro/gliogenic SVZ of the lateral ventricles, ependymal lining of
the lateral ventricles, hippocampus, hypothalamus, cortex, striatum, and the olfactory bulbs (OBs)
[497, 501]. These areas also express BMPs and/or BMP receptors (Fig A1A, B, E) [502] and are
niches of adult neural plasticity, highlighting the importance of BMP regulation within the stem cell
niches of the adult mammalian brain.
3. Localization and Expression of BMPs in the Adult Brain
Temporal and spatial changes in expression of BMP ligands and receptors occur
throughout development as well as adulthood [503-505]. In the hippocampus and substantia
nigra, expression of BMP4, BMP6, and noggin increases into adulthood, then decreases as the
animal reaches old age [503, 506]. In neurogenic niches of the adult brain, changes in Noggin
expression, BMP ligand levels, and downstream signaling pathways have been shown to regulate
adult neurogenesis and gliogenesis [496]. Dynamic expression patterns of BMP ligands and
receptors may therefore work to balance BMP signaling in the brain from development through
adulthood in response to changing needs.
There is widespread transcript and protein expression of BMP ligands and receptors
throughout the adult brain (Table A1). BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, and BMP9 are
broadly distributed across the brain, as are the receptors BMPR1A, BMPRII, and to a lesser extent
BMPR1B. In each of these brain areas, regional and cell type specific differences were observed.
Most cell types in the brain, including neurons, astrocytes, oligodendrocytes, and ependymal cells
express BMP2, BMP3, BMP4, BMP5, and BMP6 [507-511]. However, these BMPs are not
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expressed by immune cells such as microglia or macrophages. BMP6 is the only BMP ligand
studied that has been found to be expressed by oligodendrocytes [507]. Currently, comparative
expression levels have not been performed across BMP ligands, but expression across brain
regions has been performed for many individual BMPs. BMP1 is not expressed in the adult brain
[512]. BMP8b has been located to the cortex, striatum, hippocampus, hypothalamus, and medulla
[472]. BMP10 has only been observed in the cortex, although this study did not search elsewhere
in the brain [513]. BMP12, and BMP13 have been identified in the adult spinal cord, but not the
brain [514]. BMP8, BMP14, and BMP15 have not been characterized within the adult brain [494,
502]. The BMP inhibitor Noggin has been identified in many overlapping brain regions and
appears to follow similar spatial and temporal patterns of expression [496, 497, 506]. As BMPs
require proteolytic processing to yield mature proteins from their initial pro-proteins, additional
complexity can be attributed to the diverse BMP processing across tissue regions and cell types
(Reviewed in [494]).
BMPRII and BMPR1A expression is diverse in the adult mouse and rat brain [502, 515,
516]. In situ hybridization studies in the adult mouse show that the highest expression of BMPRII
is within the OB, hippocampus, and cerebellum [502]. BMPR1A and BMPRII regional expression
differences have been observed as BMPRII is expressed in the granule cell layer of the
cerebellum or the glomerular layer of the OB, while BMPR1A is not [502, 515]. BMPR1A,
BMPR1B, and BMPII receptors are co-localized with a variety of cell types in the adult CNS,
including neurons, astrocytes, oligodendrocytes, ependyma, and microglia indicating the
importance of BMP signaling throughout the entire adult brain [515].
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Appendix Table A1 – BMP Ligand and Receptor Localization in the Adult Brain
Ligand/
Receptor
BMP1

Location

BMP2

SEZ, CC

BMP3

BMP4

None

Function
Studied?
No

Not
directly
SVZ
Not
directly
CTX, HIP, STR, Not
SN
directly
OB, CTX, CC, No
HIP, THA, HYP,
MB, CB, BS,
SVZ, ChP
OB, CTX, CC, No
NA, HIP, THA,
HYP, MB, BS,
CB, SVZ, ChP
Fiber tracts, CB, No
CC, CTX
OB
No

Model

Method

Mouse,
Human
Mouse

NB
ISH

RNA or Citation
Protein
RNA
Takahara,
1994 [512]
RNA
Colak, 2008
[496]

Mouse

RT-PCR

RNA

Lim,

2000

[497]

Rat

RT-PCR

RNA

Chen,

2003

[503]

Rat

IHC

Protein

Sato,

2010

[510]

Rat

IHC

Protein

Yamashita,
2016 [511]

Rat

ISH

RNA

Mouse

WB, IHC

Protein

Charytoniuk,
2000 [502]
Peretto, 2002

Mouse

ISH

RNA

[505]

SEZ, CC

Not
directly
SVZ
Not
directly
CTX, HIP, STR, Not
SN
directly
OB, CTX, HIP, No
THA, HYP, MB,
CB, BS, SVZ,
ChP
HIP
No
BMP5

CTX, HIP, STR, Not
SN
directly
OB, CTX, HIP, No
THA, HYP, MB,
CB, BS, CC,
SVZ, ChP

Colak,

2008

[496]

Mouse
Rat

RT-PCR,
IHC
RT-PCR

RNA & Lim,
[497]
Protein
RNA
Chen,

2000
2003

[503]

Rat

IHC

Protein

Mikawa, 2006
[509]

Rat
Rat

RT-PCR,
ISH
RT-PCR

RNA

Fan,

2003

[506]

RNA

Chen,

2003

[503]

Rat
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IHC, WB

Protein

Kusakawa,
2015 [508]

Table A1 continued
BMP6

Meninges

No

Rat

ISH

RNA

OB

No

Mouse

WB, IHC

Protein

Charytoniuk,
2000 [502]
Peretto, 2002
[505]

SEZ, CC

BMP7

Not
directly
CTX, HIP, STR, Not
SN
directly
OB, CTX, HIP, No
THA, HYP, MB,
CB, BS, CC,
SVZ, ChP
Meninges,
No
Septal regions
ChP, HYP, HIP
Yes

Mouse

OB

No

ISH

RNA

Colak,

2008

[496]

Rat

RT-PCR

RNA

Chen,

2003

[503]

Rat

IHC

Protein

Hayashi, 2019
[507]

Rat

ISH, IHC

Mouse

ISH

Mouse

WB

RNA & Charytoniuk,
Protein
2000 [502]
RNA
Townsend,
2012 [476]
Protein
Peretto, 2002

Mouse

ISH

RNA

[505]

SEZ, CC

Not
directly
CTX, HIP, STR, No
SN
OB, CTX, HIP, No
THA, HYP, MB,
CB, BS, SVZ,
ChP
SVZ
Yes

Colak,

2008

[496]

Rat

RT-PCR

RNA

Chen,

2003

[503]

Rat

IHC

Protein

Kusakawa,
2017 [517]

Mouse

IHC

Protein

Lim,

2000

[497]

BMP8a

None

Rat

RT-PCR

BMP8b

CTX, STR, HIP, Yes
HYP, MED
OB, CTX, HIP, No
THA, HYP, MB,
CB, BS, SVZ
CTX
No

Mouse

ISH, RT- RNA
PCR
IHC
Protein

BMP9
BMP10
BMP11
BMP12
BMP13
BMP14
BMP15
Noggin

Not studied
Not studied
Not studied
Not studied
Not studied
SEZ, Septum

Yes

Rat

RNA

Charytoniuk,
2000 [502]
Whittle, 2012
[472]

Ogawa, 2021
[518]

Mouse

IHC, WB,
RT-PCR
ISH

RNA &
Protein
RNA

Yan,

2012

[513]

Colak,

2008

[496]

HIP

Yes

Mouse

ISH

RNA

Fan,

2003

[506]

CTX, HIP, STR, Yes
SN

Rat

RT-PCR

RNA

Chen,
[503]
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Table A1 continued
Ependyma of LV

BMPRII

Yes

OB, CTX, HIP, No
THA, HYP, MB,
HB, CB
OB, CTX, HIP, No
CB, THA, HYP,
MB, SN, SVZ,
ChP
SEZ
No

Mouse

RNA,
Protein
RNA

Lim,

Rat

RT-PCR,
IHC
NB, ISH

2000

Rat

IHC

Protein

Mikawa, 2011

[497]

Valenzuela,
1995 [541]
[501]

Mouse

ISH

RNA

Colak,

2008

[496]

SVZ

No

Mouse

RT-PCR

RNA

Lim,

2000

[497]

OB, CTX, STR,
HIP, THA, AMG,
SN, CB
OB, THA, BS,
CB, HYP, HIP,
CTX, STR
CTX, OB, HIP,
CB, HYP, SN
HYP

BMPR1A

No

Rat

ISH

RNA

Söderström,
1996 [542]

No

Rat

NB

RNA

Charytoniuk,
2000 [502]

No

Rat

ISH

RNA

No

Mouse

ISH

RNA

OB, HIP, AMG, No
THA, HYP, MB,
BS, CTX

Rat

IHC

Protein

Charytoniuk,
2000 [502]
Townsend,
2012 [476]
Miyagi, 2011

SVZ

Mouse

Yes

[515]

RT-PCR

RNA

Lim,

2000

[497]

BMPR1B

CTX, HIP, THA, No
OB, CB, BS,
ChP
HYP
Yes

Mouse

ISH

RNA

Mouse

IHC

Protein

OB, HIP, AMG, No
THA, HYP, MB,
BS, CTX
SVZ
No

Rat

IHC

Protein

Zhang,

1998

[516]

Townsend,
2017 [475]
Miyagi, 2011
[515]

Mouse

RT-PCR

RNA

Lim,

2000

[497]

Anterior olfactory No
nuclei
OB, HIP, AMG, No
THA, HYP, MB,
BS, CTX

Mouse

ISH

RNA

Zhang,

1998

[516]

Rat

IHC

Protein

Miyagi, 2011
[515]
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Table A1. Expression of BMP ligands and receptors in the adult brain. Acronyms – SEZ:
sub-ependymal zone, CC: corpus callosum, SVZ: subventricular zone, CTX: Cortex, OB:
Olfactory bulb, STR: striatum, HIP: hippocampus, THA: thalamus, AMG: amygdala, SN:
substantia nigra, HYP: hypothalamus, MB: midbrain, BS: brainstem, ChP: choroid plexus, CB:
cerebellum, MED: Medulla, ISH: in situ hybridization, IHC: immunohistochemistry, RT-PCR: realtime polymerase chain reaction, WB: Western Blot, NB: Northern Blot

3.1 – BMP Expression within Neurogenic Niches
Within the adult hippocampus, radial glial-like stem cells within the subgranular zone
(SGZ) of the dentate gyrus (DG) proliferate and differentiate to produce transit amplifying cells
(TACs), which then differentiate into neuroblasts. These cells migrate into the granule cell layer
of the hippocampus and mature into adult-born neurons. BMP ligands, receptors, and inhibitors
are expressed here, and actively play a role in modulating adult plasticity (Fig A1D) [502, 506].
BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP9, Noggin, BMPR1A, BMPR1B, and BMPRII are
all expressed in various areas of the hippocampus including the DG [501, 507-511, 517, 518].
BMP2, BMP3, BMP4, BMP5, BMP6, and BMP9 expression was localized to pyramidal cells and
granule neurons, but BMP7 was not expressed in either cell type. In contrast BMP7 was
expressed in astrocyte-like cells throughout the hippocampus [517]. BMP2 expression was found
in astrocyte-like cells as well [510]. BMP receptor expression also showed notable differences in
this region, as BMPR1A and BMPRII showed weak expression compared to BMPRIB. BMPR1A
was expressed by astrocyte-like cells and some pyramidal neurons. BMPR1B and BMPRII were
expressed by pyramidal cells [515].
The SVZ, located adjacent to the ependymal cells of the lateral ventricles, contains slowly
cycling radial glial like neural stem cells (NSCs). These cells give rise to TACs, which in turn
proliferate and differentiate into neuroblasts (Fig A1B). Neuroblasts migrate through the rostral
migratory stream to the olfactory bulb where they differentiate into interneurons that integrate into
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existing neural circuitry [19]. BMP ligands, receptors, inhibitors, and downstream gene expression
targets can be found in all SVZ cell types (Fig A1B). BMP2, BMP4, BMPR1A, and BMPRII are all
expressed by NSCs, TACs, and neuroblasts [497] (Fig A1B). However, only neuroblasts, the most
differentiated and committed of these progenitors, express BMPR1B [497] (Fig A1B), which may
provide specificity for BMP signals impacting neuroblast differentiation. BMP2 and BMP4
expression are 20 to 25-fold higher in ANSCs and TACs compared to neuroblasts [497] and may
be maintaining an undifferentiated state. BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP9,
Noggin, BMPR1A, BMPR1B, and BMPRII as well as downstream signaling molecules pSMAD1/5/8, SMAD4, and SMAD transcriptional targets Id1and Id3 are all expressed by cells
within the SVZ and ependymal niche of adult mice and rats, although many have not been
localized to specific cell types (Fig A1B) [496, 497]. This full spectrum of BMP signaling molecules
in this neurogenic niche provides insight into the importance and complexity of BMP signaling in
adult neural plasticity.
BMPs also have the potential to influence brain regions far from where they are expressed,
due to the brain’s ventricular transport system. Our previous work in Lac-Z-BMP7 reporter mice,
as well as the work of others, has demonstrated that the metabolically relevant ligand BMP7 is
expressed in the choroid plexus of the lateral ventricles of the mouse brain [476, 502] (Fig A1B).
As BMP7 has been found to circulate within the cerebrospinal fluid (CSF) [519], BMP7 could be
produced in the choroid plexus, secreted into the CSF, and bind BMP receptors on cells that lie
at the CSF-brain interface [519] (Fig A1B). BMP2, BMP3, BMP4, BMP5, and BMP6 are also
expressed in the choroid plexus and may be circulating within the CSF, but that is currently
unknown [507-511].
To respond to BMPs moving throughout the CSF, ependymal cells and other cells lining
the ventricular system of the adult mouse brain express BMP receptors. We have found that
BMPR1A is highly expressed on hypothalamic tanycytes, which line the walls of the ventral third
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ventricle (V3V) (unpublished observations) (Fig A1E). Tanycytes are ependymal, radial glial-like
cells whose cell bodies are positioned along the wall of the V3V with long apical processes
extending out into the parenchyma of the hypothalamus [52]. The positioning of these cells
between the CSF and the hypothalamic parenchyma allows these cells to respond to cues in the
CSF, including glucose, histamine, and acetylcholine, and to communicate bidirectionally with the
hypothalamus and the CSF [520]. Their processes also project to the median eminence (ME) at
the ventral portion of the hypothalamic third ventricle, where fenestrated capillaries result in a lack
of blood-brain barrier, thus allowing these tanycytes to sense factors within the blood and respond
accordingly [521]. The high expression of BMPR1A receptors on tanycytes puts them in an
opportune position to respond to BMPs circulating in the CSF.
In addition to the CSF and vasculature, expression of BMP2, BMP3, BMP4, BMP5, BMP6,
BMP7, BMP8b, and BMP9 have been identified along the ependyma of the ventricles and
throughout most hypothalamic regions (Fig A1E). Here, BMP2, BMP4, BMP6, and BMP9 are
expressed within the arcuate nucleus (ARC) [507, 509, 510, 518]. BMP3, BMP5, BMP6, BMP7,
and Noggin are expressed within the paraventricular nucleus (PVH), with BMP7 being expressed
by oxytocin-positive neurons in this region [507, 508, 511, 517]. BMP3, BMP4, BMP5, BMP6, and
BMP9 are expressed in the supraoptic nucleus (SON) [507-509, 511, 518]. BMP3, BMP5, BMP6,
and BMP9 are expressed in the ventromedial hypothalamic nucleus (VMH) [507, 508, 511, 518].
BMP3, BMP4, BMP5, BMP6, BMP7, and BMP9 are expressed along the ependyma of the V3V,
which may include tanycytes, although the specific cell types have not been studied [507-509,
511, 517, 518]. Interestingly, tanycytes are also proliferative, stem-like cells, which play a role in
adult hypothalamic plasticity [332]. Therefore, it is possible that tanycytes utilize BMP signaling to
regulate hypothalamic neuro/gliogenesis and energy balance.
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Figure A1: The role of BMP signaling on neuro/gliogenesis in the adult brain. BMPs play a
role in regulation of adult neuro/gliogenesis and proliferation in various neuro/gliogenic niches of
the adult brain. A) Sagittal view of an adult mouse brain showing known plastic, or neuro/gliogenic
areas where BMP ligands have been studied, B) BMP ligands, receptors, and inhibitors are
differentially expressed throughout the lateral ventricles, with differing expression within the SVZ,
ependymal cell layer, and choroid plexus. BMPs 3, 4, 5, 9, and Noggin are known to be expressed
within the SVZ, but the cell types that express them are currently unknown. Noggin is expressed

223

by ependymal cells as well as unknown SVZ cell types. C) BMP2, BMP4, and BMP7 halt
proliferation and turnover, while Noggin and Smad4 balance adult neurogenesis and gliogenesis
in the SVZ. D) Hippocampal BMP signaling affects proliferation of NSCs, neurogenesis, and
astrogliogenesis. Here, BMP4 signaling plays a major role in proliferation and neurogenesis, while
Noggin counters these effects. E) In the hypothalamus, various BMPs are found throughout the
CSF, ventricular wall, PVH, VMH, ARC, ME, and more (dorsal/ventral location of BMPs along the
wall in this figure are not indicative of dorsal/ventral location in the adult brain). Tanycytes, a
proposed population of hypothalamic stem cells, express BMPR1A and are hypothesized to play
a role in ventricular BMP signaling. However, the effects of BMPs and downstream signaling in
this niche remain unstudied. (OB: Olfactory bulb, Ctx: Cortex, LV: Lateral Ventricle, Hip:
Hippocampus, qANSC: quiescent adult neural stem cell, TAC: Transit amplifying cell, CPEC:
choroid plexus epithelial cell)

4. Adult Neuron and Glial Cell Maintenance
In the adult brain, neuro/gliogenesis is at least in part regulated by local and CSF-derived
BMPs and antagonists, as well as BMP receptor expression. In the SVZ and SGZ, BMP-SMAD
signaling holds stem cells in quiescence, downregulating neurogenesis and proliferation (Table
A2). Gliogenic studies of BMP-SMAD signaling implicate BMPs in inducing astrogliogenesis while
decreasing oligodendrogenesis (Table A2). Furthermore, BMPs play a major role in synaptic and
dendritic plasticity in the brain. Their role in repair after injury and aging also indicate an important
role in stem cell manipulation. Presently, the function of specific BMPs have been understudied
compared to downstream SMAD signaling, making it hard to identify the role of specific BMPs
throughout all neuro/gliogenic regions of the brain. However, it is clear that BMPs play a major
role in maintenance of the adult brain, and further elucidation of these pathways will be important
in generating a complete understanding of adult neuro/gliogenesis and plasticity. Finally, while
BMP-SMAD signaling has been functionally studied in the SVZ and hippocampus, the presence
of BMPs and their receptors in various other neuro/gliogenic and plastic brain regions hints at
undiscovered BMP-regulated functions in the adult brain (Appendix Fig A1A, Table A1).
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4.1 Adult Gliogenesis
In the adult mouse SVZ, BMP signaling inhibits oligodendrogenesis [496]. Data using a
conditional Glial High Affinity Glutamate Transporter (GLAST)-mediated SMAD4 knockout (KO)
model showed that ablation of SMAD signaling in NSCs and glia of adult mice increased
oligodendrogenesis in the SVZ in vivo [496] (Appendix Fig A1C). Infusion of the BMP inhibitor
Noggin also resulted in increased oligodendrocyte numbers [496] (Appendix Fig A1C). Adult mice
administered with BMP2 via intracerebroventricular injections into the lateral ventricles showed
decreased SVZ Oligodendrocyte Transcription Factor 2 (Olig2)-positive oligodendrocytes [522]
(Appendix Fig A1C). Postnatal BMPR1A knockout in Olig1+ oligodendrocyte precursor cells
resulted in significantly higher numbers of oligodendrocytes than WT mice, which was likely due
to reduced cell cycle length of progenitor cells, due to a loss of BMP signaling [523].
While BMP signaling appears to typically inhibit oligodendrogenesis, it promotes
astrogliogenesis throughout the brain [523, 524]. Transgenic neuron-specific enolase (NSE)
BMP4 overexpression mice, which overexpress BMP4 in neurons postnatally, had a 40%
increase in astrocytic density in multiple adult brain regions [524]. Adenoviral overexpression of
Noggin by ependyma decreased astrogliogenesis in the SVZ of adult rats [525]. When cultured
with neural precursor cells (NPCs) in vitro, NSE-BMP4 neurons derived from the hippocampus
increased astrocytic lineage commitment by the NPCs unless blocked via Noggin [524] (Appendix
Fig A1D). Astrogliogenesis also results from BMP signaling in neural stem/progenitor cells from
both the hippocampus as well as the SVZ respond to fibrinogen via BMP signaling-induced
astrogliogenesis, which is accompanied by neuronal differentiation [526].
Experiments on cells derived from embryonic striatum treated with various BMPs resulted
in cultures with higher numbers of cells expressing the astroglial protein glial fibrillary acidic
protein (GFAP) [504]. BMP2 treatment also resulted in decreased proliferation, indicating
differentiation of NSCs is driving the increased number of astrocytes, rather than astrocyte mitosis
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[504]. In this study BMP2-induced astrogliogenesis was also correlated with decreased
oligodendrogenesis, supporting the astrogliogenic and anti-oligodendrogenic actions of BMPs
[504]. Overexpression of a dominant negative BMPR1A in adult-derived hippocampal progenitor
cells also resulted in increased astroglial differentiation, but there was no change in
oligodendrogenesis [527] (Appendix Fig A1D). Interestingly, oligodendrogenesis was significantly
increased following overexpression of a dominant negative BMPR1B in hippocampal derived
NSCs, while astrogliogenesis was decreased [527]. Noggin treatment mimicked these effects in
these cells [527]. Additionally, in SVZ-derived cells Noggin inhibited astrocyte differentiation [497].
This is clearly contrasted by the finding that BMP5-induced SMAD1/5/8 signaling limited the
proliferation of astrocytes while promoting mature astrocyte differentiation from immature
astrocytes in vitro, supporting the evidence above that BMPs may be increasing astrocyte
differentiation rather than proliferation [528].
Taken together, BMP signaling works to reduce oligodendrocytic differentiation of NSCs
in the SVZ and increase astrogliogenesis throughout multiple brain regions. Currently, it is
hypothesized that BMPs hold NSCs in quiescence, and that a lack of BMP signaling leads to
unrestricted differentiation, resulting in decreased NSC levels. However, if BMPs can also act to
induce astrogliogenesis, it may be through a different mechanism. Additionally, it is important to
note that GFAP, a common marker used to measure astrocytes and measure astrogliogenesis,
is also a marker of NSCs in the SVZ and SGZ. Therefore, it is possible that GFAP+ cell numbers,
often used to measure astrogliogenesis, may be confounding data regarding astrocyte
quantification.
4.2 Adult Neurogenesis
Development of the CNS occurs through an orchestrated combination of cell proliferation,
precursor differentiation, and maintenance of the stem cell pool. In the adult mammalian brain,
NSCs reside within neurogenic niches and give rise to newborn neurons [529]. By adulthood, the
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number of dividing and proliferating cells decreases drastically in rodents and humans [179, 530].
There are a few areas of the brain that are known to maintain the ability to divide and replenish
the stem/progenitor cell niche [531]. Those areas include the SGZ [11, 532], the SVZ [19], and
the hypothalamus [58, 59, 384]. The hypothalamic niche is a more recently discovered neurogenic
niche, where tanycytes are hypothesized as one population capable of giving rise to adult-born
hypothalamic neurons or support local stem cell differentiation [129].
To allow for long-term plasticity within the neurogenic niches, NSCs require controlled
levels of proliferation, as increased proliferation and neurogenesis could result in depletion of the
NSC pool. This process is regulated in the adult brain by BMP signaling, as BMPs hold NSCs in
a quiescent, non-proliferative state, and BMP inhibition results in neurogenesis [352, 496, 497,
506, 533, 534]. In the adult SVZ, overexpression of BMP7 inhibits proliferation of precursor cells
(Appendix Fig A1C). BMP2 and BMP4 regulate adult neurogenesis as well, as treatment of SVZderived cells with BMP2 or BMP4 reduces neurogenesis in vitro [497]. Decreased neurogenesis
was also observed after viral expression of constitutively active BMPR1A and BMPR1B receptors
in SVZ-derived cells [497]. The downstream SMAD pathway also regulates these processes, as
SMAD4 KO from astrocytes and NSCs in the same niche impeded the transition of NSCs to
progenitor cells [496] (Appendix Fig A1C). SVZ BMP signaling leads to expression of the
quiescence marker Cyclin Dependent Kinase 4 Inhibitor D, indicating that BMP signaling may
promote cell cycle arrest [535]. Reduced BMP4 clearance in the SVZ resulting from LRP2
deficiency decreased proliferative capacity of NSCs in the SVZ in vivo [536]. SVZ-derived
neurospheres treated with BMP2 decreased neurosphere numbers, indicating impaired
proliferation in vitro [522]. Additionally, adherent cultures of neurosphere-generated TACs
showed reduced cell cycle marker expression after BMP2 treatment [522]. These examples
demonstrate the neurogenic regulatory capacities that BMPs have in vitro using SVZ cells, and in
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vivo within the niche, to hold cells in a quiescent and non-proliferative state. BMPs have a similar
regulatory role in other neurogenic niches.
In the hippocampus, BMPs also act to decrease proliferation and decrease the number of
NSCs in the cell cycle. Treatment with BMP4 in this niche reduced cycling NSCs, neuroblasts,
and EdU-labeled cells, but not the number of NPCs, indicating the cells were being held in a nonproliferative state [534] (Appendix Fig A1D). NSE-BMP4 mice, which overexpress BMP4 in adult
neurons, have significantly greater numbers of slowly dividing stem-like cells in the DG [533].
Slowly cycling hippocampal cells are far reduced in NSE-Noggin mice compared to both wild-type
and NSE-BMP4 mice [533]. Further studies showed that in the adult mouse Noggin acted to
accelerate NPC activation and increased the number of proliferating precursor cells and
neuroblasts [352, 534] (Appendix Fig A1D). However, the long-term effects of Noggin on the
hippocampus were decreased proliferation and fewer label retaining NSCs, indicating a reduction
in the stem cell pool or loss of proliferative abilities of SGZ NSCs [352]. Increased proliferation
followed by a reduction in NSC division and newborn precursors was also found in mice with a
conditional BMPR1A ablation in hippocampal NSCs or SMAD4 KO mice [352] (Appendix Fig
A1D). In vitro, treatment of Noggin on neurospheres generated from adult mouse hippocampus
resulted in increased numbers of neurospheres, as well as larger neurospheres, indicating higher
levels of proliferation with the BMP inhibitor [533].
Proliferation and activation of NSCs leads to the production of NPCs, which migrate and
differentiate into adult-born neurons. Studies examining neurogenesis in the SVZ reveal that
overexpression of BMP7 prevents the repopulation of NPCs in the SVZ following the loss of
proliferative progenitors [497]. Noggin expression in NSCs in the SVZ increased proliferation, as
well as the number of NPCs, but at the expense of quiescent NSCs [537]. Noggin overexpression
in the striatum also promoted neuronal differentiation of transplanted SVZ cells [497]. These
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findings are potentially due to BMPs holding NSCs in a non-committed state and preventing
differentiation to NPCs.
The anti-neurogenic role of BMPs also impacts cognition in the adult hippocampus.
Interventions known to improve cognition (which included exercise, environmental enrichment,
and maze training) increased neurogenesis and improved cognition, apparently working through
the BMP-Noggin axis, as these interventions reduced BMP signaling and increased Noggin
expression in this region [506, 538]. When mice were exposed to Morris water maze testing, they
had an increase in expression of Noggin mRNA in the DG, thus demonstrating that a decrease in
BMP signaling could lead to cognitive improvements [506]. Elective exercise in the form of wheel
running also increased Noggin expression and decreased BMP expression [538]. Exercise
resulted in increased cellular turnover, and heightened numbers of NPCs and neuroblasts [538].
Improved cognition and increased neurogenesis were mirrored in NSE-Noggin mice and
antagonized in NSE-BMP4 animals [538]. Importantly, the cognitive advancements in NSENoggin mice required neurogenesis and cell proliferation, as treatment with the mitotic inhibitor
1-β-d-Arabinofuranosyl-cytosine (Ara-C) reversed cognitive improvements in these mice [538].
BMPs are likely inhibited in states of adult neural plasticity.
In vitro studies examining the neurogenic impacts of BMP signaling in adult hippocampal
cells show a similar trend. Treatment of adult hippocampal NSCs with BMP2 or BMP4 resulted in
decreased proliferation, which was reversible with Noggin treatment [352] (Appendix Fig A1D).
Intriguingly, rat adult hippocampal NSCs treated with BMP2 or BMP4 were found to increase
neurogenesis in a WNT-dependent manner in vitro [539]. In SVZ-derived NPCs, these BMPs
reduced the number of newborn neurons in culture [497], while Noggin treatment promoted
differentiation of neurons from neurospheres [537]. Investigation of BMP signaling in neuronal
progenitor cells from the olfactory epithelium revealed that BMPs reduce neuronal colonies in
culture and inhibit proliferation in olfactory epithelium explants [540]. Taken together, BMPs
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clearly impede neurogenesis and the BMP inhibitor Noggin can increase proliferation and
neurogenesis.
Appendix Table A2 - Impact of BMPs on Adult Neural Plasticity (neurogenesis, gliogenesis)

Animal model

Wildtype mice

Wildtype mice

NSE-Noggin mice
(overexpression
in hippocampal
neurons)

Treatment(s)
Ara-C
treatment
followed by
Adenoviral
overexpression
of BMP7
BMP2, BMP4;
constitutively
active
BMPR1A/B

-

Brain Area

Findings

Subventricular
zone (SVZ)

BMP7 overexpression
inhibited proliferation and
type A cell production.

Citation

Lim, 2000
[497]

SVZ-derived
cells

Subgranular
Zone (SGZ)

C57BL/6 mice

Noggin

Hippocampusderived
neurospheres

GLAST:CreERT2/
Smad4f/fl mice
(Smad4 KO in
NSCs and glia)

-

SVZ
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BMP treatment or signaling
upregulation inhibits
neurogenesis.
Noggin overexpression in
the SGZ increased GFAP+
cell populations at the
expense of other precursors
in vivo.
Noggin treatment increases
proliferative and selfrenewal ability of NSCs and
allows for multipotential
differentiation into neurons
and glia.
Smad4 deletion in glia and
ANSCs increased
oligodendrocyte precursor
numbers and impaired
neurogenesis via BMPmediated signaling.

Bonaguidi,
2008 [533]

Colak, 2008
[496]

Table A2 continued
NSE-BMP4 mice
and NSE-Noggin
mice
(overexpression
of BMP4 or
Noggin in
hippocampal
neurons)
GLAST:CreERT2/
Smad4fl/fl mice
(Smad4 KO in
NSCs and glia)

-

-

Hippocampus

BMP4 overexpression
decreased proliferation
(CldU+ or IdU+ cells),
neurogenesis (Sox2+ or
DCX+ cells), and cognition.
Noggin overexpression
increased proliferation,
neurogenesis, and
proliferation-mediated
cognition.

Hippocampus

Noggin treatment causes
NSCs to enter the cell cycle
and increases neurogenesis
in vivo.

CD-1 mice

i.c.v. Noggin

Hippocampus

Wildtype mice

Lentiviral
BMP4,
Lentiviral
Noggin

Hippocampus

hGFAP-CreERT2
x BMPRIIflx;
RosazsG mice
(Deletion of
BMPRII from
activated ANSCs)
FVB/N x pBiNoggin-EGFP
(Conditional
Noggin
expression in
NSCs)

C57BL/7 mice

-

Hippocampus

-

SVZ

BMP2

SVZ-derived
neurospheres
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Short-term Noggin
treatment increases
proliferation of NSCs and
neuroblast number, while
chronic exposure decreases
proliferative ability of NSCs.
Overexpression of BMP4 in
the hippocampus caused
NPC cycle exit and reduced
neurogenesis.
Overexpression of Noggin
led to accelerated
neurogenesis.

Gobeske,
2009 [538]

Mira, 2010
[352]

Bond, 2014
[534]

BMPRII ablation in NSCs
accelerated maturation.
Noggin expression in
Nestin+ NSCs lead to
increased proliferation,
increased neuroblasts and
oligodendrocyte progenitors,
and decreased numbers of
quiescent NCSs.
BMP treatment limits EGFinduced proliferation of
TACs, while inhibition of
BMP-SMAD signaling
promotes activation of
quiescent NSCs.

Morell,
2015 [537]

Joppé,
2015 [522]

Table A2 continued

Crl:CD1 mice

BMP2, BMP4

Adult
hippocampal
NSCs

Exposure to BMP2 and
BMP4 ligands OR
overexpression of BMPR1A
increases neurogenesis
while decreasing
oligodendrogenesis.

Armenteros,
2018 [539]

6. The role of BMPs in the neural control of energy balance
Single nucleotide polymorphisms (SNPs) in BMP2 and BMPR1A are associated with human
obesity and BMPR1A SNPs are implicated in obesity-related traits such as plasma leptin and
plasma glucose, but their actions in the regulation of energy balance are still being investigated
[157, 158]. The two major types of adipose tissue are white adipose tissue (WAT), which is made
up of white adipocytes that store fuel, and brown adipose tissue (BAT) that can produce heat via
non-shivering thermogenesis, in response to norepinephrine released by sympathetic nerves
after cold stimulation. Our work, as well as the work of others, has demonstrated that BMPs and
their receptors are important for the regulation of energy balance both by acting in the CNS to
regulate appetite and by stimulating sympathetic activity in BAT, as well as promoting the
development and production of heat producing (thermogenic), calorie-burning brown adipocytes
[6, 9, 10].

6.1 Hypothalamic Neurogenesis
Whether BMPs are also involved in these processes in the hypothalamus remains
unknown. However, it is clear that other factors, including BDNF and CNTF are able to modulate
metabolic function through a hypothalamic pathway that incorporates neurogenesis. As previous
work has uncovered the expression of BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8b and
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BMPR1A in the V3V ependymal/ tanycytic layer, ME, ARC, VHM, and PVH, and because BMPs
affect neurogenesis in both the SVZ and SGZ, it is possible that within the hypothalamus,
hypothalamic neurogenesis could also be controlled by BMP signaling. Indeed, the presence of
BMP-rich CSF and a leaky BBB within the ME indicates a clear possibility for the complex
coordination of hypothalamic neurogenesis by both BMPs and their antagonists.
Tanycytes are known to respond to dietary changes via the creation of newborn neurons
within the hypothalamus [97, 100, 162]. After high fat diet, young adult mice showed reductions
in neurogenesis in the ARC, and female mice also had increased neurogenesis in the ME [163].
These newborn neurons within the ME were determined to be progeny of tanycytes in proximity
to the ME. In addition, irradiation of the median eminence attenuated weight gain in female mice
fed an HFD, resulting in significantly lower weight gain than their HFD-sham counterparts,
providing evidence that adult-born neurons in the median eminence respond to HFD with
increased body weight [163]. Interestingly, this effect was not seen in male mice, indicating that
adult hypothalamic neurogenesis may be a sexually dimorphic method of body weight regulation
and energy storage. This process may be regulated by BMP signaling, although the specific
pathways involved are unknown.

6.2 Appetite Regulation
The role of BMP pathways in regulating appetite can be traced back to D. melanogaster and C.
elegans. In C. elegans, the TGF-β family ligand DAF-7, signals through the canonical SMAD
signaling pathway, and is upregulated during refeeding after fasting [164, 165]. Additionally,
mutations in daf-7 and the TGF-β receptor homologs daf-1 and daf-4 play a role in quiescence
after fasting and refeeding, indicating a role for the TGF-β-SMAD signaling pathway in satiety
[164, 165]. This signaling pathway is highly similar to the BMP-SMAD signaling pathway as they
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both utilize canonical SMAD signaling, and points to a shared evolutionary role for appetite
regulation. In drosophila larvae, reduced glass bottom boat (Gbb)/BMP signaling affects
metabolism of fat body cells [166]. Additionally, the phosphorylated Smad1/5 protein homologue,
pMad, which normally accumulates in the nuclei of wild-type fat bodies, is reduced after nutrientdeprivation in larvae [166]. These studies indicate an evolutionary role of BMP-SMAD signaling
in regulating and responding to appetite and fuel storage.
BMP signaling regulates appetite in mice as well. Following HFD in adult mice housed at
23°C, Bmp8b expression increased 4-fold in BAT [6]. Changes were also seen in the expression
of transcripts of BMP8b, BMP2, BMP4, BMP5, and BMP6 in BAT after fasting and re-feeding [6].
BMP8b knockout mice consumed less energy on chow and HFD, yet still gained more weight
than their wild-type counterparts (Fig 2D). This phenotype may have occurred through a CNS
appetite axis, as neuropeptides AgRP, NPY, POMC, and cocaine and amphetamine regulated
transcript (CART) mRNA levels were all decreased in BMP8b-/- mouse hypothalami [6]. This
change in appetite may have been directly correlated with BMP and hypothalamic signaling, and
the significantly reduced metabolic rate of BMP8b-/- mice was paired with impaired
thermogenesis, which potentially also may have had a CNS origin if hypothalamic control over
adipose sympathetic drive was also affected by BMPs [6].
A study performed by our group demonstrated that systemic BMP7 treatment reduced appetite,
increased metabolic rate, and promoted weight loss in C57BL/6 mice with diet-induced obesity
[10] (Fig A2A). This weight loss resulted from decreased fat mass, not lean mass. In the same
study, systemic BMP7 treatment of leptin-deficient (ob/ob) mice resulted in weight loss associated
with decreased food intake, indicating that the decreased appetite and weight loss seen in both
mouse lines were found to be mediated via a leptin-independent rapamycin-sensitive mTOR-pp70S6K pathway [10] (Fig A2A). This study also examined the effects of BMP7 administered i.c.v.
The results showed a 44.4% decrease in food intake in C57BL/6 mice, which was mirrored in
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ob/ob mice [10] (Fig A2B). When analyzing hypothalamic neuronal activity, central BMP7
administration was associated with increased c-Fos-immunoreactive neurons in the ARC, which
houses neurons that affect food intake and energy expenditure. Additionally, hypothalamic POMC
expression (an anorexigenic neuropeptide) was increased in C57BL/6 mice that received BMP7,
supporting the relationship between BMPs and hypothalamic appetite reduction. Interestingly,
targeted knockdown of BMPRII in the brain before treatment with centrally administered BMP7
led to no reduction in food intake [10]. These data support the idea that BMPs act through the
hypothalamus to reduce appetite in a leptin-independent manner, likely via type 1 receptors.
Intriguingly, another study showed that BMP7 treatment resulted in a dose dependent
increase in food intake in C57Bl6/J mice held in subthermoneutrality. Here, BMP7 effects
appeared to have opposite effects as the prior study, but there are major differences in the mice
and treatments between these two studies. In this study where BMP7 treatment led to increased
appetite, 4-wk old male C57BL/6J mice were treated for 4 weeks with BMP7 while on a 45% HFD,
which itself can increase hyperphagia. Here, food intake was measured over 1 week during the
last week of BMP7 treatment. These mice were also housed in subthermoneutral conditions. The
previous study utilized adenoviral expression of BMP7 in C57BL/6 mice after 12 weeks of 45%
HFD when analyzing systemic BMP7 treatment in obese animals, and measured food intake over
12 days to determine if BMP7 could reverse (and not prevent as in the prior study) weight gain.
These large differences between methodology may have resulted in the opposite effects on
appetite. However, BMP7 treatment in both studies led to improved metabolic phenotype and
caused changes in appetite, leading us to conclude that BMP7 plays a role in appetite and
hypothalamic signaling in the adult mouse brain.
To identify the mechanism by which BMP7 in the hypothalamus physiologically regulates appetite,
we showed that selective knockout of BMPR1A (a BMP7 receptor) in POMC neurons of adult
mice resulted in hyperphagia as anticipated, but with a striking lack of obesity even on a 45%
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HFD for up to 24wks [9] (Fig A2C). This resistance to obesity was associated with increased
sympathetic activation and thermogenic ability of the brown adipose tissue in these animals.
There was also a compensatory increase in BMPR1A throughout the hypothalamic regions of the
VMH and ARC after the knockout, highlighting the importance of BMP signaling in regulating
energy balance, given this re-establishment of energy balance after a BMP receptor KO in the
hypothalamus was likely due to neural plasticity in the hypothalamus.

6.3 BMPs and Thermogenesis
The role of BMPs in the process of BAT thermogenesis has been linked to both input from the
CNS as well as local signals and endocrine factors. BAT, a multilocular, highly thermogenic organ
that exhibits high numbers of mitochondria uniquely expressing uncoupling protein 1 (UCP-1) to
produce heat, is controlled by BMP signaling in both development and adult maintenance [167169]. Studies in orexin-null mice showed that BMP-SMAD signaling is required for orexin-directed
brown adipogenic action and thermogenesis [170]. This process of orexin-directed brown
adipogenic action and thermogenesis was dependent on BMPR1A-Smad1/5 signaling in vitro
[170]. It is unclear if the orexin pathways involve the nervous system in activating BAT.
Additionally, BMP8b administered centrally i.c.v. improved global energy balance by increasing
body short-term body temperature and lead to the activation of thermogenic gene expression in
BAT [6]. These improvements were coordinated with sympathetic nerve activation to BAT [6],
similar to the POMC-BMPR1A KO model described above.
Much is known about the role of BMP signaling in non-CNS driven adipose thermogenesis,
including brown adipogenesis, browning of white fat, and activation of mitochondrial activity in
BAT. Neural innervation of adipose tissue also allows for the regulation of lipolysis, adipogenesis,
and browning. Our lab has previously characterized large nerves in the mouse inguinal
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subcutaneous depot and is currently working to identify the possibility of true synaptic connections
within this tissue, as well as characterizing the products that these nerves may be releasing into
adipose depots. Perhaps the nerve-adipose axis may also include local BMP regulation of neural
plasticity within adipose tissues [171-173]. Indeed, BMP8b regulated neuro-vascular remodeling
has been identified and shown to promote synaptic plasticity [174]. In this study, BMP8b, which
is secreted locally by adipose tissues, upregulated local neuregulin-4 expression and enhanced
browning and thermogenic capacity when overexpressed, leading to increased sympathetic
innervation in vivo as well as sympathetic axon growth and branching in vitro. Since BMPs in
adipose tissue development and function have been reviewed elsewhere, we will focus on the
role of BMPs in the central nervous system on the regulation of energy balance.

6.4 BMPs and Obesity
Obesity is a complex disease that involves increased mass of WAT due to energy imbalance,
which can lead to chronic inflammation, peripheral neuropathy, cardiometabolic diseases, and
type 2 diabetes mellitus. In mice, BMPs have been found to play a role in ‘browning’ of WAT,
where WAT changes to more resemble the more energetically favorable BAT with UCP1
expression and thermogenic capacity. This change has also been associated with healthier
adipose phenotypes and weight loss. BMPs also regulate obesity and body weight throughout the
adult human body. The specific ligands involved in body weight and obesity include BMP2, BMP3,
BMP3b, BMP4, BMP7, BMP8B, and BMP14 (Reviewed in [175]), but it is unclear if more than
BMP7 and BMP8B have actions in the brain. BMP2 and BMP4 expression are increased in
overweight and obese individuals [176, 177]. BMP2 and BMP4 can form heterodimers with BMP7
[178], but it is unknown if they synergize to impact energy balance. Importantly, due to the fact
that BMP heterodimers exhibit magnified effects compared to their homodimers in inducing
osteoblastogenesis and bone formation, it is possible that BMP2/7 and BMP4/7 heterodimers
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could more potently mediate browning and be used as a potential therapy to boost energy
expenditure in obese individuals [179].
BMP3b, which is increased during obesity in mouse mesenteric adipose tissue [180], protects
against HFD-induced obesity when overexpressed in adipose tissues [181]. BMP2 and BMP4
enhance white adipogenesis [182, 183], while BMP7 causes differentiation of brown
preadipocytes and commits mesenchymal progenitor cells to a brown adipocyte lineage [169].
BMP7 treatment also increased BAT weight and BAT Ucp1 expression at the subthermoneutral
temperature of 21°C in C57BL6/J mice [184]. This treatment was associated with decreased WAT
mass and upregulation of intracellular lipolysis genes, followed by browning of WAT [184].
However, except for browning, these effects were only seen at 21°C, as housing at 28°C reduced
these effects [184]. BMP7 KO eliminated brown fat and UCP-1 expression in embryos [169].
Moreover, growth of E9 rat embryo mesoderm within the BMP7-rich kidney capsule resulted in
differentiation into brown fat [185]. These results implicate sympathetic activation of BAT as a
requirement for BMP7 to induce browning and improved metabolic health. Intriguingly, BMPR1A
KO of POMC neurons in the hypothalamus leads to sympathetic activity of BAT, resulting obesity
resistance via increased energy expenditure, thermogenesis, and browning of WAT in adult mice,
highlighting the importance of BMPs in the central regulation of obesity [9].
The role of BMPs and their association with the obesity-related factors leptin and insulin have
also been studied extensively in adipose. While the relationship between BMPs and insulin within
the brain have not been studied, it is understood that insulin acts centrally by regulating POMC+
neuron activity within the hypothalamus [186]. As BMPR1A activity in POMC neurons affects
whole-body energy balance and metabolism, there is a chance that there is an insulin-BMP axis
in the CNS. Outside of the CNS, BMP-SMAD signaling enhances insulin-mediated glucose uptake
in both insulin-sensitive and insulin-insensitive adipocytes [187]. Additionally, plasma insulin
levels were elevated in BMP6-treated leptin-resistant ob/ob mice [188].
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Recent evidence

indicates that insulin resistance can be induced after loss of the bone morphogenetic proteinbinding endothelial regulator (BMPER), which adapts endothelial cells to inflammatory stress
[189]. Inducible KO of BMPER in endothelial cells or globally led to increased insulin levels,
glucose intolerance, and insulin resistance [189]. Fitting with this, in assessments of metabolic
syndrome patients, circulating levels of BMP9 reduced progressively with an increasing number
of metabolic syndrome components, and BMP9 was specifically negatively associated with fasting
blood glucose, the hemoglobin subunit alpha Hba1c, and a 2-hour oral glucose tolerance test –
all signs of insulin resistance [190]. Loss of BMP3b also leads to metabolic syndrome and
increased adipogenesis [191].
The relationship between leptin and BMP signaling is more completely understood. When
administered systemically, BMP7 was found to act independent of leptin, as decreased food
intake and weight loss in response to BMP7 were observed in both diet-induced obesity and ob/ob
animals [10]. C57BL/6 and ob/ob mice administered BMP7 centrally via i.c.v. reduced food intake
[10]. Central BMP7 treatment also induced c-Fos and alpha-melanocyte stimulating hormone (αMSH) expression and downregulated expression of NPY and AgRP in the ARC, supporting the
central mechanism of BMP7 appetite suppression. Knockdown of BMPRII via i.c.v. lentivirus
inhibited the anorexigenic effects of BMP7. [10]. The leptin-BMP axis can be seen in the brain, as
leptin-treated ARH explants show increased neurite outgrowth, which decreases to normal levels
with Noggin administration [192]. Leptin treatment of control vs. BMPR1A KO ARH explants also
showed that BMP signaling is essential for neurite outgrowth in the hypothalamus [192]. Leptin
injection induced pSMAD1/5/8 activation in AgRP+ neurons in postnatal mice in vivo [193].
Additionally, BMP8b and leptin both have been found to act on the VMH of the hypothalamus to
induce SNS-directed BAT thermogenesis [194]. Overall, BMPs act to improve metabolic health
via both systemic and central pathways. Although there appear to be BMP-leptin interactions
within the hypothalamus, the ability of certain BMPs to bypass leptin signaling to regulate food
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intake and weight loss indicates that BMPs may serve as a potential therapeutic for leptinresistant obese patients. Currently, however, these pathways and their relationship to known
metabolic pathways requires further investigation.

Figure A2. BMPs affect both arms of energy balance through actions in the nervous
system. A) BMP administered i.c.v. led to decreased food intake and increased thermogenesis
in obese adult mice via a leptin-independent pathway [10]. B) Systemic viral BMP7
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overexpression reduced appetite while increasing thermogenesis and energy expenditure in
metabolic cages [10]. C) BMPR1A KO in POMC neurons in mice fed HFD increased sympathetic
activity of BAT and resulted in increased appetite, thermogenesis, and energy expenditure in
metabolic cages, as well as a lack of obesity and browning. Here, these improvements may have
resulted from a compensatory increase in BMPR1A expression [9]. D) BMP8b KO mice are
metabolically unhealthy and show increased weight gain with reduced energy expenditure,
thermogenesis, and appetite [6]. E) In contrast, i.c.v. treatment with BMP8b resulted in increased
sympathetic activity, thermogenesis, and energy expenditure, indicating improved metabolic
health [6].
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Summary
The ability to permanently mark stem cells and their progeny with a fluorophore using an
inducible transgenic lineage tracing mouse line allows for spatial and temporal analysis of
activation, proliferation, migration, and/or differentiation in vivo. Lineage tracing can reveal novel
information about lineage commitment, response to intervention(s), and multipotency.

Abstract
A telomerase reverse transcriptase (Tert) lineage-tracing mouse line was developed to investigate
the behavior and fate of adult tissue stem cells, by crossing the ‘Tet-On’ system oTet-Cre mouse
with a novel reverse tetracycline transactivator (rtTA) transgene linked to the Tert promoter [287].
This is one example of a transgenic mouse approach to lineage tracing adult brain stem cells.
When a tetracycline derivative, doxycycline, is administered to the mouse this indelibly marks a
population of cells that express a 4.4kb fragment of the promoter region of the gene Tert, which
we have demonstrated to mark a novel population of adult brain stem cells. When using the
Rosa-mTmG reporter mated to the mTert-rtTA::oTet-Cre double-positive mice, expression of
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membrane tdTomato (mTomato) is replaced with membrane EGFP (mGFP) in cells that also
express the rtTA, upon induction with doxycycline. The triple-transgenic mTert-rtTA::oTetCre::Rosa-mTmG mice are given doxycycline (the “pulse” period during which TERT expressing
cells are marked), followed by observation of the indelibly marked mGFP+ cells that can be
tracked for any desirable amount of time after doxycycline removal (the “chase” period), even if
Tert expression is subsequently lost. Brains are then perfusion-fixed and processed for
immunofluorescence and other downstream applications, in order to interpret changes to stem
cell activation, proliferation, lineage commitment, migration to various brain niches, and
differentiation to mature cell types. Using this system, any rtTA mouse can be mated to oTet-Cre
and a Rosa reporter to conduct doxycycline-inducible “pulse-chase” lineage tracing experiments
using markers of stem cells.

Introduction
Value of a lineage tracing mouse line
Analysis of stem cells in vivo can be difficult since many assays that examine such cells
only focus on characterizing these cells at the time of death of the animal, which represents a
terminal snapshot in time. To better understand the processes of proliferation, differentiation, and
migration of progenitor, intermediate/transition cell types, and mature cells over time, a
longitudinal analysis approach is required. This can be achieved with lineage tracing studies
whereby stem/progenitor cells are marked indelibly and can be followed for any length of time
after this.
In the adult mammalian brain, the process of neurogenesis by which adult-born neurons
are created from stem and progenitor cells was first analyzed via label retention with thymidineH3 [4, 5, 543] or 5-bromo-2’-deoxyuridine (BrdU) [10, 11, 40, 544]. In these studies, proliferative
cells were marked with the thymine analog, which was incorporated into the cells’ DNA during
replication and cell division/proliferation. The marked cell, as well as their progeny, therefore
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contained this analog, which were then identified post-mortem. However, while thymidine-H3 and
BrdU allowed for the marking of proliferative cells and their progeny in brain regions where stem
cells were poorly understood, these studies were hindered by the downsides of these tools.
Thymidine-H3 induces cell-cycle arrest, apoptosis, and dose-dependent DNA synthesis inhibition
[12], while BrdU marks cells at varying levels depending on the route of administration [13] and is
taken up by cells during repair or apoptosis, as well as during cell division [14]. More efficient
labeling methods have been utilized recently, such as labeling with 5-ethynyl-2’-deoxyuridine
(EdU), but many of the same issues as BrdU still remain [15]. These approaches are also limiting
in that they mark any proliferative cell, not just stem cells, and thus interpretation of results can
be confounded. In the neurogenic lineage, all stem and progenitor cells retain mitotic capacity,
and only terminal/mature neurons are not proliferative. For astrocytes and microglia, but not
oligodendrocytes, proliferation is maintained indefinitely [545-547].
Transgenic mice used to lineage trace only cells that express a protein of interest, such
as one confirmed to identify adult stem cells as we use here, have therefore become more
common when investigating stem cells and their progeny. While difficult to generate through
mouse transgenic approaches, lineage-tracing mouse lines allow for the tracing of specifically
marked cells in the brain, and do not rely on proliferation alone. In Tet-On transgenic mouse
system, administration of tetracycline or doxycycline (a tetracycline derivative) induces Crerecombinase expression in cells that have been engineered with a reverse tetracycline
transactivator (rtTA), which is transcribed by a promoter of interest. The Tet-inducible Cre-driven
recombination will then activate the expression of an indelible fluorescent or luminescent protein
in the cells of interest, depending on the Rosa-reporter mouse employed. These indelibly marked
cells continue to express this reporter after division, differentiation, or migration, allowing the
tracking of these cells and their progeny over time or after different interventions [548].
Advantages of transgenic lineage-tracing approaches include: 1) specificity of tracing to a
particular cell lineage or progenitor/stem cell marked by the rtTA, 2) indelible expression of the
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fluorescent or luminescent protein despite cell turnover or differentiation, 3) low toxicity, 4)
conditional activation during any point in the animal’s life cycle, and 5) ease of use with common
assays, including immunostaining/immunofluorescence [548].
Other methods of temporally inducible reporter tools in mice include the use of Cre-ERT2
mice, which can be paired with ROSA-GFP, ROSA-mTmG, or other fluorescent reporter
transgenes. In these animals, a cell-specific regulatory element, such as a promoter or enhancer
region of interest, drives the production of Cre recombinase, which can only be activated via the
administration of tamoxifen. While Cre-ERT2 mouse lines allow for the induction of Cre in specific
cell lines, there is a wealth of knowledge detailing the effects of tamoxifen on adult neurogenesis
[549, 550]. Additionally, there exist many ROSA-driven fluorescent reporter genes that can be
utilized instead of GFP or mTmG, including YFP or CFP, which would allow for alternate
fluorescent labeling in other fluorescent wavelengths. These fluorescent reporter genes can be
used with Tet-On or Cre-ERT2 systems.
Telomerase reverse transcriptase (TERT) is the rate-limiting component of the
holoenzyme telomerase, which works to extend telomeres after they are shortened during cell
division [258, 259]. TERT has been identified as a marker of adult tissue stem cells in the intestine
[284, 285], bone marrow [284], liver [286], adipose [551], endometrium [283, 344] and bone [287].
Whether TERT expression in these adult stem cells is solely for telomerase-extending activity or
to perform non-canonical TERT roles [313] is still unknown. TERT-expressing quiescent adult
stem cells (qASCs) have been identified and traced throughout the body with transgenic lineage
tracing mice to study the multipotency and self-renewal ability of these stem cells, as well as their
potential to activate, proliferate, differentiate, and migrate [285-288]. The creation of the Tert-rtTA
transgene has been performed previously [287]. In this paper, we will describe the use of a lineage
tracing TERT mouse line to study TERT+ qASCs which we have identified as a novel ASC
population in the adult mouse brain.
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Generation of a transgenic lineage tracing mouse line
To generate a lineage-tracing mouse line using the Tet-On system, three transgenes must
be combined within a single animal through mouse mating. The first is a rtTA, expressed under
the control of the promoter of the gene of interest (ours is TERT-rtTA). In a cell that expresses
this gene of interest, the rtTA will therefore be expressed. The second is an oTet-Cre gene, which
contains a tetracycline response element (TRE) that will allow for the transcription of Cre
recombinase in the presence of both a rtTA fusion transcript and tetracycline or doxycycline.
Tetracycline or doxycycline can be administered to an animal via drinking water or chow
[552]. Finally, there must be a gene that will be activated by Cre recombinase cleavage. In this
manuscript, the labeling gene we will describe is the Rosa26-mTmG gene, which until Cre
recombination will ubiquitously transcribe mTomato (membrane red fluorescence in all cells).
However, if a cell expresses the rtTA transcript and contains tetracycline or doxycycline, Cre
recombination of a set of lox P sites between the mTomato and mGFP sites will change the R26
site and cause the cell to produce membrane EGFP (mGFP, or membrane green fluorescence)
instead of membrane tomato. The indelible nature of this mGFP signal will allow for in vivo labeling
and tracing of cells as they proliferate, migrate, and differentiate. Following the trace, cells can be
analyzed for expression of GFP via immunofluorescence in standard cryosections or thicker
optically cleared brains.
In this paper, we will describe the use of the specific mouse line, mTert-rtTA::oTet-Cre::RosamTmG. To create this triple transgenic mouse line, we first mated oTet-Cre animals (The
Jackson Lab strain #006234) to Rosa-mTmG animals (The Jackson Lab strain #007676) to
create oTet-Cre::Rosa-mTmG double transgenic mice. These animals were genotyped with
primers and PCR templates indicated in Supplementary Tables 1-2. mTert-rtTA mice (created
by David Breault [287]) were mated to oTet-Cre::Rosa-mTmG animals to create mTertrtTA::oTet-Cre::Rosa-mTmG mice (Figure A3A) [287, 553]. The mechanism of action of the
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mTert-rtTA::oTet-Cre::Rosa-mTmG mouse line is illustrated in Figure A3B.
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Figure A3. Generation of a Tet-On mouse line.
A) Outline of the breeding scheme for the creation of mTert-rtTA::oTet-Cre::Rosa-mTmG mice
from individual mouse lines.
B) Schematic of the Tet-On system in the mTert-rtTA::oTet-Cre::Rosa-mTmG mouse line.
C-D) Representative images of ear clips imaged with FITC channel of an epifluorescent
microscope from non-germline (C) and germline (D) mTert-rtTA::oTet-Cre::Rosa-mTmG mice.

Doxycycline induction and pulse-chase design
When planning experiments, it is important to consider several factors that will affect the
outcome of lineage tracing experiments, including the age of the animal at doxycycline induction,
the length of doxycycline administration (the “pulse” period), the length of time after doxycycline
removal before tissue collection (the “chase” period), and the timing of any interventions during
these processes. These study design considerations are essential for understanding the labeled
cells and their progeny at the conclusion of the experiment. The first step in the process is to
identify the age of interest of the animal and the length of the doxycycline administration. Longer
pulse periods will allow for the potential for more cells to express the rtTA-linked promoter to be
expressed and more cells of interest to be indelibly marked. A cell type that exhibits transient
expression of the gene of interest may require a longer pulse period than cells that continuously
express the gene of interest. However, if the goal of the study is to understand short-term effects
of the cell of interest or an acute intervention, the pulse period cannot be too long, as once a cell
is marked, it will be traced through any number of changes during the remainder of the pulse
period. In some of our studies, a 2-day pulse with no chase period was used to more closely
mimic a direct-reporter for TERT. This is because the minimum length of time for recombination
of the Rosa-mTmG gene is 2 days [359].
The next essential period in a pulse-chase experiment is the length between removal of
doxycycline and perfusion of the animal, also known as the ‘chase’. The half-life of doxycycline in
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mice is approximately 170 minutes regardless of administration route, allowing for the conclusion
that doxycycline induction is likely no longer occurring several hours after removal [554]. However,
it is important to note that doxycycline metabolism is slowed in aged mice, which may lead to
longer effective ‘pulse’ periods than young animals [555].
During the chase period, labeled cells will continue to be labeled, even after proliferation,
differentiation, or migration. The progeny of these cells will also be labeled. The goal of the study
will shape the length of the pulse-chase paradigm. Perhaps the goal of the study is to understand
the regeneration of a tissue over a long period of time with the cells of interest. In this case, a long
chase period may be required. Finally, the timing of any interventions or treatments must be
decided. Administration during the pulse period will affect the cells expressing the gene of interest
as well as any progeny created during this time, whereas administration during the chase period
may affect mostly progeny of the cells of interest, although this will depend on how quickly the
labeled cells divide or differentiate. Examples of pulse-chase experimental designs we have
utilized are outlined in Figure A4A.
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Figure A4. Experimental designs with lineage tracing Tet-On mice.
A) Illustrations of experiments possible with Tet-On mice from basal proliferation, migration, and
differentiation (1) to treatments during dox pulse with no chase for regeneration or re-equilibration
(2), interventions during pulse with an opportunity to visualize long-term effects (3). A short pulse
of 2 days with no subsequent chase will provide insight into a near-basal state of TERT+ cells, as
these cells will have little time to activate, proliferate, migrate, or differentiate (4).

It is also important to be aware of the possibility of background GFP signal due to leaky
expression. Leaky expression occurs as a result of inherent binding potential between rtTA and
the Otet sequences in the absence of doxycycline, and residual activity of the Otet transgene in
the absence of rtTA (reviewed in [556]). Leaky expression represents one weakness of the Tet
systems, and although the leak is often an acceptable downside to the system, situations where
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the leaky expression can lead to toxicity and mortality, such as with diptheria toxin (DTA) in OtetDTA animals can limit the use of these systems [557].

Brain processing, sectioning, and immunofluorescence of thin sections for microscopy
To analyze the brains of mice after a lineage tracing experiment, mice must first be
perfused via transcardial perfusion to remove blood and CSF that can lead to high
autofluorescence in the brain. There are two commonly used fixatives that the animal may be
perfused with; Histochoice Tissue Fixative, a glyoxal fixative (GF) or 4% paraformaldehyde (PFA).
Glyoxal fixatives allow for a relatively gentle fixation process with less cross-linking than PFA.
This reduces tissue stiffness, reduces the need for antigen retrieval, and allows for less
concentrated antibody solutions during immunostaining. However, if they contain methanol this
may serve to increase autofluorescence [558]. On the other hand, PFA will often allow for a more
robust fixation and while antigen retrieval will be required during immunostaining, there are
antibodies that will only work with PFA-fixed tissues, and perfusion with 4% PFA is required for
the optical clearing technique described later.
Following perfusion is a post-fixation step, in which brains are immersed in the same type
of fixative utilized during the perfusion overnight. This allows for any brain regions that may not
have been fully fixed during the perfusion to continue to fix. Next, brains will be incubated in
sucrose in phosphate buffered saline (PBS) to remove as much water as possible before the
freezing step to prevent ice formation within the tissue (“cryo-preservation”). Brains may then be
cut into any number of sagittal, coronal, or transverse tissue sections for processing. For both
precision and reproducibility, calibrated brain blocks need to be used in a way that ensures
consistent bregma cuts between animals. The most important factor that can affect how brains
are sectioned is the brain region(s) of interest. For example, while a sagittal cut may allow for
more brain regions to be analyzed in one tissue section, this cut will not allow analysis of
neuro/gliogenic regions of the ventricular-subventricular zone (V-SVZ) as the lateral and medial
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sides of the lateral ventricle will be impossible to discern in that dimension and are better observed
in the coronal plane. This can be an important distinction to make in adult neurogenesis studies,
as the lateral side of the lateral ventricle contains the neurogenic V-SVZ, while the medial wall of
the lateral ventricle is a more gliogenic niche [93].
After tissues have been divided into coronal, sagittal, or transverse sections, they will be
frozen into blocks using Optimal Cooling Temperature (OCT) embedding solution. Here, brains
are frozen within this embedding material, with the use of a mixture of dry ice and ethanol. If thin
section analysis is required, blocks will be sliced on a cryostat and depending on the downstream
analysis required can be adhered to positively charged glass slides as thin sections (<20µm).
Glass slides that are not charged can also be used, but the use of uncharged slides may result in
tissues becoming unstuck from the slides [559]. If medium-thickness free-floating tissue sections
(>20µm) are required, tissues will be collected as free-floating sections. If thick sections (0.54mm) are required, slicing non-frozen brain sections with a vibratome is required. It is important
to note the storage differences between sections on slides, which require freezing at -20 to -80
degrees Celsius and free-floating sections, which will be stored at 4 degrees Celsius.

Protocol

1.

Creation of a lineage tracing Tet-On mouse line, breeding strategies, and genotyping for

experimental cohort mice - Here, we outline creation of Tet-On mouse system with Rosa-mTmG
as the fluorescent reporter gene that undergoes Cre recombination, however various other Crerecombination-driven reporter lines can be utilized with the Tet-On system as well.
1.1.

Set up a mating cage of 1 oTet-Cre (+/-) male with 1 or more R26(mTmG) (+/+) females.

See Figure 3 for an overview of the experimental mouse mating setup.
1.2.

Resulting pups (F1) will be oTet-Cre (+/-) or oTet-Cre (-/-) and R26(mTmG) (+/-). Perform

genotyping according to the primers in Supplemental Table 1 and protocols in Supplementary
Table 2.
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1.3.

At weaning, perform germline testing by taking an ear punch from each weanling. Examine

the ear punch under an epifluorescent microscope in the GFP/FITC spectrum to determine
whether the animal had undergone germline recombination in development. If so, the animal will
express GFP in every cell, and the ear punch will fluoresce with mGFP signal. These animals
cannot be used for matings or experiments.
1.3.1. NOTE: Ear clips from mice that are not germline show only endogenous fluorescence
under the microscope (Figure A3C), while germline animals show a bright GFP signal (Figure
A3D). Control ears can be from mice that do not contain fluorescent transgenes. As a note, ear
hairs have high endogenous fluorescence and must not be used as a determining factor (Figure
A3C). Additionally, differences in endogenous fluorescence are observed between mice of white
vs. black coat color, and controls from mice of the same coat color as mice being tested will need
to be used in this analysis.
1.4.

Mate 1 male oTet-Cre (+/-) x R26(mTmG) (+/-) with 1 or more female oTet-Cre (-/-) x

R26(mTmG) mice.
1.5.

The resulting generation (F2) will be ¼ R26(mTmG) (+/+) and ½ Cre (+/-). These animals

will then be crossed with mTert-rtTA (+/+) animals by mating 1 oTet-Cre (+/-) x R26(mTmG) (+/+)
with 1 or more mTert-rtTA (+/+) animals.
1.5.1. Note: We used mTert-rtTA (+/+) animals, but this process can be performed with any rtTA
mouse line [553].
1.6.

For experimental animals, set up breedings to generate mTert-rtTA (+/+) or (+/-) x oTet-

Cre (+/-) x R26(mTmG) (+/+) or (+/-).
2.

Doxycycline induction of Cre and pulse-chase design

2.1.

When animals are at the correct age for the study to begin, replace their drinking water

with dox water: drinking water containing 5% sucrose and 2mg/ml doxycycline hyclate. Crenegative animals that receive the same doxycycline pulse-chase as experimental animals will be
used as a control group for the resulting fluorescent expression patterns.
2.1.1. NOTE: After preparation, dox water must be stored at 4°C for up to 1 month. See Solution
Composition Table for more information. Dox water may be administered to animals in drinking
bottles for up to 5 days before being changed out, as fungal growth can occur if dox water is left
out at room temperature for longer periods of time.
2.1.2. NOTE: A doxycycline pulse of at least 2 days is required for induction of mGFP signal
when utilizing the mTmG transgene (initial mTmG paper).
2.1.3. NOTE: We have not tested doxycycline concentrations other than 2mg/ml. Previous
literature has identified that this concentration has the highest effects when administered through
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drinking water [552]. The amount of doxycycline delivered may differ depending on the amount of
drinking done by each animal. Doxycycline injection or gavage may also be done in order to be
consistent between animals [560].
2.2.

After the pulse period has ended, dox water is to be removed from the cages and replaced

with normal drinking water. The animals will now be in the ‘chase’ period until death.
3.

Transcardial perfusion and brain dissection

3.1.

Remove a mouse from its cage and restrain the animal using your left thumb and

forefinger. Inject the animal via intraperitoneal (i.p.) injection with a solution of 100mg/ml ketamine
and 20mg/ml Xylazine in 0.9% sterile saline for a final concentration of 200 mg/kg ketamine and
20 mg/kg xylazine. See Solution Composition Table for more information.
3.2.

Caution: The protocols for anesthesia may differ depending on the country. Additionally,

there are effects of anesthetics on the brain including changes in microglial morphology and action
and corticosterone levels that must be understood when performing perfusions for the purpose of
brain collection and analysis [561, 562].
3.3.

After approximately 1-2 minutes the animal will lose its righting reflex. To test this, simply

roll the animal on its back and if it cannot roll back onto its feet it has lost the righting reflex.
3.4.

After approximately 5-10 minutes the animal will lose its pedal reflex. To check the pedal

reflex, use your thumb and forefinger to pinch each of the animal’s feet. If there is no response,
in the form of a jump or muscle spasm, use the nails of your thumb and forefinger to pinch each
of the animal’s feet. If there is no response, the animal has lost the pedal reflex.
3.4.1. NOTE: If the animal responds to the pedal reflex for greater than 15 minutes after injection,
an additional injection of ½ of the initial ketamine/xylazine injection may be required. Age, sex,
genotype, phenotype, and treatment may affect the response of the animal to this drug cocktail.
3.5.

After the righting and pedal reflexes are lost, test the ocular reflex by lightly contacting the

mouse eyeball with a gloved finger. A lack of response indicates that the ocular reflex has been
lost.
3.6.

Secure the mouse in a supine position with paws pinned to a pinnable work surface.

3.7.

Make an incision through the skin with surgical scissors along the thoracic midline

approximately 1-2cm below the xiphoid process. Cut superior until at the xiphoid process.
3.8.

Grasp the cartilage of the xiphoid process with forceps. Insert scissors and cut through

the musculature and ribcage diagonally along the mouses right side to the level of the clavicles.
Raise the thoracic musculature with forceps and slice through the diaphragm until you can
visualize the heart. Then make an identical diagonal cut along the mouse’s left side, making sure
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to prevent any contact with the heart. Use a hemostat to keep the thoracic musculature away from
the cavity.
3.8.1. NOTE: At this point, the mouse will not be able to breathe any longer, so work quickly to
prevent death prior to the next steps.
3.9.

Secure the beating heart with blunt forceps and insert a dispensing needle into the left

ventricle through the base of the aortic arch.
3.10.

Clamp the needle base to the left ventricle just above the insertion site.

3.11.

Make an incision in the right atrium, and at the first sign of blood flow, begin perfusing the

animal with 20ml 1X PBS at 8.11 ml/minute.
3.12.

After the 1X PBS has perfused the body, switch to the appropriate fixative for your

downstream application and perfuse the mouse with 20 ml of fixative.
3.12.1. NOTE: For frozen sectioning and immunostaining, perfuse animal with the glyoxal fixative
for brain clearing, perfuse animal with 4% PFA in 1X PBS (pH 7.4).
3.12.2. NOTE: Signs of a successful perfusion include animal stiffness (slight stiffness with
glyoxal, intense stiffness with PFA) and a lack of visible blood vessels throughout the tissues.
3.13.

Decapitate the mouse and remove the brain by inserting scissors into the brainstem and

cutting along the squamosal suture through to the frontomaxillary suture on each side. Then cut
across the fontonasal suture to remove the skull cap, being careful not to damage the olfactory
bulb. From there, turn the skull upside down, and use curve forceps to remove the brain, making
sure to sever the optic nerve.
3.14.

Place the perfused brain in a tissue cartridge and immerse in the fixative used to perfuse

the animal overnight at 4°C.
4.

Brain treatment, slicing, and immunostaining

4.1.

Brain Treatment and Slicing

4.1.1. Remove brain cartridges from the glyoxal fixative and incubate in 15% sucrose in 1X PBS
for 2 days at 4°C or until brains sink.
4.1.2. Remove brain cartridges from 15% sucrose and incubate in 30% sucrose in 1X PBS for 2
days at 4°C or until brains sink.
4.1.2.1.

NOTE: See Solution Composition Table for more information.

4.1.3. Remove brains from 30% sucrose in 1X PBS and separate brain into various ‘blocks’ using
a coronal brain block or sagittal brain block.

255

4.1.4. Embed coronal or sagittal brain sections in OCT compound by placing brain sections on
a mixture of dry ice and ethanol (EtOH). After OCT has turned white and become solid, remove
from dry ice-EtOH mixture and store wrapped in parafilm, inside an air-tight bag at -20°C.
4.1.5. Remove frozen blocks from the freezer and place inside a cryostat with an internal
temperature set to -20°C. Use OCT to attach the block to a metal chuck so that the tissue is solidly
attached. Allow ~5 minutes for the tissue to freeze to the chuck. Slice the tissue at 7um, placing
each tissue slice on a charged glass slide.
4.1.6. Allow for slides to bake overnight at 37°C, then place at -20°C until used for
immunostaining.
4.2.

Immunostaining

4.2.1. Warm slides to room temperature (RT) and post-fix with ice-cold acetone (Fisher
Scientific) for 15 minutes.
4.2.2. Wash slides for 5 minutes in 1X IHC Select TBS Rinse Buffer (rinse buffer) shaking at 60
rpm at RT between each step.
4.2.3. Permeabilize for staining of nuclear antigens with 0.3% Triton X-100 for 10 minutes at RT.
Permeabilize for staining of cytoplasmic antigens with 0.3% Tween-20 for 10 minutes at RT.
4.2.4. Perform antigen retrieval by microwaving slides in 50-100mL 1X DAKO Antigen Retrieval
Solution on low for 10 minutes, twice. Then rinse with rinse buffer 5m at RT.
4.2.5. Incubate slides in 0.3% Typogen Black in 70% EtOH for 20 minutes at RT then wash with
Rinse Buffer.
4.2.6. Block for 20 minutes at 37°C with Millipore Blocking Reagent, and incubate with primary
antibody diluted in antibody diluent overnight at 4°C.
4.2.7. The next day, incubate sections in Alexa Fluor secondary antibodies for 10 minutes at RT,
then wash slides in rinse Buffer.
4.2.8. Cover brain sections in 100uL of 1:500 anti-GFP antibody conjugated to AlexaFluor 488
and incubate overnight at 4°C.
4.2.9. The next day, wash with rinse Buffer 2x, then wash in running DI water for 5 minutes.
4.2.10. Counterstain with 100ng/mL 4′,6-diamidino-2-phenylindole (DAPI) for 5 minutes, then
wash in running DI water for 5 minutes.
4.2.11. Add a drop of mounting medium on top of the tissue and seal with a 22 x 22mm coverslip.
Imaging is recommended on the day of mounting to ensure optimal signal.
5.

iDISCO brain clearing (adapted from [563])

5.1.

Fixation and Sectioning
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5.1.1. Post-fix brains in 4% PFA overnight at 4°C and then again for 1 hour at RT.
5.1.2. Wash brains in 1X PBS for an hour, twice, at RT and then cut into 1mm thick sections
using the necessary brain block and place into 5mL microcentrifuge tubes containing 1X PBS.
5.2.

Methanol Pre-treatment (with methanol)

5.2.1.

NOTE: Due to the possibility of methanol impacting immunostaining of certain proteins,

the authors would like to point the reader to Renier et al., 2014 for a protocol to a methanol free
iDISCO protocol alternative [563]
5.2.2. NOTE: See Solution Composition Table for more information regarding the following
solutions in this section.
5.2.3. Wash with 1X PBS for 1 hour twice (shaking) at RT.
5.2.4. Wash in 50% methanol (Fisher; in PBS) for 1 hour (shaking) at RT.
5.2.5. Wash in 80% methanol for 1 hour (shaking) at RT.
5.2.6. Wash in 100% methanol for 1 hour twice (shaking) at RT.
5.2.7. Bleach samples with 5% hydrogen peroxide (H2O2) in 20% dimethyl sulfoxide
(DMSO)/methanol (1 volume 30%H2O2/1 volume DMSO/4 volume methanol, ice cold) at 4oC
overnight (shaking).
5.2.8. After bleaching, wash samples in methanol for 1 hour twice (shaking) at RT.
5.2.9. Wash in 20% DMSO/methanol for 1 hour twice (shaking) at RT.
5.2.10. Wash in 80% methanol for 1 hour (shaking) at RT.
5.2.11. Wash in 50% methanol for 1 hour (shaking) at RT.
5.2.12. Wash in PBS for 1 hour twice (shaking) at RT.
5.2.13. Wash in PBS/0.2% Triton X-100 for 1 hour twice (shaking) at RT.
5.3.

Immunostaining of clearing brains

5.3.1. Incubate samples in 1X PBS/0.2% Triton X-100 /20% DMSO/0.3M glycine at 37°C
overnight on an orbital shaker.
5.3.2. Block in 1X PBS/0.2% Triton X-100/10% DMSO/6% goat serum at 37°C for 3 days on an
orbital shaker.
5.3.3. Wash samples in 1X PBS/0.2% Tween-20/10 μg/ml heparin sodium salt from porcine
mucosa for 1 hour twice at 37°C and then incubate in 1X PBS/0.2% Tween-20 /10μg/ml heparin
/5% DMSO/ 3% goat serum containing 1:500 concentration of rabbit anti-GFP AlexaFluor 488 at
37°C on an orbital shaker for 2 days.
5.3.4. Wash samples in 1X PBS /0.2% Tween-20 with 10 μg/ml heparin for 1 hour at 37°C on
orbital shaker, 3 times, and then once a day for 2 days.
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5.3.5. Incubate samples overnight in 10mL of 50% v/v Tetrahydrofuran (THF)/H2O in a 15mL
conical tube.
5.3.6. Incubate samples for 1 hour in 10mL of 80% THF/H2O.
5.3.7. Incubate samples twice for 1 hour in 100% THF.
5.3.8. Dry samples with a sterile wipe and incubate in dichloromethane until they sink to the
bottom of the vial (approximately 40min). Do not incubate >60min.
5.3.8.1.

NOTE: Be sure to handle dichloromethane under a fume hood.

5.3.9. Incubate samples in 18mL of Dibenzyl Ether (DBE) until clear (>2hrs)
5.3.10. Store samples in DBE at RT until ready to image.
5.3.10.1.

NOTE: For best results, it is important to image samples as soon as possible after

clearing is complete.

Representative Results
While the fluorescent signal resulting from a Tet-On system with a fluorescent reporter will
vary depending on the promoter of interest and fluorophore(s) used, we will describe how findings
were analyzed with mTert-rtTA::oTet-Cre::Rosa-mTmG animals. Analysis of adult brains after a
pulse-chase resulted in membrane GFP-expressing cells throughout various anatomical niches.
The difference in fluorescent intensity between various cell types must be noted. One variable
regarding fluorescent intensity is the size of the cell membrane. For instance, choroid epithelial
cells (CPECs) in the choroid plexus have a thick cell membrane and strong fluorescent signal that
was easily distinguished from the surrounding cells (Fig. A5A, B). However, other smaller and
currently unidentified cell types in the choroid plexus stroma had a weaker GFP signal (Fig A5C).
In the cerebellum, Bergmann glial cells expressed higher levels of mGFP than basket cells, and
variation in mGFP expression even existed between individual basket cells (Fig A5D). Olfactory
sensory neuron axons within the glomerular layer of the olfactory bulb also expressed high levels
of mGFP (Fig. A5A, E). To ensure that all mGFP+ cells are identified, it is therefore important to
identify both bright and dim GFP+ cells throughout the brains of mTmG animals. In mTert-
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rtTA::oTet-Cre::Rosa-mTmG animals, we observed low background mGFP expression across
brain regions including the cerebral cortex (Fig. A5A). Interestingly, the cerebellum and brainstem
showed lower background mGFP expression in this manner (Fig. A5A).
During analysis of brain tissue after a lineage trace there will be differences in mGFP and
mTomato expression patterns across both brain regions and cell types. Olfactory sensory neuron
axons that fill the glomerular layer of the olfactory bulb expressed high levels of membrane tomato
when compared to most other brain regions, even when the same neurons are mGFP+, indicating
that some cells appeared to lose mTomato signal more slowly (Fig. A5D). In contrast, in the
choroid plexus mGFP+ cells expressed low mTomato (Fig. A5B, C). In most other brain regions
tomato signal is spread evenly between cell types with endothelial cells being some of the only
cells whose fluorescent signal was bright enough to stand out from the red fluorescent
background (Fig. A5B). The activation of mGFP expression and cleavage of mTomato from the
genome during recombination results in a loss of mTomato expression, but the mTomato
fluorophores that are expressed on the membrane are retained until they degrade. For this
reason, mGFP+ cells will often express variable mTomato signal which will depend on the recency
of the recombination, the cell type, and size of the cell membrane. Therefore, it is important to
analyze cells based on the expression of mGFP and to not exclude them from analysis if they
express both mGFP and mTomato.
Alternative reporters may also be utilized in conjunction with the Tet-On system. Cre
recombination may act to induce expression of GFP or RFP in cells that will not normally not
express any fluorescent tag in Rosa-GFP or Rosa-RFP animals. Here, analysis of GFP or RFP
will indicate the expression of the promoter of interest and no fluorophore signal will be removed
such as with mTmG animals. Single-fluorophore reporters allow for immunostaining with more
fluorescent antibody combinations, as the membrane tomato in mTmG animals prevents staining
in the red wavelength.
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Figure A5. Lineage tracing of adult mTert-rtTA::oTet-Cre::Rosa-mTmG mouse brains after
a 3-week pulse and 11-day chase.
A) Cleared brain section of adult mTert-rtTA::oTet-Cre::Rosa-mTmG mouse with specific areas
of mGFP signal shown with insets (N=3 male mice).
B-C) Representative image of mTert-rtTA::oTet-Cre::Rosa-mTmG choroid plexus identifying
mGFP+ CPECs (B) and smaller, fainter mGFP+ cell types (C; N=4 males, N=6 females)
D) Representative image of mTert-rtTA::oTet-Cre::Rosa-mTmG cerebellar Bergmann glia (bright)
and basket cells in the molecular layer of the cerebellum (dim; N=4 males, N=6 females).
E) Representative image of the olfactory glomerular layer of mTert-rtTA::oTet-Cre::Rosa-mTmG
brains. Dotted lines indicate glomerular compartments (N=4 males, N=6 females).
Scale bars are 100µm.

Discussion
A method for the creation, utilization, and analysis of a triple transgenic lineage tracing
mouse line marking stem cells within the adult mouse brain in vivo is described. When combined
with immunostaining or brain clearing, the identification and characterization of traced fluorescent
cells across the brain can be accomplished. This technique offers the ability to understand the
plastic/regenerative/remodeling potential of labeled stem cells as they activate, migrate,
differentiate, or proliferate. While previous data obtained via label retention with thymidineH3 and
BrdU concluded that the V-SVZ, olfactory bulb, and subgranular zone of the dentate gyrus were
the only neurogenic brain regions in adult mammals [4, 5, 10, 11, 40, 543, 544, 564], it is now
understood that adult neurogenesis also occurs in the cortex [73], hypothalamus [58, 565], and
striatum [566-568], as well as potentially other novel niches that have not been well-studied. Adult
gliogenesis, the process by which glial precursor cells create newborn astrocytes and
oligodendrocytes, occurs throughout the brain as well [93], and glia and neurons are hypothesized
to derive from the same multipotent stem cell. For these reasons, lineage tracing studies have
been integral in understanding the role of various stem cell types that contribute to replenishing
and regenerating neurons and glia in the adult mammalian brain (reviewed in [569]).
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For studies in adult brain plasticity, the optimal age is 12 weeks of age, when the murine
brain has completed development [570]. When planning the length of the doxycycline pulse and
subsequent chase, an understanding of the process of interest is crucial, so that the pulse-chase
timing is long enough to allow for the processes of interest to occur. For example, the creation of
newborn neurons in the olfactory bulb from adult neural stem cells (ANSCs) in the V-SVZ is
approximately 4 weeks, as determined by previous lineage tracing studies [340]. A pulse-chase
study that will label the ANSCs in the V-SVZ must therefore be within that timeframe to allow for
the ANSCs in the V-SVZ to divide, for these ANSCs to differentiate into intermediate cell types,
and for these intermediate cell types to migrate to the olfactory bulb and differentiate into adultborn neurons. The length of the chase will determine the amount of time that labeled cells and
their progeny must continue their migration and differentiation, although these processes will
occur during the pulse as well. Taken together it is important to understand the processes
involved, as the timeline of each lineage tracing experiment must allow for the proper processes
to occur.
While this manuscript details the Tet-On system, other lineage tracing transgenes exist
that may be utilized. The CreERT2 transgene allows for the expression of a Cre recombinase that
is only active in the presence of tamoxifen or 4-OHT, a tamoxifen derivative. When this Cre is
regulated by a promoter of interest, 4-OHT or tamoxifen administration will only produce Cre
recombination in cells that express that promoter. When paired with a reporter gene such as
Rosa-LSL-GFP or Rosa-mTmG, Cre-lox recombination will indelibly mark the cells that express
Cre during tamoxifen administration. One downside of this system is the use of tamoxifen, which
has long-lasting adverse effects on neurogenesis in both prenatal and adult brains [549]. For this
reason, lineage tracing studies with CreERT2 lines will need to consider the caveats involved.
Lineage tracing studies in the adult brain are often performed with markers of stem cells
such as Nestin or markers of glial precursor cells including NG2 [571, 572]. While resulting data
indicates the turnover and differentiation of these cells into newborn mature cell types, the
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expression of these markers by various other cell types in the adult brain can be confounding.
For example, Nestin, an intermediate filament protein involved in mitosis [573] is also expressed
by mature neurons [574] and meningeal cell types [154]. Other stem cell markers include glial
fibrillary acidic protein (GFAP) [18, 19], and glutamate aspartate transporter 1 (GLAST) [575] are
also expressed by astrocytes throughout the adult brain [576]. For this reason, lineage tracing
studies with additional markers are needed. As we learn more about the broad impact of adult
plasticity in the brain, the characterization and analysis of the cells that play a role in these
processes and their progeny remain vitally important to our understanding of neurogenic and
gliogenic pathways involved in neurodegenerative health and more.
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